Protein IDs;Majority protein IDs;Protein names;Gene names;Fasta headers;Peptides;Unique peptides;Sequence coverage [%]
Q86V21;Q86V21;Acetoacetyl-CoA synthetase;AACS;>AACS_HUMAN|Q86V21|Acetoacetyl-CoA synthetase (6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog);4;4;4,9
"Q2M2I8;Q9NSY1";Q2M2I8;AP2-associated protein kinase 1;AAK1;>AAK1_HUMAN|Q2M2I8|AP2-associated protein kinase 1 (2.7.11.1) (Adaptor-associated kinase 1);3;3;4
P49588;P49588;Alanine--tRNA ligase, cytoplasmic;AARS;>SYAC_HUMAN|P49588|Alanine--tRNA  ligase,  cytoplasmic  (6.1.1.7  ) (Alanyl-tRNA synthetase ) (AlaRS ) (Renal carcinoma antigen NY-REN-42);28;28;37,3
Q9NRN7;Q9NRN7;L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase;AASDHPPT;>ADPPT_HUMAN|Q9NRN7|L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (2.7.8.-) (4-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog);4;4;13,3
"P08183;P21439";P08183;Multidrug resistance protein 1;ABCB1;>MDR1_HUMAN|P08183|Multidrug resistance protein 1 (3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD243);44;43;35,8
P61221;P61221;ATP-binding cassette sub-family E member 1;ABCE1;>ABCE1_HUMAN|P61221|ATP-binding cassette sub-family E member 1 (2-5-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I);3;3;5,5
Q9NUQ8;Q9NUQ8;ATP-binding cassette sub-family F member 3;ABCF3;>ABCF3_HUMAN|Q9NUQ8|ATP-binding cassette sub-family F member 3;3;3;4,5
Q96IU4;Q96IU4;Alpha/beta hydrolase domain-containing protein 14B;ABHD14B;>ABHEB_HUMAN|Q96IU4|Protein ABHD14B  (3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B ) (Abhydrolase domain-containing protein 14B ) (CCG1-interacting factor B);9;9;51
Q5VST6;Q5VST6;Alpha/beta hydrolase domain-containing protein 17B;ABHD17B;>AB17B_HUMAN|Q5VST6|Protein ABHD17B  (3.-.-.-) (Alpha/beta hydrolase domain-containing protein 17B ) (Abhydrolase domain-containing protein 17B ) (Precursor);4;4;17
Q6PCB6;Q6PCB6;Alpha/beta hydrolase domain-containing protein 17C;ABHD17C;>AB17C_HUMAN|Q6PCB6|Protein ABHD17C  (3.-.-.-) (Alpha/beta hydrolase domain-containing protein 17C ) (Abhydrolase domain-containing protein 17C );6;6;24,6
Q8IZP0;Q8IZP0;Abl interactor 1;ABI1;>ABI1_HUMAN|Q8IZP0|Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1);11;8;25,6
Q9NYB9;Q9NYB9;Abl interactor 2;ABI2;>ABI2_HUMAN|Q9NYB9|Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1);6;3;15,8
Q9P1F3;Q9P1F3;Costars family protein ABRACL;ABRACL;>ABRAL_HUMAN|Q9P1F3|Costars family protein ABRACL (ABRA C-terminal-like protein);3;3;46,9
Q9BWD1;Q9BWD1;Acetyl-CoA acetyltransferase, cytosolic;ACAT2;>THIC_HUMAN|Q9BWD1|Acetyl-CoA  acetyltransferase,  cytosolic (2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase);13;13;35,8
P12821;P12821;"Angiotensin-converting enzyme;Angiotensin-converting enzyme, soluble form";ACE;>ACE_HUMAN|P12821|Angiotensin-converting enzyme (ACE) (3.2.1.-) (3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD143) (Angiotensin-converting  enzyme,  soluble form) (Precursor);33;33;28,5
Q9BYF1;Q9BYF1;"Angiotensin-converting enzyme 2;Processed angiotensin-converting enzyme 2";ACE2;>ACE2_HUMAN|Q9BYF1|Angiotensin-converting enzyme 2 (3.4.17.23) (ACE-related carboxypeptidase) (Angiotensin-converting enzyme homolog) (ACEH) (Metalloprotease MPROT15) (Processed angiotensin-converting enzyme 2) (Precursor);13;13;20,4
P53396;P53396;ATP-citrate synthase;ACLY;>ACLY_HUMAN|P53396|ATP-citrate synthase (2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme);39;39;41,1
"P21399;O00408";P21399;Cytoplasmic aconitate hydratase;ACO1;>ACOC_HUMAN|P21399|Cytoplasmic aconitate hydratase (Aconitase) (4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1);29;29;35,4
"Q86TX2;P49753";"Q86TX2;P49753";"Acyl-coenzyme A thioesterase 1;Acyl-coenzyme A thioesterase 2, mitochondrial";ACOT1;">ACOT1_HUMAN|Q86TX2|Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (3.1.2.2) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase);>ACOT2_HUMAN|P49753|";4;4;9
P24666;P24666;Low molecular weight phosphotyrosine protein phosphatase;ACP1;>PPAC_HUMAN|P24666|Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (3.1.3.2) (Red cell acid phosphatase 1);4;4;32,9
P11117;P11117;Lysosomal acid phosphatase;ACP2;>PPAL_HUMAN|P11117|Lysosomal acid phosphatase (LAP) (3.1.3.2) (Precursor);8;8;16,5
P15309;P15309;"Prostatic acid phosphatase;PAPf39";ACPP;>PPAP_HUMAN|P15309|Prostatic acid phosphatase (PAP) (3.1.3.2) (5-nucleotidase) (5-NT) (3.1.3.5) (Ecto-5-nucleotidase) (Thiamine monophosphatase) (TMPase) (PAPf39) (Precursor);23;23;43,3
"O60488;O95573";O60488;Long-chain-fatty-acid--CoA ligase 4;ACSL4;>ACSL4_HUMAN|O60488|Long-chain-fatty-acid--CoA ligase 4 (6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4);11;11;19,4
Q9NR19;Q9NR19;Acetyl-coenzyme A synthetase, cytoplasmic;ACSS2;>ACSA_HUMAN|Q9NR19|Acetyl-coenzyme A  synthetase,  cytoplasmic (6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme);3;3;4,1
"P63261;Q6S8J3;A5A3E0;P0CG38;P0CG39;Q9BYX7";P63261;"Actin, cytoplasmic 2;Actin, cytoplasmic 2, N-terminally processed";ACTG1;>ACTG_HUMAN|P63261| Actin,  cytoplasmic 2 (Gamma-actin)  (Actin,  cytoplasmic  2,  N-terminally processed);26;1;74,7
"P12814;P35609";P12814;Alpha-actinin-1;ACTN1;>ACTN1_HUMAN|P12814|Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1);32;16;42,6
"O43707;Q08043";O43707;Alpha-actinin-4;ACTN4;>ACTN4_HUMAN|O43707|Alpha-actinin-4  (Non-muscle alpha-actinin 4 );45;27;58
P61163;P61163;Alpha-centractin;ACTR1A;>ACTZ_HUMAN|P61163|Alpha-centractin (Centractin) (ARP1) (Actin-RPV) (Centrosome-associated actin homolog);7;3;19,9
P61160;P61160;Actin-related protein 2;ACTR2;>ARP2_HUMAN|P61160|Actin-related protein 2 (Actin-like protein 2);9;9;28,7
"P61158;Q9P1U1;Q9C0K3";P61158;Actin-related protein 3;ACTR3;>ARP3_HUMAN|P61158|Actin-related protein 3 (Actin-like protein 3);14;14;38
Q03154;Q03154;Aminoacylase-1;ACY1;>ACY1_HUMAN|Q03154|Aminoacylase-1 (ACY-1) (3.5.1.14) (N-acyl-L-amino-acid amidohydrolase);21;21;52,7
O14672;O14672;Disintegrin and metalloproteinase domain-containing protein 10;ADAM10;>ADA10_HUMAN|O14672|Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD156c) (Precursor);11;11;19,7
Q13443;Q13443;Disintegrin and metalloproteinase domain-containing protein 9;ADAM9;>ADAM9_HUMAN|Q13443|Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase) (Precursor);12;12;16,4
"Q9UHI8;Q8TE58";Q9UHI8;A disintegrin and metalloproteinase with thrombospondin motifs 1;ADAMTS1;>ATS1_HUMAN|Q9UHI8|A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (3.4.24.-) (METH-1) (Precursor);12;12;19,3
P11766;P11766;Alcohol dehydrogenase class-3;ADH5;>ADHX_HUMAN|P11766|Alcohol dehydrogenase class-3 (1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (1.1.1.-) (S-(hydroxym;12;12;34,8
Q9BV57;Q9BV57;1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase;ADI1;>MTND_HUMAN|Q9BV57| 1,2-dihydroxy-3-keto-5-methylthiopentene  dioxygenase  (1.13.11.54 ) (Acireductone dioxygenase (Fe(2+)-requiring) ) (ARD ) (Fe-ARD ) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1 ) (MTCBP-1 ) (Submergence-;2;2;11,2
Q15847;Q15847;Adipogenesis regulatory factor;ADIRF;>ADIRF_HUMAN|Q15847|Adipogenesis regulatory factor (Adipogenesis factor rich in obesity) (Adipose most abundant gene transcript 2 protein) (Adipose-specific protein 2) (apM-2);4;4;39,5
P55263;P55263;Adenosine kinase;ADK;>ADK_HUMAN|P55263|Adenosine kinase (AK) (2.7.1.20) (Adenosine 5-phosphotransferase);3;3;14,4
"P25098;P35626";P25098;Beta-adrenergic receptor kinase 1;ADRBK1;>ARBK1_HUMAN|P25098|Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (2.7.11.15) (G-protein coupled receptor kinase 2 );4;4;4,9
P30566;P30566;Adenylosuccinate lyase;ADSL;>PUR8_HUMAN|P30566|Adenylosuccinate lyase  (ADSL ) (ASL) (4.3.2.2  ) (Adenylosuccinase ) (ASase);4;4;10,3
"P30520;Q8N142";P30520;Adenylosuccinate synthetase isozyme 2;ADSS;>PURA2_HUMAN|P30520|Adenylosuccinate synthetase isozyme 2  (AMPSase 2 ) (AdSS 2 ) (6.3.4.4 ) (Adenylosuccinate  synthetase,  acidic isozyme ) (Adenylosuccinate  synthetase,  liver isozyme ) (L-type adenylosuccinate synthetase ) (IMP--aspartate ligase 2 );8;8;18,6
P20933;P20933;"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase;Glycosylasparaginase alpha chain;Glycosylasparaginase beta chain";AGA;>ASPG_HUMAN|P20933|N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) (Glycosylasparaginase alpha chain) (Glycosylasparaginase beta chain) (Prec;3;3;11,6
P35573;P35573;"Glycogen debranching enzyme;4-alpha-glucanotransferase;Amylo-alpha-1,6-glucosidase";AGL;>GDE_HUMAN|P35573|Glycogen debranching enzyme (Glycogen debrancher) (4-alpha-glucanotransferase) (2.4.1.25)  (Oligo-1,4-1,4-glucantransferase)   (Amylo-alpha-1,6-glucosidase)   (Amylo-1,6-glucosidase)  (3.2.1.33) (Dextrin 6-alpha-D-glucosidase);20;20;14,6
P23526;P23526;Adenosylhomocysteinase;AHCY;>SAHH_HUMAN|P23526|Adenosylhomocysteinase (AdoHcyase) (3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);23;23;47,7
O43865;O43865;Putative adenosylhomocysteinase 2;AHCYL1;>SAHH2_HUMAN|O43865|S-adenosylhomocysteine hydrolase-like protein 1  (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2);10;3;22,3
Q09666;Q09666;Neuroblast differentiation-associated protein AHNAK;AHNAK;>AHNK_HUMAN|Q09666|Neuroblast differentiation-associated protein AHNAK (Desmoyokin);36;36;19,9
O95433;O95433;Activator of 90 kDa heat shock protein ATPase homolog 1;AHSA1;>AHSA1_HUMAN|O95433|Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38);11;11;31,7
Q96BJ3;Q96BJ3;Axin interactor, dorsalization-associated protein;AIDA;>AIDA_HUMAN|Q96BJ3|Axin  interactor,  dorsalization-associated protein (Axin interaction partner and dorsalization antagonist);7;7;27,1
Q12904;Q12904;"Aminoacyl tRNA synthase complex-interacting multifunctional protein 1;Endothelial monocyte-activating polypeptide 2";AIMP1;>AIMP1_HUMAN|Q12904|Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) (Endothelial monocyte-activating polypeptide 2) (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (S;2;2;9,3
Q13155;Q13155;Aminoacyl tRNA synthase complex-interacting multifunctional protein 2;AIMP2;>AIMP2_HUMAN|Q13155|Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1);3;3;9,1
O00170;O00170;AH receptor-interacting protein;AIP;>AIP_HUMAN|O00170|AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9);4;4;14,2
"P00568;Q9Y6K8";P00568;Adenylate kinase isoenzyme 1;AK1;>KAD1_HUMAN|P00568|Adenylate kinase isoenzyme 1  (AK 1 ) (2.7.4.3 ) (2.7.4.6 ) (ATP-AMP transphosphorylase 1 ) (ATP:AMP phosphotransferase ) (Adenylate monophosphate kinase ) (Myokinase );7;7;47,4
Q02952;Q02952;A-kinase anchor protein 12;AKAP12;>AKA12_HUMAN|Q02952|A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen);35;35;30,5
"O43687;Q9P0M2";"O43687;Q9P0M2";"A-kinase anchor protein 7 isoforms alpha and beta;A-kinase anchor protein 7 isoform gamma";AKAP7;">AKA7A_HUMAN|O43687|A-kinase anchor protein 7 isoforms alpha and beta (AKAP-7 isoforms alpha and beta) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoforms alpha/beta) (PRKA7 isoforms alpha/beta);>AKA7G_HUMAN|Q9P0M2|A-k";5;5;53,8
P14550;P14550;Alcohol dehydrogenase [NADP(+)];AKR1A1;>AK1A1_HUMAN|P14550|Alcohol dehydrogenase [NADP(+)] (1.1.1.2) (Aldehyde reductase) (Aldo-keto reductase family 1 member A1);22;22;74,8
"P15121;C9JRZ8";P15121;Aldose reductase;AKR1B1;>ALDR_HUMAN|P15121|Aldose reductase (AR) (1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1);12;12;46,5
"Q04828;P52895;P17516";"Q04828;P52895;P17516";"Aldo-keto reductase family 1 member C1;Aldo-keto reductase family 1 member C2;Aldo-keto reductase family 1 member C4";AKR1C1;>AK1C1_HUMAN|Q04828|Aldo-keto reductase family 1 member C1 (1.1.1.-) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (1.1.1.149  ) (Chlordecone reductase homolog HAKRC) (Dihydrodiol dehydrogenase 1/2) (DD1/DD2) (High-affinity hepatic bile acid-bindi;6;1;20,4
O43488;O43488;Aflatoxin B1 aldehyde reductase member 2;AKR7A2;>ARK72_HUMAN|O43488|Aflatoxin B1 aldehyde reductase member 2 (1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase);10;6;38,4
O95154;O95154;Aflatoxin B1 aldehyde reductase member 3;AKR7A3;>ARK73_HUMAN|O95154|Aflatoxin B1 aldehyde reductase member 3 (1.-.-.-) (AFB1 aldehyde reductase 2) (AFB1-AR 2);7;4;26,9
"P31749;Q9Y243";P31749;RAC-alpha serine/threonine-protein kinase;AKT1;>AKT1_HUMAN|P31749|RAC-alpha serine/threonine-protein kinase (2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha);7;5;19
P31751;P31751;RAC-beta serine/threonine-protein kinase;AKT2;>AKT2_HUMAN|P31751|RAC-beta serine/threonine-protein kinase (2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta);4;2;10,4
P13716;P13716;Delta-aminolevulinic acid dehydratase;ALAD;>HEM2_HUMAN|P13716|Delta-aminolevulinic acid dehydratase (ALADH) (4.2.1.24) (Porphobilinogen synthase);13;13;40,6
"CON__P02768-1;P02768";"CON__P02768-1;P02768";Serum albumin;ALB;">P02768-1 SWISS-PROT:P02768-1 Tax_Id=9606 Gene_Symbol=ALB Isoform 1 of Serum albumin precursor;>ALBU_HUMAN|P02768|Serum albumin (Precursor)";45;41;69,1
P00352;P00352;Retinal dehydrogenase 1;ALDH1A1;>AL1A1_HUMAN|P00352|Retinal dehydrogenase 1  (RALDH 1 ) (RalDH1 ) (1.2.1.-  ) (1.2.1.36 ) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1 ) (Aldehyde  dehydrogenase,  cytosolic );17;13;38,9
"P47895;P30837;O94788";P47895;Aldehyde dehydrogenase family 1 member A3;ALDH1A3;>AL1A3_HUMAN|P47895|Aldehyde dehydrogenase family 1 member A3 (1.2.1.5 ) (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3) (RALDH-3) (RalDH3);20;18;44,9
"O75891;Q3SY69";O75891;Cytosolic 10-formyltetrahydrofolate dehydrogenase;ALDH1L1;>AL1L1_HUMAN|O75891|Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (1.5.1.6) (Aldehyde dehydrogenase family 1 member L1);12;12;16,6
"P43353;P48448;P30838";P43353;Aldehyde dehydrogenase family 3 member B1;ALDH3B1;>AL3B1_HUMAN|P43353|Aldehyde dehydrogenase family 3 member B1 (1.2.1.5) (Aldehyde dehydrogenase 7) (Precursor);10;9;25,2
P49419;P49419;Alpha-aminoadipic semialdehyde dehydrogenase;ALDH7A1;>AL7A1_HUMAN|P49419|Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (1.2.1.8) (Delta1-piperideine-6-carboxylate dehydro;21;21;47,9
P49189;P49189;4-trimethylaminobutyraldehyde dehydrogenase;ALDH9A1;>AL9A1_HUMAN|P49189|4-trimethylaminobutyraldehyde dehydrogenase (TMABADH) (1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (1.2.1.19) (R-aminobutyraldehyde dehydro;21;21;43,1
P04075;P04075;Fructose-bisphosphate aldolase A;ALDOA;>ALDOA_HUMAN|P04075|Fructose-bisphosphate aldolase A (4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase);28;23;74,5
P05062;P05062;Fructose-bisphosphate aldolase B;ALDOB;>ALDOB_HUMAN|P05062|Fructose-bisphosphate aldolase B (4.1.2.13) (Liver-type aldolase);19;17;59,9
P09972;P09972;Fructose-bisphosphate aldolase C;ALDOC;>ALDOC_HUMAN|P09972|Fructose-bisphosphate aldolase C (4.1.2.13) (Brain-type aldolase);15;9;45,9
O15296;O15296;Arachidonate 15-lipoxygenase B;ALOX15B;>LX15B_HUMAN|O15296|Arachidonate 15-lipoxygenase B (15-LOX-B) (1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (1.13.11.-);14;14;24,6
"P05186;REV__Q86WI3";P05186;Alkaline phosphatase, tissue-nonspecific isozyme;ALPL;>PPBT_HUMAN|P05186|Alkaline  phosphatase,  tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (3.1.3.1  ) (Alkaline phosphatase liver/bone/kidney isozyme) (Precursor);10;10;17,9
P02760;P02760;"Protein AMBP;Alpha-1-microglobulin;Inter-alpha-trypsin inhibitor light chain;Trypstatin";AMBP;>AMBP_HUMAN|P02760|Protein AMBP (Alpha-1-microglobulin) (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge) (Inter-alpha-trypsin inhibitor light chain) (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein);13;12;45,7
Q9P2R3;Q9P2R3;Ankyrin repeat and FYVE domain-containing protein 1;ANKFY1;>ANFY1_HUMAN|Q9P2R3|Rabankyrin-5  (Rank-5 ) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif);12;12;14,5
Q9P2G1;Q9P2G1;Ankyrin repeat and IBR domain-containing protein 1;ANKIB1;>AKIB1_HUMAN|Q9P2G1|Ankyrin repeat and IBR domain-containing protein 1 (2.3.2.- );8;8;10,5
"Q8IZ07;Q6ZTN6";"Q8IZ07;Q6ZTN6";"Ankyrin repeat domain-containing protein 13A;Ankyrin repeat domain-containing protein 13D";ANKRD13A;">AN13A_HUMAN|Q8IZ07|Ankyrin repeat domain-containing protein 13A (Protein KE03);>AN13D_HUMAN|Q6ZTN6|Ankyrin repeat domain-containing protein 13D";2;2;4,2
Q4KMQ2;Q4KMQ2;Anoctamin-6;ANO6;>ANO6_HUMAN|Q4KMQ2|Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F);15;15;17,7
Q6IWH7;Q6IWH7;Anoctamin-7;ANO7;>ANO7_HUMAN|Q6IWH7|Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);13;13;16,4
P15144;P15144;Aminopeptidase N;ANPEP;>AMPN_HUMAN|P15144|Aminopeptidase N  (AP-N) (hAPN) (3.4.11.2  ) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD13);53;53;49,2
P04083;P04083;Annexin A1;ANXA1;>ANXA1_HUMAN|P04083|Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I ) (Phospholipase A2 inhibitory protein) (p35);28;28;73,7
"P50995;P27216";P50995;Annexin A11;ANXA11;>ANX11_HUMAN|P50995|Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50);29;28;45,7
"P07355;A6NMY6";"P07355;A6NMY6";"Annexin A2;Putative annexin A2-like protein";ANXA2;">ANXA2_HUMAN|P07355|Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36);>AXA2L_HUMAN|A6NMY6|Putative annexin A2-like protei";29;29;71,7
P12429;P12429;Annexin A3;ANXA3;>ANXA3_HUMAN|P12429|Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol  1,2-cyclic  phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III);23;23;60,7
P09525;P09525;Annexin A4;ANXA4;>ANXA4_HUMAN|P09525|Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II);25;25;66,8
P08758;P08758;Annexin A5;ANXA5;>ANXA5_HUMAN|P08758|Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoag;24;24;68,4
P08133;P08133;Annexin A6;ANXA6;>ANXA6_HUMAN|P08133|Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70);40;40;58,2
P20073;P20073;Annexin A7;ANXA7;>ANXA7_HUMAN|P20073|Annexin A7 (Annexin VII) (Annexin-7) (Synexin);23;22;46,7
P19801;P19801;Amiloride-sensitive amine oxidase [copper-containing];AOC1;>AOC1_HUMAN|P19801|Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (1.4.3.22 ) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO) (Precursor);6;6;10,1
Q06278;Q06278;Aldehyde oxidase;AOX1;>AOXA_HUMAN|Q06278|Aldehyde oxidase (1.2.3.1  ) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (1.17.3.-);11;11;9,6
Q10567;Q10567;AP-1 complex subunit beta-1;AP1B1;>AP1B1_HUMAN|Q10567|AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1;21;8;23
O43747;O43747;AP-1 complex subunit gamma-1;AP1G1;>AP1G1_HUMAN|O43747|AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin su;12;12;17,6
O75843;O75843;AP-1 complex subunit gamma-like 2;AP1G2;>AP1G2_HUMAN|O75843|AP-1 complex subunit gamma-like 2 (Gamma2-adaptin) (G2ad);2;2;2,4
Q9BXS5;Q9BXS5;AP-1 complex subunit mu-1;AP1M1;>AP1M1_HUMAN|Q9BXS5|AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly pr;4;3;12,3
Q9Y6Q5;Q9Y6Q5;AP-1 complex subunit mu-2;AP1M2;>AP1M2_HUMAN|Q9Y6Q5|AP-1 complex subunit mu-2 (AP-mu chain family member mu1B) (Adaptor protein complex AP-1 subunit mu-2) (Adaptor-related protein complex 1 subunit mu-2) (Clathrin assembly protein complex 1 mu-2 medium chain 2) (Golgi adaptor HA1/AP1 ada;6;5;17
"P61966;P56377";P61966;AP-1 complex subunit sigma-1A;AP1S1;>AP1S1_HUMAN|P61966|AP-1 complex subunit sigma-1A (Adaptor protein complex AP-1 subunit sigma-1A) (Adaptor-related protein complex 1 subunit sigma-1A) (Clathrin assembly protein complex 1 sigma-1A small chain) (Clathrin coat assembly protein AP19) (Golgi a;4;4;25,3
O95782;O95782;AP-2 complex subunit alpha-1;AP2A1;>AP2A1_HUMAN|O95782|AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 a;13;5;14,2
O94973;O94973;AP-2 complex subunit alpha-2;AP2A2;>AP2A2_HUMAN|O94973|AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 a;18;10;22,2
P63010;P63010;AP-2 complex subunit beta;AP2B1;>AP2B1_HUMAN|P63010|AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adap;19;7;22,8
Q96CW1;Q96CW1;AP-2 complex subunit mu;AP2M1;>AP2M1_HUMAN|Q96CW1|AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (;7;7;19,8
P53680;P53680;AP-2 complex subunit sigma;AP2S1;>AP2S1_HUMAN|P53680|AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated pr;2;2;11,3
"O00203;Q13367";O00203;AP-3 complex subunit beta-1;AP3B1;>AP3B1_HUMAN|O00203|AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain);10;10;10,8
P13798;P13798;Acylamino-acid-releasing enzyme;APEH;>ACPH_HUMAN|P13798|Acylamino-acid-releasing enzyme (AARE) (3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH);14;14;21,7
Q06481;Q06481;Amyloid-like protein 2;APLP2;>APLP2_HUMAN|Q06481|Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP) (Precursor);4;3;5
"P02647;CON__P15497";P02647;"Apolipoprotein A-I;Proapolipoprotein A-I;Truncated apolipoprotein A-I";APOA1;>APOA1_HUMAN|P02647|Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) (Proapolipoprotein A-I) (ProapoA-I) (Truncated apolipoprotein A-I) (Apolipoprotein A-I(1-242)) (Precursor);13;13;53,9
Q8NCW5;Q8NCW5;NAD(P)H-hydrate epimerase;APOA1BP;>NNRE_HUMAN|Q8NCW5|NAD(P)H-hydrate epimerase  (5.1.99.6) (Apolipoprotein A-I-binding protein ) (AI-BP ) (NAD(P)HX epimerase ) (YjeF N-terminal domain-containing protein 1) (YjeF_N1) (Precursor);6;6;29,2
"P06727;CON__Q32PJ2";P06727;Apolipoprotein A-IV;APOA4;>APOA4_HUMAN|P06727|Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4) (Precursor);13;13;39,1
"P04114;CON__ENSEMBL:ENSBTAP00000032840";P04114;"Apolipoprotein B-100;Apolipoprotein B-48";APOB;>APOB_HUMAN|P04114|Apolipoprotein B-100 (Apo B-100) (Apolipoprotein B-48) (Apo B-48) (Precursor);4;4;0,9
P05090;P05090;Apolipoprotein D;APOD;>APOD_HUMAN|P05090|Apolipoprotein D (Apo-D) (ApoD) (Precursor);6;6;30,2
"P02649;CON__Q03247";P02649;Apolipoprotein E;APOE;>APOE_HUMAN|P02649|Apolipoprotein E (Apo-E) (Precursor);19;19;59
"P02749;CON__P17690";P02749;Beta-2-glycoprotein 1;APOH;>APOH_HUMAN|P02749|Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI) (Precursor);4;4;16,2
P05067;P05067;"Amyloid beta A4 protein;N-APP;Soluble APP-alpha;Soluble APP-beta;C99;Beta-amyloid protein 42;Beta-amyloid protein 40;C83;P3(42);P3(40);C80;Gamma-secretase C-terminal fragment 59;Gamma-secretase C-terminal fragment 57;Gamma-secretase C-terminal fragment 50;C31";APP;>A4_HUMAN|P05067|Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein ) (Beta-amyloid precursor protein ) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) (N-APP) (Soluble ;7;6;10,4
Q9UKG1;Q9UKG1;DCC-interacting protein 13-alpha;APPL1;>DP13A_HUMAN|Q9UKG1|DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH  domain,  PTB domain and leucine zipper motif 1);14;14;24,5
Q8NEU8;Q8NEU8;DCC-interacting protein 13-beta;APPL2;>DP13B_HUMAN|Q8NEU8|DCC-interacting protein 13-beta (Dip13-beta) (Adapter protein containing PH  domain,  PTB domain and leucine zipper motif 2);23;23;42,3
P07741;P07741;Adenine phosphoribosyltransferase;APRT;>APT_HUMAN|P07741|Adenine phosphoribosyltransferase (APRT) (2.4.2.7);6;6;32,8
P29972;P29972;Aquaporin-1;AQP1;>AQP1_HUMAN|P29972|Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule);4;4;18,6
P41181;P41181;Aquaporin-2;AQP2;>AQP2_HUMAN|P41181|Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct);5;5;14
P10398;P10398;Serine/threonine-protein kinase A-Raf;ARAF;>ARAF_HUMAN|P10398|Serine/threonine-protein kinase A-Raf (2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks);5;4;10,1
P48444;P48444;Coatomer subunit delta;ARCN1;>COPD_HUMAN|P48444|Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP);9;9;20
"P84077;P61204";"P84077;P61204";"ADP-ribosylation factor 1;ADP-ribosylation factor 3";ARF1;">ARF1_HUMAN|P84077|ADP-ribosylation factor 1;>ARF3_HUMAN|P61204|ADP-ribosylation factor 3";10;6;64,1
P18085;P18085;ADP-ribosylation factor 4;ARF4;>ARF4_HUMAN|P18085|ADP-ribosylation factor 4;9;6;64,4
P84085;P84085;ADP-ribosylation factor 5;ARF5;>ARF5_HUMAN|P84085|ADP-ribosylation factor 5;7;3;56,1
P62330;P62330;ADP-ribosylation factor 6;ARF6;>ARF6_HUMAN|P62330|ADP-ribosylation factor 6;6;6;47,4
Q9NP61;Q9NP61;ADP-ribosylation factor GTPase-activating protein 3;ARFGAP3;>ARFG3_HUMAN|Q9NP61|ADP-ribosylation factor GTPase-activating protein 3 (ARF GAP 3);3;3;5,8
Q9Y6D5;Q9Y6D5;Brefeldin A-inhibited guanine nucleotide-exchange protein 2;ARFGEF2;>BIG2_HUMAN|Q9Y6D5|Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2);13;5;9,1
Q5TH69;Q5TH69;Brefeldin A-inhibited guanine nucleotide-exchange protein 3;ARFGEF3;>BIG3_HUMAN|Q5TH69|Brefeldin A-inhibited guanine nucleotide-exchange protein 3  (ARFGEF family member 3 );13;13;8,6
Q07960;Q07960;Rho GTPase-activating protein 1;ARHGAP1;>RHG01_HUMAN|Q07960|Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP);12;12;33,9
Q8N392;Q8N392;Rho GTPase-activating protein 18;ARHGAP18;>RHG18_HUMAN|Q8N392|Rho GTPase-activating protein 18 (MacGAP ) (Rho-type GTPase-activating protein 18);18;18;29,4
Q6ZUM4;Q6ZUM4;Rho GTPase-activating protein 27;ARHGAP27;>RHG27_HUMAN|Q6ZUM4|Rho GTPase-activating protein 27 (CIN85-associated multi-domain-containing Rho GTPase-activating protein 1) (Rho-type GTPase-activating protein 27) (SH3 domain-containing protein 20);4;4;5,4
Q52LW3;Q52LW3;Rho GTPase-activating protein 29;ARHGAP29;>RHG29_HUMAN|Q52LW3|Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29);3;3;3,2
O43182;O43182;Rho GTPase-activating protein 6;ARHGAP6;>RHG06_HUMAN|O43182|Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1);11;11;14,4
P52565;P52565;Rho GDP-dissociation inhibitor 1;ARHGDIA;>GDIR1_HUMAN|P52565|Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha);8;8;44,1
P52566;P52566;Rho GDP-dissociation inhibitor 2;ARHGDIB;>GDIR2_HUMAN|P52566|Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI ) (Rho-GDI beta);5;5;25,9
A1IGU5;A1IGU5;Rho guanine nucleotide exchange factor 37;ARHGEF37;>ARH37_HUMAN|A1IGU5|Rho guanine nucleotide exchange factor 37;8;8;14,5
Q3SXY8;Q3SXY8;ADP-ribosylation factor-like protein 13B;ARL13B;>AR13B_HUMAN|Q3SXY8|ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1);7;7;19,9
Q9NXU5;Q9NXU5;ADP-ribosylation factor-like protein 15;ARL15;>ARL15_HUMAN|Q9NXU5|ADP-ribosylation factor-like protein 15 (ADP-ribosylation factor-related protein 2) (ARF-related protein 2);5;5;34,3
P36405;P36405;ADP-ribosylation factor-like protein 3;ARL3;>ARL3_HUMAN|P36405|ADP-ribosylation factor-like protein 3;10;10;58,8
Q96BM9;Q96BM9;ADP-ribosylation factor-like protein 8A;ARL8A;>ARL8A_HUMAN|Q96BM9|ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2);5;2;36
Q9NVJ2;Q9NVJ2;ADP-ribosylation factor-like protein 8B;ARL8B;>ARL8B_HUMAN|Q9NVJ2|ADP-ribosylation factor-like protein 8B (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1);5;2;36,6
Q6NXE6;Q6NXE6;Armadillo repeat-containing protein 6;ARMC6;>ARMC6_HUMAN|Q6NXE6|Armadillo repeat-containing protein 6;3;3;6,6
Q92747;Q92747;Actin-related protein 2/3 complex subunit 1A;ARPC1A;>ARC1A_HUMAN|Q92747|Actin-related protein 3-Feb complex subunit 1A (SOP2-like protein);7;7;21,1
O15143;O15143;Actin-related protein 2/3 complex subunit 1B;ARPC1B;>ARC1B_HUMAN|O15143|Actin-related protein 3-Feb complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC);10;10;33,6
O15144;O15144;Actin-related protein 2/3 complex subunit 2;ARPC2;>ARPC2_HUMAN|O15144|Actin-related protein 3-Feb complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC);11;11;30
O15145;O15145;Actin-related protein 2/3 complex subunit 3;ARPC3;>ARPC3_HUMAN|O15145|Actin-related protein 3-Feb complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC);8;8;40,4
P59998;P59998;Actin-related protein 2/3 complex subunit 4;ARPC4;>ARPC4_HUMAN|P59998|Actin-related protein 3-Feb complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC);7;7;48,8
O15511;O15511;Actin-related protein 2/3 complex subunit 5;ARPC5;>ARPC5_HUMAN|O15511|Actin-related protein 3-Feb complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC);2;2;20,5
P49407;P49407;Beta-arrestin-1;ARRB1;>ARRB1_HUMAN|P49407|Beta-arrestin-1 (Arrestin beta-1);7;7;24,2
Q8N5I2;Q8N5I2;Arrestin domain-containing protein 1;ARRDC1;>ARRD1_HUMAN|Q8N5I2|Arrestin domain-containing protein 1;9;9;25,2
Q13510;Q13510;"Acid ceramidase;Acid ceramidase subunit alpha;Acid ceramidase subunit beta";ASAH1;>ASAH1_HUMAN|Q13510|Acid ceramidase (AC) (ACDase) (Acid CDase) (3.5.1.23 ) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) (Acid ceramidase subunit alpha) (Acid ceramidase subunit beta) (Precursor);13;13;34,7
P04424;P04424;Argininosuccinate lyase;ASL;>ARLY_HUMAN|P04424|Argininosuccinate lyase (ASAL) (4.3.2.1) (Arginosuccinase);9;9;24,1
O95671;O95671;N-acetylserotonin O-methyltransferase-like protein;ASMTL;>ASML_HUMAN|O95671|N-acetylserotonin O-methyltransferase-like protein (ASMTL) (2.1.1.-);13;13;31,2
O43681;O43681;ATPase ASNA1;ASNA1;>ASNA_HUMAN|O43681|ATPase ASNA1  (3.6.-.- ) (Arsenical pump-driving ATPase ) (Arsenite-stimulated ATPase ) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I);6;6;19,8
Q9BZE9;Q9BZE9;Tether containing UBX domain for GLUT4;ASPSCR1;>ASPC1_HUMAN|Q9BZE9|Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9);2;2;4,7
Q7L266;Q7L266;"Isoaspartyl peptidase/L-asparaginase;Isoaspartyl peptidase/L-asparaginase alpha chain;Isoaspartyl peptidase/L-asparaginase beta chain";ASRGL1;>ASGL1_HUMAN|Q7L266|Isoaspartyl peptidase/L-asparaginase (3.4.19.5 ) (3.5.1.1  ) (Asparaginase-like protein 1 ) (Beta-aspartyl-peptidase ) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) (Isoaspartyl peptidase/L-asparaginase alpha chain) (Isoaspart;8;8;39,9
P00966;P00966;Argininosuccinate synthase;ASS1;>ASSY_HUMAN|P00966|Argininosuccinate synthase  (6.3.4.5  ) (Citrulline--aspartate ligase);17;17;34,7
Q9Y4P1;Q9Y4P1;Cysteine protease ATG4B;ATG4B;>ATG4B_HUMAN|Q9Y4P1|Cysteine protease ATG4B (3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B);3;3;10,7
Q9H1Y0;Q9H1Y0;Autophagy protein 5;ATG5;>ATG5_HUMAN|Q9H1Y0|Autophagy protein 5 (APG5-like) (Apoptosis-specific protein);9;9;40,4
P31939;P31939;"Bifunctional purine biosynthesis protein PURH;Phosphoribosylaminoimidazolecarboxamide formyltransferase;IMP cyclohydrolase";ATIC;>PUR9_HUMAN|P31939|Bifunctional purine biosynthesis protein PURH (Phosphoribosylaminoimidazolecarboxamide formyltransferase) (2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase) (IMP cyclohydrolase) (3.5.4.10) ;21;21;46,8
O00244;O00244;Copper transport protein ATOX1;ATOX1;>ATOX1_HUMAN|O00244|Copper transport protein ATOX1 (Metal transport protein ATX1);4;4;64,7
Q9Y2G3;Q9Y2G3;Probable phospholipid-transporting ATPase IF;ATP11B;>AT11B_HUMAN|Q9Y2G3|Probable phospholipid-transporting ATPase IF (3.6.3.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B);3;3;2,7
"P54707;REV__Q15772";P54707;Potassium-transporting ATPase alpha chain 2;ATP12A;>AT12A_HUMAN|P54707|Potassium-transporting ATPase alpha chain 2 (3.6.3.10) (Non-gastric H(+)/K(+) ATPase subunit alpha) (Proton pump);20;16;21,2
Q9H7F0;Q9H7F0;Probable cation-transporting ATPase 13A3;ATP13A3;>AT133_HUMAN|Q9H7F0|Probable cation-transporting ATPase 13A3 (3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1);4;4;3,9
"P05023;P20648";P05023;Sodium/potassium-transporting ATPase subunit alpha-1;ATP1A1;>AT1A1_HUMAN|P05023|Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (3.6.3.9) (Sodium pump subunit alpha-1) (Precursor);32;18;35,6
P05026;P05026;Sodium/potassium-transporting ATPase subunit beta-1;ATP1B1;>AT1B1_HUMAN|P05026|Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1);12;12;34
Q15904;Q15904;V-type proton ATPase subunit S1;ATP6AP1;>VAS1_HUMAN|Q15904|V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1) (Precursor);4;4;7,9
"Q93050;Q9Y487;Q13488";Q93050;V-type proton ATPase 116 kDa subunit a isoform 1;ATP6V0A1;>VPP1_HUMAN|Q93050|V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vac;22;20;29,2
Q9HBG4;Q9HBG4;V-type proton ATPase 116 kDa subunit a isoform 4;ATP6V0A4;>VPP4_HUMAN|Q9HBG4|V-type proton ATPase 116 kDa subunit a isoform 4 (V-ATPase 116 kDa isoform a4) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform);19;17;24,2
P61421;P61421;V-type proton ATPase subunit d 1;ATP6V0D1;>VA0D1_HUMAN|P61421|V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (p39) (Vacuolar proton pump subunit d 1);11;11;31,9
Q8N8Y2;Q8N8Y2;V-type proton ATPase subunit d 2;ATP6V0D2;>VA0D2_HUMAN|Q8N8Y2|V-type proton ATPase subunit d 2 (V-ATPase subunit d 2) (Vacuolar proton pump subunit d 2);7;7;24
P38606;P38606;V-type proton ATPase catalytic subunit A;ATP6V1A;>VATA_HUMAN|P38606|V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha);28;28;51,4
P15313;P15313;V-type proton ATPase subunit B, kidney isoform;ATP6V1B1;>VATB1_HUMAN|P15313|V-type proton ATPase subunit  B,  kidney isoform (V-ATPase subunit B 1) (Endomembrane proton pump 58 kDa subunit) (Vacuolar proton pump subunit B 1);17;12;40,9
P21281;P21281;V-type proton ATPase subunit B, brain isoform;ATP6V1B2;>VATB2_HUMAN|P21281|V-type proton ATPase subunit  B,  brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2);15;10;34,6
P21283;P21283;V-type proton ATPase subunit C 1;ATP6V1C1;>VATC1_HUMAN|P21283|V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1);16;16;45,5
Q9Y5K8;Q9Y5K8;V-type proton ATPase subunit D;ATP6V1D;>VATD_HUMAN|Q9Y5K8|V-type proton ATPase subunit D (V-ATPase subunit D) (V-ATPase 28 kDa accessory protein) (Vacuolar proton pump subunit D);7;7;36
"P36543;Q96A05";P36543;V-type proton ATPase subunit E 1;ATP6V1E1;>VATE1_HUMAN|P36543|V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1);12;12;45,1
Q16864;Q16864;V-type proton ATPase subunit F;ATP6V1F;>VATF_HUMAN|Q16864|V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F);4;4;32,8
"O75348;O95670";O75348;V-type proton ATPase subunit G 1;ATP6V1G1;>VATG1_HUMAN|O75348|V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16);5;5;42,4
Q9UI12;Q9UI12;V-type proton ATPase subunit H;ATP6V1H;>VATH_HUMAN|Q9UI12|V-type proton ATPase subunit H (V-ATPase subunit H) (Nef-binding protein 1) (NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD);16;16;31,7
Q9Y2Q0;Q9Y2Q0;Phospholipid-transporting ATPase IA;ATP8A1;>AT8A1_HUMAN|Q9Y2Q0|Phospholipid-transporting ATPase IA (3.6.3.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1);28;27;26,6
"O43520;Q8TF62;P98198;O60423;O60312";O43520;Phospholipid-transporting ATPase IC;ATP8B1;>AT8B1_HUMAN|O43520|Phospholipid-transporting ATPase IC (3.6.3.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1);14;13;15
"O75110;O43861";O75110;Probable phospholipid-transporting ATPase IIA;ATP9A;>ATP9A_HUMAN|O75110|Probable phospholipid-transporting ATPase IIA (3.6.3.1) (ATPase class II type 9A);35;35;30,2
O75882;O75882;Attractin;ATRN;>ATRN_HUMAN|O75882|Attractin (DPPT-L) (Mahogany homolog) (Precursor);16;16;14
Q9UBB4;Q9UBB4;Ataxin-10;ATXN10;>ATX10_HUMAN|Q9UBB4|Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein);9;9;22,7
P25311;P25311;Zinc-alpha-2-glycoprotein;AZGP1;>ZA2G_HUMAN|P25311|Zinc-alpha-2-glycoprotein (Zn-alpha-2-GP) (Zn-alpha-2-glycoprotein) (Precursor);18;18;50,3
P61769;P61769;"Beta-2-microglobulin;Beta-2-microglobulin form pI 5.3";B2M;>B2MG_HUMAN|P61769|Beta-2-microglobulin (Beta-2-microglobulin form pI 5.3) (Precursor);2;2;16,8
Q9Y5Z0;Q9Y5Z0;Beta-secretase 2;BACE2;>BACE2_HUMAN|Q9Y5Z0|Beta-secretase 2 (3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin;8;8;15,6
O95816;O95816;BAG family molecular chaperone regulator 2;BAG2;>BAG2_HUMAN|O95816|BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2);4;4;20,4
Q9UL15;Q9UL15;BAG family molecular chaperone regulator 5;BAG5;>BAG5_HUMAN|Q9UL15|BAG family molecular chaperone regulator 5 (BAG-5) (Bcl-2-associated athanogene 5);4;4;11,9
Q9UQB8;Q9UQB8;Brain-specific angiogenesis inhibitor 1-associated protein 2;BAIAP2;>BAIP2_HUMAN|Q9UQB8|Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insul;33;33;62,5
Q9UHR4;Q9UHR4;Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1;BAIAP2L1;>BI2L1_HUMAN|Q9UHR4|Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate);27;27;56,4
O75531;O75531;"Barrier-to-autointegration factor;Barrier-to-autointegration factor, N-terminally processed";BANF1;>BAF_HUMAN|O75531|Barrier-to-autointegration factor (Breakpoint cluster region protein 1) (Barrier-to-autointegration  factor,  N-terminally processed);7;7;57,3
P80723;P80723;Brain acid soluble protein 1;BASP1;>BASP1_HUMAN|P80723|Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22);21;21;85,5
Q07812;Q07812;Apoptosis regulator BAX;BAX;>BAX_HUMAN|Q07812|Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4);3;3;24
O75936;O75936;Gamma-butyrobetaine dioxygenase;BBOX1;>BODG_HUMAN|O75936|Gamma-butyrobetaine dioxygenase (1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH)  (Gamma-butyrobetaine,2-oxoglutarate  dioxygenase);6;6;19,6
P50895;P50895;Basal cell adhesion molecule;BCAM;>BCAM_HUMAN|P50895|Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD239) (Precursor);21;21;47,1
O75363;O75363;Breast carcinoma-amplified sequence 1;BCAS1;>BCAS1_HUMAN|O75363|Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1);18;18;45,4
"P11274;Q12979";P11274;Breakpoint cluster region protein;BCR;>BCR_HUMAN|P11274|Breakpoint cluster region protein (2.7.11.1) (Renal carcinoma antigen NY-REN-26);12;12;9,6
Q9BUT1;Q9BUT1;3-hydroxybutyrate dehydrogenase type 2;BDH2;>BDH2_HUMAN|Q9BUT1|3-hydroxybutyrate dehydrogenase type 2 (1.1.1.-) (1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (Oxidoreductase UCPA) (R-beta-hydroxybutyrate dehydrogenase) (Short chain dehydrogenase/reductase family 15C member 1);9;9;38,4
Q93088;Q93088;Betaine--homocysteine S-methyltransferase 1;BHMT;>BHMT1_HUMAN|Q93088|Betaine--homocysteine S-methyltransferase 1 (2.1.1.5);17;13;55,9
"O00499;Q9UBW5;P49418";O00499;Myc box-dependent-interacting protein 1;BIN1;>BIN1_HUMAN|O00499|Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1);6;6;14,2
Q9NQY0;Q9NQY0;Bridging integrator 3;BIN3;>BIN3_HUMAN|Q9NQY0|Bridging integrator 3;2;2;8,7
P53004;P53004;Biliverdin reductase A;BLVRA;>BIEA_HUMAN|P53004|Biliverdin reductase A (BVR A) (1.3.1.24) (Biliverdin-IX alpha-reductase) (Precursor);8;8;32,8
P30043;P30043;Flavin reductase (NADPH);BLVRB;>BLVRB_HUMAN|P30043|Flavin reductase (NADPH) (FR) (1.5.1.30  ) (Biliverdin reductase B) (BVR-B) (1.3.1.24  ) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR);10;10;58,7
O95861;O95861;3(2),5-bisphosphate nucleotidase 1;BPNT1;>BPNT1_HUMAN|O95861| 3(2),5-bisphosphate  nucleotidase 1 (3.1.3.7) (Bisphosphate 3-nucleotidase 1) (PAP-inositol  1,4-phosphatase)  (PIP);10;10;36
Q8WUW1;Q8WUW1;Protein BRICK1;BRK1;>BRK1_HUMAN|Q8WUW1|Protein BRICK1 (BRK1);4;4;53,3
Q5VW32;Q5VW32;BRO1 domain-containing protein BROX;BROX;>BROX_HUMAN|Q5VW32|BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein) (Precursor);15;15;39,4
P35613;P35613;Basigin;BSG;>BASI_HUMAN|P35613|Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD147) (Prec;5;5;16,9
Q5W0U4;Q5W0U4;B box and SPRY domain-containing protein;BSPRY;>BSPRY_HUMAN|Q5W0U4|B box and SPRY domain-containing protein;5;5;13,4
Q10588;Q10588;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2;BST1;>BST1_HUMAN|Q10588|ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD157) (Precursor);7;7;23,3
Q7L1Q6;Q7L1Q6;Basic leucine zipper and W2 domain-containing protein 1;BZW1;>BZW1_HUMAN|Q7L1Q6|Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf);10;9;22,2
Q9Y6E2;Q9Y6E2;Basic leucine zipper and W2 domain-containing protein 2;BZW2;>BZW2_HUMAN|Q9Y6E2|Basic leucine zipper and W2 domain-containing protein 2;3;2;4,3
Q96A22;Q96A22;Uncharacterized protein C11orf52;C11orf52;>CK052_HUMAN|Q96A22|Uncharacterized protein C11orf52;8;8;79,7
Q9H0W9;Q9H0W9;Ester hydrolase C11orf54;C11orf54;>CK054_HUMAN|Q9H0W9|Ester hydrolase C11orf54 (3.1.-.-);11;11;43,8
Q9H3H3;Q9H3H3;UPF0696 protein C11orf68;C11orf68;>CK068_HUMAN|Q9H3H3|UPF0696 protein C11orf68 (Basophilic leukemia-expressed protein Bles03) (Protein p5326);3;3;13,9
Q86TY3;Q86TY3;Uncharacterized protein C14orf37;C14orf37;>CN037_HUMAN|Q86TY3|Uncharacterized protein C14orf37 (Precursor);2;2;2,5
Q9NWV4;Q9NWV4;UPF0587 protein C1orf123;C1orf123;>CA123_HUMAN|Q9NWV4|UPF0587 protein C1orf123;3;3;25,6
Q8WWB7;Q8WWB7;Lysosomal protein NCU-G1;C1orf85;>GLMP_HUMAN|Q8WWB7|Glycosylated lysosomal membrane protein  (Lysosomal protein NCU-G1 ) (Precursor);2;2;8,6
P0C0L5;P0C0L5;"Complement C4-B;Complement C4 beta chain;Complement C4-B alpha chain;C4a anaphylatoxin;C4b-B;C4d-B;Complement C4 gamma chain";C4B;>CO4B_HUMAN|P0C0L5|Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) (Complement C4 beta chain) (Complement C4-B alpha chain) (C4a anaphylatoxin) (C4b-B) (C4d-B) (Complement C4 gamma chain) (Precursor;6;1;3,7
Q8IY42;Q8IY42;Uncharacterized protein C4orf19;C4orf19;>CD019_HUMAN|Q8IY42|Uncharacterized protein C4orf19;4;4;19,4
Q5T0Z8;Q5T0Z8;Uncharacterized protein C6orf132;C6orf132;>CF132_HUMAN|Q5T0Z8|Uncharacterized protein C6orf132;5;5;6,3
Q5T6V5;Q5T6V5;UPF0553 protein C9orf64;C9orf64;>CI064_HUMAN|Q5T6V5|UPF0553 protein C9orf64;5;5;12
P00918;P00918;Carbonic anhydrase 2;CA2;>CAH2_HUMAN|P00918|Carbonic anhydrase 2 (4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II);13;13;65
P22748;P22748;Carbonic anhydrase 4;CA4;>CAH4_HUMAN|P22748|Carbonic anhydrase 4 (4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) (Precursor);11;11;34
Q9Y376;Q9Y376;Calcium-binding protein 39;CAB39;>CAB39_HUMAN|Q9Y376|Calcium-binding protein 39 (MO25alpha) (Protein Mo25);16;13;38,4
Q9H9S4;Q9H9S4;Calcium-binding protein 39-like;CAB39L;>CB39L_HUMAN|Q9H9S4|Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein);14;11;38,6
P54289;P54289;"Voltage-dependent calcium channel subunit alpha-2/delta-1;Voltage-dependent calcium channel subunit alpha-2-1;Voltage-dependent calcium channel subunit delta-1";CACNA2D1;>CA2D1_HUMAN|P54289|Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) (Voltage-dependent calcium channel subunit alpha-2-1) (Voltage-dependent calcium channel subunit delta-1) (Precursor);24;23;26,1
Q9HB71;Q9HB71;Calcyclin-binding protein;CACYBP;>CYBP_HUMAN|Q9HB71|Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein);5;5;29,8
"Q86UW7;Q9ULU8";Q86UW7;Calcium-dependent secretion activator 2;CADPS2;>CAPS2_HUMAN|Q86UW7|Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2) (CAPS-2);22;22;22,5
"P05937;P22676";P05937;Calbindin;CALB1;>CALB1_HUMAN|P05937|Calbindin (Calbindin D28) (D-28K) (Vitamin D-dependent calcium-binding  protein,  avian-type);13;13;45,6
P27797;P27797;Calreticulin;CALR;>CALR_HUMAN|P27797|Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60) (Precursor);10;10;28,3
"Q14012;Q8IU85";Q14012;Calcium/calmodulin-dependent protein kinase type 1;CAMK1;>KCC1A_HUMAN|Q14012|Calcium/calmodulin-dependent protein kinase type 1 (2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha);9;9;29,5
"Q13557;Q9UQM7";Q13557;Calcium/calmodulin-dependent protein kinase type II subunit delta;CAMK2D;>KCC2D_HUMAN|Q13557|Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (2.7.11.17);9;5;20,6
P49913;P49913;"Cathelicidin antimicrobial peptide;Antibacterial protein FALL-39;Antibacterial protein LL-37";CAMP;>CAMP_HUMAN|P49913|Cathelicidin antimicrobial peptide  (18 kDa cationic antimicrobial protein ) (CAP-18 ) (hCAP-18 ) (Antibacterial peptide FALL-39 ) (FALL-39 peptide antibiotic ) (Antibacterial peptide LL-37 ) (Precursor);3;3;12,4
"Q86VP6;O75155";Q86VP6;Cullin-associated NEDD8-dissociated protein 1;CAND1;>CAND1_HUMAN|Q86VP6|Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1);24;24;21,4
P27824;P27824;Calnexin;CANX;>CALX_HUMAN|P27824|Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90) (Precursor);5;5;11,7
"Q01518;P40123";Q01518;Adenylyl cyclase-associated protein 1;CAP1;>CAP1_HUMAN|Q01518|Adenylyl cyclase-associated protein 1 (CAP 1);18;18;39,4
P40121;P40121;Macrophage-capping protein;CAPG;>CAPG_HUMAN|P40121|Macrophage-capping protein (Actin regulatory protein CAP-G);13;13;47,7
P07384;P07384;Calpain-1 catalytic subunit;CAPN1;>CAN1_HUMAN|P07384|Calpain-1 catalytic subunit  (3.4.22.52 ) (Calcium-activated neutral proteinase 1 ) (CANP 1 ) (Calpain mu-type ) (Calpain-1 large subunit ) (Cell proliferation-inducing gene 30 protein ) (Micromolar-calpain ) (muCANP );27;27;36,7
P17655;P17655;Calpain-2 catalytic subunit;CAPN2;>CAN2_HUMAN|P17655|Calpain-2 catalytic subunit (3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain) (Precursor);17;17;27,9
O15484;O15484;Calpain-5;CAPN5;>CAN5_HUMAN|O15484|Calpain-5 (3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3);27;27;47,3
Q9Y6W3;Q9Y6W3;Calpain-7;CAPN7;>CAN7_HUMAN|Q9Y6W3|Calpain-7 (3.4.22.-) (PalB homolog) (PalBH);40;40;52,5
"P04632;Q96L46";P04632;Calpain small subunit 1;CAPNS1;>CPNS1_HUMAN|P04632|Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit);9;9;35,8
Q13938;Q13938;Calcyphosin;CAPS;>CAYP1_HUMAN|Q13938|Calcyphosin (Calcyphosine);9;9;51,3
P52907;P52907;F-actin-capping protein subunit alpha-1;CAPZA1;>CAZA1_HUMAN|P52907|F-actin-capping protein subunit alpha-1 (CapZ alpha-1);14;11;64,7
P47755;P47755;F-actin-capping protein subunit alpha-2;CAPZA2;>CAZA2_HUMAN|P47755|F-actin-capping protein subunit alpha-2 (CapZ alpha-2);13;10;67,8
P47756;P47756;F-actin-capping protein subunit beta;CAPZB;>CAPZB_HUMAN|P47756|F-actin-capping protein subunit beta (CapZ beta);14;14;49,1
Q8IW45;Q8IW45;ATP-dependent (S)-NAD(P)H-hydrate dehydratase;CARKD;>NNRD_HUMAN|Q8IW45|ATP-dependent (S)-NAD(P)H-hydrate dehydratase  (4.2.1.93 ) (ATP-dependent NAD(P)HX dehydratase ) (Carbohydrate kinase domain-containing protein ) (NAD(P)HX dehydratase );5;5;21
Q86X55;Q86X55;Histone-arginine methyltransferase CARM1;CARM1;>CARM1_HUMAN|Q86X55|Histone-arginine methyltransferase CARM1 (2.1.1.319 ) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4);3;3;5,1
P42574;P42574;"Caspase-3;Caspase-3 subunit p17;Caspase-3 subunit p12";CASP3;>CASP3_HUMAN|P42574|Caspase-3 (CASP-3) (3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) (Caspase-3 subunit p17) (Caspase-3 subunit p12) (Precursor);2;2;6,9
P55210;P55210;"Caspase-7;Caspase-7 subunit p20;Caspase-7 subunit p11";CASP7;>CASP7_HUMAN|P55210|Caspase-7 (CASP-7) (3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) (Caspase-7 subunit p20) (Caspase-7 subunit p11) (Precursor);5;5;21,5
P20810;P20810;Calpastatin;CAST;>ICAL_HUMAN|P20810|Calpastatin (Calpain inhibitor) (Sperm BS-17 component);5;5;9,9
P04040;P04040;Catalase;CAT;>CATA_HUMAN|P04040|Catalase (1.11.1.6);9;9;21,1
P16152;P16152;Carbonyl reductase [NADPH] 1;CBR1;>CBR1_HUMAN|P16152|Carbonyl reductase [NADPH] 1 (1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (1.1.1.189) (Short chain dehyd;16;14;75,1
O75828;O75828;Carbonyl reductase [NADPH] 3;CBR3;>CBR3_HUMAN|O75828|Carbonyl reductase [NADPH] 3 (1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Short chain dehydrogenase/reductase family 21C member 2);6;4;26
Q6P1N0;Q6P1N0;Coiled-coil and C2 domain-containing protein 1A;CC2D1A;>C2D1A_HUMAN|Q6P1N0|Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1) (Putative NF-kappa-B-activ;25;24;35,1
Q5T0F9;Q5T0F9;Coiled-coil and C2 domain-containing protein 1B;CC2D1B;>C2D1B_HUMAN|Q5T0F9|Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2) (FRE under dual repression-binding protein 2) (Freud-2);5;4;6,1
Q8IVM0;Q8IVM0;Coiled-coil domain-containing protein 50;CCDC50;>CCD50_HUMAN|Q8IVM0|Coiled-coil domain-containing protein 50 (Protein Ymer);2;2;7,5
Q16204;Q16204;Coiled-coil domain-containing protein 6;CCDC6;>CCDC6_HUMAN|Q16204|Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4);4;4;8,9
Q9BSQ5;Q9BSQ5;Malcavernin;CCM2;>CCM2_HUMAN|Q9BSQ5|Cerebral cavernous malformations 2 protein (Malcavernin );6;6;18,2
Q8ND76;Q8ND76;Cyclin-Y;CCNY;>CCNY_HUMAN|Q8ND76|Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X);5;4;16,4
P78371;P78371;T-complex protein 1 subunit beta;CCT2;>TCPB_HUMAN|P78371|T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta);22;22;48,4
P49368;P49368;T-complex protein 1 subunit gamma;CCT3;>TCPG_HUMAN|P49368|T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5);21;21;49,4
P50991;P50991;T-complex protein 1 subunit delta;CCT4;>TCPD_HUMAN|P50991|T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding);19;19;40,3
P48643;P48643;T-complex protein 1 subunit epsilon;CCT5;>TCPE_HUMAN|P48643|T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon);14;14;27,5
P40227;P40227;T-complex protein 1 subunit zeta;CCT6A;>TCPZ_HUMAN|P40227|T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20);13;10;27,1
Q99832;Q99832;T-complex protein 1 subunit eta;CCT7;>TCPH_HUMAN|Q99832|T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) (T-complex protein 1 subunit  eta,  N-terminally processed);16;16;32,6
P50990;P50990;T-complex protein 1 subunit theta;CCT8;>TCPQ_HUMAN|P50990|T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Renal carcinoma antigen NY-REN-15);25;25;43,8
P08571;P08571;"Monocyte differentiation antigen CD14;Monocyte differentiation antigen CD14, urinary form;Monocyte differentiation antigen CD14, membrane-bound form";CD14;>CD14_HUMAN|P08571|Monocyte differentiation antigen CD14  (Myeloid cell-specific leucine-rich glycoprotein) (CD14) (Monocyte differentiation antigen  CD14,  urinary form) (Monocyte differentiation antigen  CD14,  membrane-bound form) (Precursor);4;4;17,1
P48509;P48509;CD151 antigen;CD151;>CD151_HUMAN|P48509|CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD151);5;5;17,4
Q8N6Q3;Q8N6Q3;CD177 antigen;CD177;>CD177_HUMAN|Q8N6Q3|CD177 antigen (Human neutrophil alloantigen 2a) (HNA-2a) (NB1 glycoprotein) (NB1 GP) (Polycythemia rubra vera protein 1) (PRV-1) (CD177) (Precursor);12;12;34,3
Q9Y5K6;Q9Y5K6;CD2-associated protein;CD2AP;>CD2AP_HUMAN|Q9Y5K6|CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains);24;24;44,4
P28907;P28907;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1;CD38;>CD38_HUMAN|P28907|ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (3.2.2.6) (2-phospho-ADP-ribosyl cyclase) (2-phospho-ADP-ribosyl cyclase/2-phospho-cyclic-ADP-ribose transferase) (2.4.99.20) (2-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cy;23;23;54
P16070;P16070;CD44 antigen;CD44;>CD44_HUMAN|P16070|CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) ;5;5;7,8
P15529;P15529;Membrane cofactor protein;CD46;>MCP_HUMAN|P15529|Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD46) (Precursor);5;5;12,2
Q08722;Q08722;Leukocyte surface antigen CD47;CD47;>CD47_HUMAN|Q08722|Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD47) (Precursor);3;3;9
P08174;P08174;Complement decay-accelerating factor;CD55;>DAF_HUMAN|P08174|Complement decay-accelerating factor (CD55) (Precursor);15;15;43,6
P19256;P19256;Lymphocyte function-associated antigen 3;CD58;>LFA3_HUMAN|P19256|Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD58) (Precursor);2;2;9,2
P13987;P13987;CD59 glycoprotein;CD59;>CD59_HUMAN|P13987|CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (;6;6;25,8
P08962;P08962;CD63 antigen;CD63;>CD63_HUMAN|P08962|CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD63);5;5;22,7
P60033;P60033;CD81 antigen;CD81;>CD81_HUMAN|P60033|CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD81);4;4;27,5
P27701;P27701;CD82 antigen;CD82;>CD82_HUMAN|P27701|CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD82);3;3;11,6
P21926;P21926;CD9 antigen;CD9;>CD9_HUMAN|P21926|CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD9);11;11;33,3
Q16543;Q16543;"Hsp90 co-chaperone Cdc37;Hsp90 co-chaperone Cdc37, N-terminally processed";CDC37;>CDC37_HUMAN|Q16543|Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) (Hsp90 co-chaperone  Cdc37,  N-terminally processed);4;4;11,6
P60953;P60953;Cell division control protein 42 homolog;CDC42;>CDC42_HUMAN|P60953|Cell division control protein 42 homolog (G25K GTP-binding protein) (Precursor);9;8;48,7
Q9Y5S2;Q9Y5S2;Serine/threonine-protein kinase MRCK beta;CDC42BPB;>MRCKB_HUMAN|Q9Y5S2|Serine/threonine-protein kinase MRCK beta (2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like b;10;8;7,1
P12830;P12830;"Cadherin-1;E-Cad/CTF1;E-Cad/CTF2;E-Cad/CTF3";CDH1;>CADH1_HUMAN|P12830|Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD324) (E-Cad/CTF1) (E-Cad/CTF2) (E-Cad/CTF3) (Precursor);3;3;5,2
"P55287;Q9ULB5;P55286;P55289";P55287;Cadherin-11;CDH11;>CAD11_HUMAN|P55287|Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin) (Precursor);2;2;2,8
Q9HBB8;Q9HBB8;Cadherin-related family member 5;CDHR5;>CDHR5_HUMAN|Q9HBB8|Cadherin-related family member 5  (Mu-protocadherin ) (Mucin and cadherin-like protein ) (Mucin-like protocadherin ) (MLPCDH ) (Precursor);5;5;8,2
Q00535;Q00535;Cyclin-dependent-like kinase 5;CDK5;>CDK5_HUMAN|Q00535|Cyclin-dependent-like kinase 5 (2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit);6;5;20,5
P13688;P13688;Carcinoembryonic antigen-related cell adhesion molecule 1;CEACAM1;>CEAM1_HUMAN|P13688|Carcinoembryonic antigen-related cell adhesion molecule 1  (Biliary glycoprotein 1 ) (BGP-1) (CD66a) (Precursor);5;4;12,2
P06731;P06731;Carcinoembryonic antigen-related cell adhesion molecule 5;CEACAM5;>CEAM5_HUMAN|P06731|Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD66e) (Precursor);3;2;4,6
P31997;P31997;Carcinoembryonic antigen-related cell adhesion molecule 8;CEACAM8;>CEAM8_HUMAN|P31997|Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD66b) (Precursor);3;2;9,7
O60308;O60308;Centrosomal protein of 104 kDa;CEP104;>CE104_HUMAN|O60308|Centrosomal protein of 104 kDa (Cep104);4;4;6,5
P23528;P23528;Cofilin-1;CFL1;>COF1_HUMAN|P23528|Cofilin-1 (18 kDa phosphoprotein) (p18)  (Cofilin,  non-muscle isoform);14;11;78,9
Q9Y259;Q9Y259;Choline/ethanolamine kinase;CHKB;>CHKB_HUMAN|Q9Y259|Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB);5;5;16,5
Q9HD42;Q9HD42;Charged multivesicular body protein 1a;CHMP1A;>CHM1A_HUMAN|Q9HD42|Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) (Vacuolar protein sorting-associated protein 46-1) (Vps46-1) (hVps46-1);9;9;30,1
Q7LBR1;Q7LBR1;Charged multivesicular body protein 1b;CHMP1B;>CHM1B_HUMAN|Q7LBR1|Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2);8;8;30,2
O43633;O43633;Charged multivesicular body protein 2a;CHMP2A;>CHM2A_HUMAN|O43633|Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1);14;14;41,9
Q9UQN3;Q9UQN3;Charged multivesicular body protein 2b;CHMP2B;>CHM2B_HUMAN|Q9UQN3|Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b) (CHMP2b) (Vacuolar protein sorting-associated protein 2-2) (Vps2-2) (hVps2-2);10;9;35,2
Q9Y3E7;Q9Y3E7;Charged multivesicular body protein 3;CHMP3;>CHMP3_HUMAN|Q9Y3E7|Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24);4;4;14,9
Q9BY43;Q9BY43;Charged multivesicular body protein 4a;CHMP4A;>CHM4A_HUMAN|Q9BY43|Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1);7;7;36,9
"Q9H444;P59074";Q9H444;Charged multivesicular body protein 4b;CHMP4B;>CHM4B_HUMAN|Q9H444|Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2);14;12;53,1
Q96CF2;Q96CF2;Charged multivesicular body protein 4c;CHMP4C;>CHM4C_HUMAN|Q96CF2|Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3) (hSnf7-3) (Vacuolar protein sorting-associated protein 32-3) (Vps32-3) (hVps32-3);11;9;36,5
Q9NZZ3;Q9NZZ3;Charged multivesicular body protein 5;CHMP5;>CHMP5_HUMAN|Q9NZZ3|Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60);9;9;37,4
Q96FZ7;Q96FZ7;Charged multivesicular body protein 6;CHMP6;>CHMP6_HUMAN|Q96FZ7|Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20);6;6;27,9
Q9UHD1;Q9UHD1;Cysteine and histidine-rich domain-containing protein 1;CHORDC1;>CHRD1_HUMAN|Q9UHD1|Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (CHP-1) (Protein morgana);3;3;16,6
Q99653;Q99653;Calcineurin B homologous protein 1;CHP1;>CHP1_HUMAN|Q99653|Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);6;6;44,1
P0CG12;P0CG12;Chromosome transmission fidelity protein 8 homolog isoform 2;CHTF8;>CTF8A_HUMAN|P0CG12|Chromosome transmission fidelity protein 8 homolog isoform 2 (Decreased expression in renal and prostate cancer protein);4;4;8,4
Q99828;Q99828;Calcium and integrin-binding protein 1;CIB1;>CIB1_HUMAN|Q99828|Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28);13;13;63,9
Q14008;Q14008;Cytoskeleton-associated protein 5;CKAP5;>CKAP5_HUMAN|Q14008|Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG);38;38;21,9
"P12277;P06732";P12277;Creatine kinase B-type;CKB;>KCRB_HUMAN|P12277|Creatine kinase B-type (2.7.3.2) (B-CK) (Creatine kinase B chain);18;18;62,7
P78369;P78369;Claudin-10;CLDN10;>CLD10_HUMAN|P78369|Claudin-10 (OSP-like protein);4;4;21,1
O15551;O15551;Claudin-3;CLDN3;>CLD3_HUMAN|O15551|Claudin-3 (Clostridium perfringens enterotoxin receptor 2) (CPE-R 2) (CPE-receptor 2) (Rat ventral prostate.1 protein homolog) (hRVP1);4;4;12,7
O00501;O00501;Claudin-5;CLDN5;>CLD5_HUMAN|O00501|Claudin-5 (Transmembrane protein deleted in VCFS) (TMDVCF);4;4;18,3
O00299;O00299;Chloride intracellular channel protein 1;CLIC1;>CLIC1_HUMAN|O00299|Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC);19;19;85,5
O95833;O95833;Chloride intracellular channel protein 3;CLIC3;>CLIC3_HUMAN|O95833|Chloride intracellular channel protein 3;6;6;36
Q9Y696;Q9Y696;Chloride intracellular channel protein 4;CLIC4;>CLIC4_HUMAN|Q9Y696|Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1);11;11;52,2
Q9NZA1;Q9NZA1;Chloride intracellular channel protein 5;CLIC5;>CLIC5_HUMAN|Q9NZA1|Chloride intracellular channel protein 5;5;4;18,5
Q96NY7;Q96NY7;Chloride intracellular channel protein 6;CLIC6;>CLIC6_HUMAN|Q96NY7|Chloride intracellular channel protein 6 (Parchorin);7;6;18,5
Q14677;Q14677;Clathrin interactor 1;CLINT1;>EPN4_HUMAN|Q14677|Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR);4;4;8,3
P30622;P30622;CAP-Gly domain-containing linker protein 1;CLIP1;>CLIP1_HUMAN|P30622|CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin);7;7;5,8
Q8NCR9;Q8NCR9;Clarin-3;CLRN3;>CLRN3_HUMAN|Q8NCR9|Clarin-3 (Transmembrane protein 12) (Usher syndrome type-3A-like protein 1);2;2;12,4
P09496;P09496;Clathrin light chain A;CLTA;>CLCA_HUMAN|P09496|Clathrin light chain A (Lca);4;4;12,9
"Q00610;P53675";Q00610;Clathrin heavy chain 1;CLTC;>CLH1_HUMAN|Q00610|Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17);47;47;34,3
P10909;P10909;"Clusterin;Clusterin beta chain;Clusterin alpha chain";CLU;>CLUS_HUMAN|P10909|Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein  SP-40,40)  (Ku70-binding protein 1) (NA1/NA2) (Testosterone-repressed prostate message 2) (TRPM;13;13;33,2
Q96DG6;Q96DG6;Carboxymethylenebutenolidase homolog;CMBL;>CMBL_HUMAN|Q96DG6|Carboxymethylenebutenolidase homolog (3.1.-.-);12;12;42,4
P30085;P30085;UMP-CMP kinase;CMPK1;>KCY_HUMAN|P30085|UMP-CMP kinase  (2.7.4.14 ) (Deoxycytidylate kinase ) (CK ) (dCMP kinase ) (Nucleoside-diphosphate kinase ) (2.7.4.6 ) (Uridine monophosphate/cytidine monophosphate kinase ) (UMP/CMP kinase ) (UMP/CMPK );13;13;63,3
P62633;P62633;Cellular nucleic acid-binding protein;CNBP;>CNBP_HUMAN|P62633|Cellular nucleic acid-binding protein (CNBP) (Zinc finger protein 9);3;3;17,5
Q96KP4;Q96KP4;Cytosolic non-specific dipeptidase;CNDP2;>CNDP2_HUMAN|Q96KP4|Cytosolic non-specific dipeptidase (3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II ) (Epididymis secretory protein Li 13 ) (Glutamate carboxypeptidase-like protein 1) (Peptidase A);29;29;65,9
P09543;P09543;2,3-cyclic-nucleotide 3-phosphodiesterase;CNP;>CN37_HUMAN|P09543| 2,3-cyclic-nucleotide  3-phosphodiesterase (CNP) (CNPase) (3.1.4.37) (Precursor);25;25;49,9
Q13057;Q13057;"Bifunctional coenzyme A synthase;Phosphopantetheine adenylyltransferase;Dephospho-CoA kinase";COASY;>COASY_HUMAN|Q13057|Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) (Phosphopantetheine adenylyltransferase) (2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT) (Dephospho-CoA kinase) (DPCK) (2.7.1.2;10;10;22,3
Q53SF7;Q53SF7;Cordon-bleu protein-like 1;COBLL1;>COBL1_HUMAN|Q53SF7|Cordon-bleu protein-like 1;8;8;8,3
Q9Y5P4;Q9Y5P4;Collagen type IV alpha-3-binding protein;COL4A3BP;>C43BP_HUMAN|Q9Y5P4|Collagen type IV alpha-3-binding protein (Ceramide transfer protein) (hCERT) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11);4;4;7,5
Q9Y6G5;Q9Y6G5;COMM domain-containing protein 10;COMMD10;>COMDA_HUMAN|Q9Y6G5|COMM domain-containing protein 10;3;3;14,4
P21964;P21964;Catechol O-methyltransferase;COMT;>COMT_HUMAN|P21964|Catechol O-methyltransferase (2.1.1.6);12;12;46,5
P53621;P53621;"Coatomer subunit alpha;Xenin;Proxenin";COPA;>COPA_HUMAN|P53621|Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) (Xenin) (Xenopsin-related peptide) (Proxenin);16;16;14,8
P53618;P53618;Coatomer subunit beta;COPB1;>COPB_HUMAN|P53618|Coatomer subunit beta (Beta-coat protein) (Beta-COP);15;15;20
P35606;P35606;Coatomer subunit beta;COPB2;>COPB2_HUMAN|P35606|Coatomer subunit beta (Beta-coat protein) (Beta-COP) (p102);18;18;26,6
O14579;O14579;Coatomer subunit epsilon;COPE;>COPE_HUMAN|O14579|Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP);4;4;17,9
"Q9Y678;Q9UBF2";Q9Y678;Coatomer subunit gamma-1;COPG1;>COPG1_HUMAN|Q9Y678|Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP);11;11;16,7
P61201;P61201;COP9 signalosome complex subunit 2;COPS2;>CSN2_HUMAN|P61201|COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15);7;7;19,2
Q9UNS2;Q9UNS2;COP9 signalosome complex subunit 3;COPS3;>CSN3_HUMAN|Q9UNS2|COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3) (JAB1-containing signalosome subunit 3);6;6;15,4
Q9BT78;Q9BT78;COP9 signalosome complex subunit 4;COPS4;>CSN4_HUMAN|Q9BT78|COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4);7;7;19,7
Q92905;Q92905;COP9 signalosome complex subunit 5;COPS5;>CSN5_HUMAN|Q92905|COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (3.4.-.-) (Jun activation domain-binding protein 1);5;5;16,8
Q7L5N1;Q7L5N1;COP9 signalosome complex subunit 6;COPS6;>CSN6_HUMAN|Q7L5N1|COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) (JAB1-containing signalosome subunit 6) (MOV34 homolog) (Vpr-interacting protein) (hVIP);2;2;7,3
Q9UBW8;Q9UBW8;COP9 signalosome complex subunit 7a;COPS7A;>CSN7A_HUMAN|Q9UBW8|COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a);4;4;16
P61923;P61923;Coatomer subunit zeta-1;COPZ1;>COPZ1_HUMAN|P61923|Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP);3;3;22
"Q9BR76;A9Z1Z3";Q9BR76;Coronin-1B;CORO1B;>COR1B_HUMAN|Q9BR76|Coronin-1B (Coronin-2);14;14;31,3
Q14019;Q14019;Coactosin-like protein;COTL1;>COTL1_HUMAN|Q14019|Coactosin-like protein;6;6;47,2
"P00450;CON__ENSEMBL:ENSBTAP00000031900";P00450;Ceruloplasmin;CP;>CERU_HUMAN|P00450|Ceruloplasmin (1.16.3.1) (Ferroxidase) (Precursor);7;7;9
P16870;P16870;Carboxypeptidase E;CPE;>CBPE_HUMAN|P16870|Carboxypeptidase E (CPE) (3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase) (Precursor);14;14;33,4
P14384;P14384;Carboxypeptidase M;CPM;>CBPM_HUMAN|P14384|Carboxypeptidase M (CPM) (3.4.17.12 ) (Precursor);19;19;43,6
Q99829;Q99829;Copine-1;CPNE1;>CPNE1_HUMAN|Q99829|Copine-1  (Chromobindin 17 ) (Copine I  );5;5;9,9
O75131;O75131;Copine-3;CPNE3;>CPNE3_HUMAN|O75131|Copine-3  (Copine III  );22;21;40,2
"Q96A23;Q9UBL6";Q96A23;Copine-4;CPNE4;>CPNE4_HUMAN|Q96A23|Copine-4  (Copine IV  ) (Copine-8 );16;15;36,1
"Q9HCH3;Q8IYJ1";Q9HCH3;Copine-5;CPNE5;>CPNE5_HUMAN|Q9HCH3|Copine-5  (Copine V  );19;10;34,2
Q86YQ8;Q86YQ8;Copine-8;CPNE8;>CPNE8_HUMAN|Q86YQ8|Copine-8  (Copine VIII );26;17;50,2
Q9BRF8;Q9BRF8;Serine/threonine-protein phosphatase CPPED1;CPPED1;>CPPED_HUMAN|Q9BRF8|Serine/threonine-protein phosphatase CPPED1 (3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1);7;7;23,9
Q9Y646;Q9Y646;Carboxypeptidase Q;CPQ;>CBPQ_HUMAN|Q9Y646|Carboxypeptidase Q (3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase) (Precursor);4;4;9,1
Q9H3G5;Q9H3G5;Probable serine carboxypeptidase CPVL;CPVL;>CPVL_HUMAN|Q9H3G5|Probable serine carboxypeptidase CPVL (3.4.16.-)  (Carboxypeptidase,  vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) (Precursor);7;7;17,2
"P17927;Q2VPA4";P17927;Complement receptor type 1;CR1;>CR1_HUMAN|P17927|Complement receptor type 1 (C3b/C4b receptor) (CD35) (Precursor);25;25;30,5
"P29373;P29762";P29373;Cellular retinoic acid-binding protein 2;CRABP2;>RABP2_HUMAN|P29373|Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II);6;6;39,1
Q9BSW2;Q9BSW2;EF-hand calcium-binding domain-containing protein 4B;CRACR2A;>EFC4B_HUMAN|Q9BSW2|EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A);9;9;27,1
Q5IJ48;Q5IJ48;Protein crumbs homolog 2;CRB2;>CRUM2_HUMAN|Q5IJ48|Protein crumbs homolog 2  (Crumbs-like protein 2) (Precursor);19;19;18,4
Q9BUF7;Q9BUF7;Protein crumbs homolog 3;CRB3;>CRUM3_HUMAN|Q9BUF7|Protein crumbs homolog 3 (Precursor);3;3;21,7
Q96SW2;Q96SW2;Protein cereblon;CRBN;>CRBN_HUMAN|Q96SW2|Protein cereblon;2;2;5,2
Q9NZV1;Q9NZV1;"Cysteine-rich motor neuron 1 protein;Processed cysteine-rich motor neuron 1 protein";CRIM1;>CRIM1_HUMAN|Q9NZV1|Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) (Processed cysteine-rich motor neuron 1 protein) (Precursor);14;14;17,5
P46108;P46108;Adapter molecule crk;CRK;>CRK_HUMAN|P46108|Adapter molecule crk (Proto-oncogene c-Crk) (p38);12;12;53,9
P46109;P46109;Crk-like protein;CRKL;>CRKL_HUMAN|P46109|Crk-like protein;7;7;28,1
P02511;P02511;Alpha-crystallin B chain;CRYAB;>CRYAB_HUMAN|P02511|Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component);10;10;46,3
Q9Y2S2;Q9Y2S2;Lambda-crystallin homolog;CRYL1;>CRYL1_HUMAN|Q9Y2S2|Lambda-crystallin homolog (1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH);14;14;51,1
Q14894;Q14894;Ketimine reductase mu-crystallin;CRYM;>CRYM_HUMAN|Q14894|Ketimine reductase mu-crystallin (1.5.1.25) (NADP-regulated thyroid-hormone-binding protein);12;12;45,9
Q08257;Q08257;Quinone oxidoreductase;CRYZ;>QOR_HUMAN|Q08257|Quinone oxidoreductase (1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin);10;10;33,4
O75534;O75534;Cold shock domain-containing protein E1;CSDE1;>CSDE1_HUMAN|O75534|Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR);5;5;6,4
P55060;P55060;Exportin-2;CSE1L;>XPO2_HUMAN|P55060|Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein ) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter);5;5;6,3
"P41240;P42679";P41240;Tyrosine-protein kinase CSK;CSK;>CSK_HUMAN|P41240|Tyrosine-protein kinase CSK (2.7.10.2  ) (C-Src kinase) (Protein-tyrosine kinase CYL);7;7;17,6
P48729;P48729;Casein kinase I isoform alpha;CSNK1A1;>KC1A_HUMAN|P48729|Casein kinase I isoform alpha (CKI-alpha) (2.7.11.1) (CK1);6;6;22,8
"Q9Y6M4;P78368";"Q9Y6M4;P78368";"Casein kinase I isoform gamma-3;Casein kinase I isoform gamma-2";CSNK1G3;">KC1G3_HUMAN|Q9Y6M4|Casein kinase I isoform gamma-3 (CKI-gamma 3) (2.7.11.1);>KC1G2_HUMAN|P78368|Casein kinase I isoform gamma-2 (CKI-gamma 2) (2.7.11.1)";9;3;17,9
P19784;P19784;Casein kinase II subunit alpha;CSNK2A2;>CSK22_HUMAN|P19784|Casein kinase II subunit alpha (CK II alpha) (2.7.11.1);2;2;6,6
"Q8NEV1;P68400";"Q8NEV1;P68400";"Casein kinase II subunit alpha 3;Casein kinase II subunit alpha";CSNK2A3;">CSK23_HUMAN|Q8NEV1|Casein kinase II subunit alpha 3 (CK II alpha 3) (2.7.11.1) (Casein kinase II alpha 1 polypeptide pseudogene);>CSK21_HUMAN|P68400|Casein kinase II subunit alpha (CK II alpha) (2.7.11.1)";3;3;11,5
P67870;P67870;Casein kinase II subunit beta;CSNK2B;>CSK2B_HUMAN|P67870|Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a);2;2;11,6
Q1MSJ5;Q1MSJ5;Centrosome and spindle pole-associated protein 1;CSPP1;>CSPP1_HUMAN|Q1MSJ5|Centrosome and spindle pole-associated protein 1;2;2;2,9
P21291;P21291;Cysteine and glycine-rich protein 1;CSRP1;>CSRP1_HUMAN|P21291|Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141);8;8;53,4
P04080;P04080;Cystatin-B;CSTB;>CYTB_HUMAN|P04080|Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B);5;5;77,6
Q9GZU7;Q9GZU7;Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1;CTDSP1;>CTDS1_HUMAN|Q9GZU7|Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (3.1.3.16  ) (Nuclear LIM interactor-interacting factor 3) (NLI-IF) (NLI-interacting factor 3) (Small C-terminal domain phosphatase 1) (SCP1) (Small CTD phospha;5;4;24,1
P32929;P32929;Cystathionine gamma-lyase;CTH;>CGL_HUMAN|P32929|Cystathionine gamma-lyase (4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase);6;6;18,3
"P35221;Q9UI47;P26232";P35221;Catenin alpha-1;CTNNA1;>CTNA1_HUMAN|P35221|Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13);6;6;9,9
P35222;P35222;Catenin beta-1;CTNNB1;>CTNB1_HUMAN|P35222|Catenin beta-1 (Beta-catenin);12;9;16,9
Q9NRF8;Q9NRF8;CTP synthase 2;CTPS2;>PYRG2_HUMAN|Q9NRF8|CTP synthase 2 (6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2);8;7;14,2
P07858;P07858;"Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain";CTSB;>CATB_HUMAN|P07858|Cathepsin B (3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) (Cathepsin B light chain) (Cathepsin B heavy chain) (Precursor);3;3;12,4
P07339;P07339;"Cathepsin D;Cathepsin D light chain;Cathepsin D heavy chain";CTSD;>CATD_HUMAN|P07339|Cathepsin D (3.4.23.5) (Cathepsin D light chain) (Cathepsin D heavy chain) (Precursor);8;8;25
P09668;P09668;"Pro-cathepsin H;Cathepsin H mini chain;Cathepsin H;Cathepsin H heavy chain;Cathepsin H light chain";CTSH;>CATH_HUMAN|P09668|Pro-cathepsin H (Cathepsin H mini chain) (Cathepsin H) (3.4.22.16) (Cathepsin H heavy chain) (Cathepsin H light chain) (Precursor);4;4;14
Q14247;Q14247;Src substrate cortactin;CTTN;>SRC8_HUMAN|Q14247|Src substrate cortactin (Amplaxin) (Oncogene EMS1);17;17;36
O60494;O60494;Cubilin;CUBN;>CUBN_HUMAN|O60494|Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) (Precursor);16;16;6,1
Q13618;Q13618;Cullin-3;CUL3;>CUL3_HUMAN|Q13618|Cullin-3 (CUL-3);10;10;15,5
"Q13619;Q13620";Q13619;Cullin-4A;CUL4A;>CUL4A_HUMAN|Q13619|Cullin-4A (CUL-4A);6;6;8,7
Q93034;Q93034;Cullin-5;CUL5;>CUL5_HUMAN|Q93034|Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1);15;15;19,1
O60888;O60888;Protein CutA;CUTA;>CUTA_HUMAN|O60888|Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor) (Precursor);2;2;14,5
P78310;P78310;Coxsackievirus and adenovirus receptor;CXADR;>CXAR_HUMAN|P78310|Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR) (Precursor);2;2;7,4
P49447;P49447;Cytochrome b561;CYB561;>CY561_HUMAN|P49447|Cytochrome b561 (Cytochrome b-561);2;2;10,4
Q53TN4;Q53TN4;Cytochrome b reductase 1;CYBRD1;>CYBR1_HUMAN|Q53TN4|Cytochrome b reductase 1 (1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3);5;5;18,9
Q7L576;Q7L576;Cytoplasmic FMR1-interacting protein 1;CYFIP1;>CYFP1_HUMAN|Q7L576|Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1);31;19;27
Q96F07;Q96F07;Cytoplasmic FMR1-interacting protein 2;CYFIP2;>CYFP2_HUMAN|Q96F07|Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121);19;7;16,9
Q9H1C7;Q9H1C7;Cysteine-rich and transmembrane domain-containing protein 1;CYSTM1;>CYTM1_HUMAN|Q9H1C7|Cysteine-rich and transmembrane domain-containing protein 1;2;2;11,3
P98082;P98082;Disabled homolog 2;DAB2;>DAB2_HUMAN|P98082|Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2);5;5;7,3
Q14118;Q14118;"Dystroglycan;Alpha-dystroglycan;Beta-dystroglycan";DAG1;>DAG1_HUMAN|Q14118|Dystroglycan (Dystrophin-associated glycoprotein 1) (Alpha-dystroglycan) (Alpha-DG) (Beta-dystroglycan) (Beta-DG) (Precursor);8;8;10,7
Q3LXA3;Q3LXA3;"Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing);ATP-dependent dihydroxyacetone kinase;FAD-AMP lyase (cyclizing)";DAK;>TKFC_HUMAN|Q3LXA3|Triokinase/FMN cyclase  (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) (ATP-dependent dihydroxyacetone kinase) (DHA kinase) (2.7.1.28) (2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase) (FAD-AMP ly;18;18;37,6
P14868;P14868;Aspartate--tRNA ligase, cytoplasmic;DARS;>SYDC_HUMAN|P14868|Aspartate--tRNA  ligase,  cytoplasmic (6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein);10;10;25,3
P07108;P07108;Acyl-CoA-binding protein;DBI;>ACBP_HUMAN|P07108|Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP);6;6;70,1
Q9UJU6;Q9UJU6;Drebrin-like protein;DBNL;>DBNL_HUMAN|Q9UJU6|Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7);14;14;43,5
Q14203;Q14203;Dynactin subunit 1;DCTN1;>DCTN1_HUMAN|Q14203|Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued);15;15;14,5
Q13561;Q13561;Dynactin subunit 2;DCTN2;>DCTN2_HUMAN|Q13561|Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin);12;12;37,4
O75935;O75935;Dynactin subunit 3;DCTN3;>DCTN3_HUMAN|O75935|Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22);4;4;19,4
Q9UJW0;Q9UJW0;Dynactin subunit 4;DCTN4;>DCTN4_HUMAN|Q9UJW0|Dynactin subunit 4 (Dyn4) (Dynactin subunit p62);3;3;8,3
Q7Z4W1;Q7Z4W1;L-xylulose reductase;DCXR;>DCXR_HUMAN|Q7Z4W1|L-xylulose reductase (XR) (1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H);14;14;59,8
O94760;O94760;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1;DDAH1;>DDAH1_HUMAN|O94760| N(G),N(G)-dimethylarginine  dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (3.5.3.18) (DDAHI) (Dimethylargininase-1);15;14;64,2
O95865;O95865;N(G),N(G)-dimethylarginine dimethylaminohydrolase 2;DDAH2;>DDAH2_HUMAN|O95865| N(G),N(G)-dimethylarginine  dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dimethylaminohydrolase 2) (3.5.3.18) (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein);9;8;44,6
Q16531;Q16531;DNA damage-binding protein 1;DDB1;>DDB1_HUMAN|Q16531|DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a) (DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1) (XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1) (UV-DDB;22;22;22
P20711;P20711;Aromatic-L-amino-acid decarboxylase;DDC;>DDC_HUMAN|P20711|Aromatic-L-amino-acid decarboxylase (AADC) (4.1.1.28) (DOPA decarboxylase) (DDC);12;12;25
Q5TDH0;Q5TDH0;Protein DDI1 homolog 2;DDI2;>DDI2_HUMAN|Q5TDH0|Protein DDI1 homolog 2;7;7;26,6
"P30046;A6NHG4";"P30046;A6NHG4";"D-dopachrome decarboxylase;D-dopachrome decarboxylase-like protein";DDT;">DOPD_HUMAN|P30046|D-dopachrome decarboxylase (4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II);>DDTL_HUMAN|A6NHG4|D-dopachrome decarboxylase-like protein (4.1.1.-) (D-dopachrome tautomerase-like protein)";7;7;63,6
Q92499;Q92499;ATP-dependent RNA helicase DDX1;DDX1;>DDX1_HUMAN|Q92499|ATP-dependent RNA helicase DDX1 (3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB);3;3;4,1
"Q9NUU7;Q9UMR2;Q9UHL0";"Q9NUU7;Q9UMR2";"ATP-dependent RNA helicase DDX19A;ATP-dependent RNA helicase DDX19B";DDX19A;">DD19A_HUMAN|Q9NUU7|ATP-dependent RNA helicase DDX19A (3.6.4.13) (DDX19-like protein) (DEAD box protein 19A);>DD19B_HUMAN|Q9UMR2|ATP-dependent RNA helicase DDX19B (3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B)";7;7;14,9
"O00571;O15523;Q9NQI0";"O00571;O15523";"ATP-dependent RNA helicase DDX3X;ATP-dependent RNA helicase DDX3Y";DDX3X;">DDX3X_HUMAN|O00571|ATP-dependent RNA helicase DDX3X (3.6.4.13) (DEAD box protein  3,  X-chromosomal) (DEAD  box,  X isoform) (Helicase-like protein 2) (HLP2);>DDX3Y_HUMAN|O15523|ATP-dependent RNA helicase DDX3Y (3.6.4.13) (DEAD box protein  3,  Y-chromoso";8;8;14,5
P26196;P26196;Probable ATP-dependent RNA helicase DDX6;DDX6;>DDX6_HUMAN|P26196|Probable ATP-dependent RNA helicase DDX6  (3.6.4.13 ) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK);2;2;4,3
"P59666;P59665";"P59666;P59665";"Neutrophil defensin 3;HP 3-56;Neutrophil defensin 2;Neutrophil defensin 1;HP 1-56;Neutrophil defensin 2";DEFA3;">DEF3_HUMAN|P59666|Neutrophil defensin 3  (Defensin,  alpha 3) (HNP-3) (HP-3) (HP3) (HP 3-56) (Neutrophil defensin 2) (HNP-2) (HP-2) (HP2) (Precursor);>DEF1_HUMAN|P59665|Neutrophil defensin 1  (Defensin,  alpha 1) (HNP-1) (HP-1) (HP1) (HP 1-56) (Neutrophil";4;4;20,2
O43583;O43583;Density-regulated protein;DENR;>DENR_HUMAN|O43583|Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3);4;4;20,2
Q8TB45;Q8TB45;DEP domain-containing mTOR-interacting protein;DEPTOR;>DPTOR_HUMAN|Q8TB45|DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6);3;3;7,1
O00273;O00273;DNA fragmentation factor subunit alpha;DFFA;>DFFA_HUMAN|O00273|DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD);4;4;12,4
Q6UWP2;Q6UWP2;Dehydrogenase/reductase SDR family member 11;DHRS11;>DHR11_HUMAN|Q6UWP2|Dehydrogenase/reductase SDR family member 11 (1.1.-.-) (Short-chain dehydrogenase/reductase family 24C member 1 ) (Precursor);3;3;14,6
Q9Y394;Q9Y394;Dehydrogenase/reductase SDR family member 7;DHRS7;>DHRS7_HUMAN|Q9Y394|Dehydrogenase/reductase SDR family member 7 (1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Precursor);5;5;16,2
Q14689;Q14689;Disco-interacting protein 2 homolog A;DIP2A;>DIP2A_HUMAN|Q14689|Disco-interacting protein 2 homolog A (DIP2 homolog A);9;4;6,1
Q9P265;Q9P265;Disco-interacting protein 2 homolog B;DIP2B;>DIP2B_HUMAN|Q9P265|Disco-interacting protein 2 homolog B (DIP2 homolog B);12;10;10,2
Q9Y2E4;Q9Y2E4;Disco-interacting protein 2 homolog C;DIP2C;>DIP2C_HUMAN|Q9Y2E4|Disco-interacting protein 2 homolog C (DIP2 homolog C);11;8;7,8
Q9Y2H0;Q9Y2H0;Disks large-associated protein 4;DLGAP4;>DLGP4_HUMAN|Q9Y2H0|Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4);7;7;8,4
Q9Y485;Q9Y485;DmX-like protein 1;DMXL1;>DMXL1_HUMAN|Q9Y485|DmX-like protein 1 (X-like 1 protein);36;36;14,2
P31689;P31689;DnaJ homolog subfamily A member 1;DNAJA1;>DNJA1_HUMAN|P31689|DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2) (Precursor);11;11;34,3
O60884;O60884;DnaJ homolog subfamily A member 2;DNAJA2;>DNJA2_HUMAN|O60884|DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14) (Precursor);8;8;20,6
"P25685;Q9UDY4";P25685;DnaJ homolog subfamily B member 1;DNAJB1;>DNJB1_HUMAN|P25685|DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1);10;10;29,4
P25686;P25686;DnaJ homolog subfamily B member 2;DNAJB2;>DNJB2_HUMAN|P25686|DnaJ homolog subfamily B member 2  (Heat shock 40 kDa protein 3 ) (Heat shock protein J1 ) (HSJ-1 ) (Precursor);6;5;18,8
"O75190;Q8WWF6;Q8NHS0";O75190;DnaJ homolog subfamily B member 6;DNAJB6;>DNJB6_HUMAN|O75190|DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1);4;3;13,2
O75165;O75165;DnaJ homolog subfamily C member 13;DNAJC13;>DJC13_HUMAN|O75165|DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8);3;3;1,6
Q9H3Z4;Q9H3Z4;DnaJ homolog subfamily C member 5;DNAJC5;>DNJC5_HUMAN|Q9H3Z4|DnaJ homolog subfamily C member 5  (Ceroid-lipofuscinosis neuronal protein 4 ) (Cysteine string protein ) (CSP );7;7;41,9
"P50570;Q9UQ16;Q05193";P50570;Dynamin-2;DNM2;>DYN2_HUMAN|P50570|Dynamin-2 (3.6.5.5);17;17;21,6
Q9ULA0;Q9ULA0;Aspartyl aminopeptidase;DNPEP;>DNPEP_HUMAN|Q9ULA0|Aspartyl aminopeptidase (3.4.11.21);7;7;17,1
O43598;O43598;2-deoxynucleoside 5-phosphate N-hydrolase 1;DNPH1;>DNPH1_HUMAN|O43598|2-deoxynucleoside 5-phosphate N-hydrolase 1  (3.2.2.-  ) (c-Myc-responsive protein RCL );5;5;31
Q14185;Q14185;Dedicator of cytokinesis protein 1;DOCK1;>DOCK1_HUMAN|Q14185|Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180);2;2;1,1
"Q9Y3R5;Q5JWR5";Q9Y3R5;Protein dopey-2;DOPEY2;>DOP2_HUMAN|Q9Y3R5|Protein dopey-2;95;95;45,2
P16444;P16444;Dipeptidase 1;DPEP1;>DPEP1_HUMAN|P16444|Dipeptidase 1 (3.4.13.19) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) (Precursor);21;21;71,8
Q9NY33;Q9NY33;Dipeptidyl peptidase 3;DPP3;>DPP3_HUMAN|Q9NY33|Dipeptidyl peptidase 3 (3.4.14.4  ) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B);10;10;17,6
P27487;P27487;"Dipeptidyl peptidase 4;Dipeptidyl peptidase 4 membrane form;Dipeptidyl peptidase 4 soluble form";DPP4;>DPP4_HUMAN|P27487|Dipeptidyl peptidase 4 (3.4.14.5 ) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD26) (Dipeptidyl peptidase 4 membrane form) (Dipeptidyl peptidas;45;45;47,5
P42658;P42658;Dipeptidyl aminopeptidase-like protein 6;DPP6;>DPP6_HUMAN|P42658|Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI);4;4;5,9
Q9UHL4;Q9UHL4;Dipeptidyl peptidase 2;DPP7;>DPP2_HUMAN|Q9UHL4|Dipeptidyl peptidase 2 (3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) (Precursor);6;6;16,5
Q14117;Q14117;Dihydropyrimidinase;DPYS;>DPYS_HUMAN|Q14117|Dihydropyrimidinase (DHP) (DHPase) (3.5.2.2 ) (Dihydropyrimidine amidohydrolase) (Hydantoinase);8;7;18,7
"Q14195;Q14194;Q16555";Q14195;Dihydropyrimidinase-related protein 3;DPYSL3;>DPYL3_HUMAN|Q14195|Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1);7;6;16,7
P55039;P55039;Developmentally-regulated GTP-binding protein 2;DRG2;>DRG2_HUMAN|P55039|Developmentally-regulated GTP-binding protein 2 (DRG-2);4;3;10,4
P60981;P60981;Destrin;DSTN;>DEST_HUMAN|P60981|Destrin (Actin-depolymerizing factor) (ADF);9;8;45,5
P51452;P51452;Dual specificity protein phosphatase 3;DUSP3;>DUS3_HUMAN|P51452|Dual specificity protein phosphatase 3 (3.1.3.16) (3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);4;4;30,8
Q14204;Q14204;Cytoplasmic dynein 1 heavy chain 1;DYNC1H1;>DYHC1_HUMAN|Q14204|Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy  chain,  cytosolic);124;124;30
Q13409;Q13409;Cytoplasmic dynein 1 intermediate chain 2;DYNC1I2;>DC1I2_HUMAN|Q13409|Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain  2,  cytosolic) (DH IC-2);8;8;12,4
Q9Y6G9;Q9Y6G9;Cytoplasmic dynein 1 light intermediate chain 1;DYNC1LI1;>DC1L1_HUMAN|Q9Y6G9|Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain  1,  cytosolic);10;9;22,6
O43237;O43237;Cytoplasmic dynein 1 light intermediate chain 2;DYNC1LI2;>DC1L2_HUMAN|O43237|Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain  2,  cytosolic) (LIC-2) (LIC53/55);7;6;20,7
Q96FJ2;Q96FJ2;Dynein light chain 2, cytoplasmic;DYNLL2;>DYL2_HUMAN|Q96FJ2|Dynein light chain  2,  cytoplasmic (8 kDa dynein light chain b) (DLC8b) (Dynein light chain LC8-type 2);5;2;58,4
"Q9NP97;Q8TF09";"Q9NP97;Q8TF09";"Dynein light chain roadblock-type 1;Dynein light chain roadblock-type 2";DYNLRB1;">DLRB1_HUMAN|Q9NP97|Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain  2A,  cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1);>DLRB2_HUMAN|Q8TF09|Dynein light chain roadblock-type 2";4;4;43,8
"Q92630;O43781";Q92630;Dual specificity tyrosine-phosphorylation-regulated kinase 2;DYRK2;>DYRK2_HUMAN|Q92630|Dual specificity tyrosine-phosphorylation-regulated kinase 2 (2.7.12.1);3;3;6
Q5VYK3;Q5VYK3;Proteasome-associated protein ECM29 homolog;ECM29;>ECM29_HUMAN|Q5VYK3|Proteasome-associated protein ECM29 homolog (Ecm29);6;6;4,1
Q15075;Q15075;Early endosome antigen 1;EEA1;>EEA1_HUMAN|Q15075|Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2);8;8;7,2
"P68104;Q5VTE0";"P68104;Q5VTE0";"Elongation factor 1-alpha 1;Putative elongation factor 1-alpha-like 3";EEF1A1;">EF1A1_HUMAN|P68104|Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7);>EF1A3_HUMAN|Q5VTE0|Putative elongation factor 1-alpha-like 3 (EF-1-alpha-lik";22;13;43,9
P24534;P24534;Elongation factor 1-beta;EEF1B2;>EF1B_HUMAN|P24534|Elongation factor 1-beta (EF-1-beta);3;2;17,3
P26641;P26641;Elongation factor 1-gamma;EEF1G;>EF1G_HUMAN|P26641|Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma);7;7;18,3
"P13639;Q15029";P13639;Elongation factor 2;EEF2;>EF2_HUMAN|P13639|Elongation factor 2 (EF-2);35;35;40,9
Q96C19;Q96C19;EF-hand domain-containing protein D2;EFHD2;>EFHD2_HUMAN|Q96C19|EF-hand domain-containing protein D2 (Swiprosin-1);8;6;36,7
P98172;P98172;Ephrin-B1;EFNB1;>EFNB1_HUMAN|P98172|Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) (Precursor);7;7;35
Q14156;Q14156;Protein EFR3 homolog A;EFR3A;>EFR3A_HUMAN|Q14156|Protein EFR3 homolog A  (Protein EFR3-like);8;8;11
P01133;P01133;"Pro-epidermal growth factor;Epidermal growth factor";EGF;>EGF_HUMAN|P01133|Pro-epidermal growth factor (EGF) (Epidermal growth factor) (Urogastrone) (Precursor);7;7;7,8
Q9H4M9;Q9H4M9;EH domain-containing protein 1;EHD1;>EHD1_HUMAN|Q9H4M9|EH domain-containing protein 1  (PAST homolog 1 ) (hPAST1 ) (Testilin );32;22;67,2
Q9H223;Q9H223;EH domain-containing protein 4;EHD4;>EHD4_HUMAN|Q9H223|EH domain-containing protein 4  (Hepatocellular carcinoma-associated protein 11-Oct ) (PAST homolog 4 );26;20;54
Q14232;Q14232;Translation initiation factor eIF-2B subunit alpha;EIF2B1;>EI2BA_HUMAN|Q14232|Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha);4;4;13,8
P05198;P05198;Eukaryotic translation initiation factor 2 subunit 1;EIF2S1;>IF2A_HUMAN|P05198|Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha);6;6;21
P20042;P20042;Eukaryotic translation initiation factor 2 subunit 2;EIF2S2;>IF2B_HUMAN|P20042|Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta);4;4;12,6
"P41091;Q2VIR3";"P41091;Q2VIR3";"Eukaryotic translation initiation factor 2 subunit 3;Putative eukaryotic translation initiation factor 2 subunit 3-like protein";EIF2S3;">IF2G_HUMAN|P41091|Eukaryotic translation initiation factor 2 subunit 3 (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF-2-gamma X) (eIF-2gX);>IF2GL_HUMAN|Q2VIR3|Putative eukaryotic translation initiation factor 2 subunit 3-like protein (E";9;9;25,2
Q14152;Q14152;Eukaryotic translation initiation factor 3 subunit A;EIF3A;>EIF3A_HUMAN|Q14152|Eukaryotic translation initiation factor 3 subunit A  (eIF3a ) (Eukaryotic translation initiation factor 3 subunit 10 ) (eIF-3-theta ) (eIF3 p167) (eIF3 p180) (eIF3 p185);6;6;4,1
P55884;P55884;Eukaryotic translation initiation factor 3 subunit B;EIF3B;>EIF3B_HUMAN|P55884|Eukaryotic translation initiation factor 3 subunit B  (eIF3b ) (Eukaryotic translation initiation factor 3 subunit 9 ) (Prt1 homolog) (hPrt1) (eIF-3-eta ) (eIF3 p110 ) (eIF3 p116);6;6;7,4
"Q99613;B5ME19";"Q99613;B5ME19";"Eukaryotic translation initiation factor 3 subunit C;Eukaryotic translation initiation factor 3 subunit C-like protein";EIF3C;">EIF3C_HUMAN|Q99613|Eukaryotic translation initiation factor 3 subunit C  (eIF3c ) (Eukaryotic translation initiation factor 3 subunit 8 ) (eIF3 p110 );>EIFCL_HUMAN|B5ME19|Eukaryotic translation initiation factor 3 subunit C-like protein";4;4;4,2
Q13347;Q13347;Eukaryotic translation initiation factor 3 subunit I;EIF3I;>EIF3I_HUMAN|Q13347|Eukaryotic translation initiation factor 3 subunit I  (eIF3i ) (Eukaryotic translation initiation factor 3 subunit 2 ) (TGF-beta receptor-interacting protein 1) (TRIP-1) (eIF-3-beta ) (eIF3 p36 );3;3;10,8
O75822;O75822;Eukaryotic translation initiation factor 3 subunit J;EIF3J;>EIF3J_HUMAN|O75822|Eukaryotic translation initiation factor 3 subunit J  (eIF3j ) (Eukaryotic translation initiation factor 3 subunit 1 ) (eIF-3-alpha ) (eIF3 p35 );2;2;9,7
Q9Y262;Q9Y262;Eukaryotic translation initiation factor 3 subunit L;EIF3L;>EIF3L_HUMAN|Q9Y262|Eukaryotic translation initiation factor 3 subunit L  (eIF3l ) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein ) (Eukaryotic translation initiation factor 3 subunit E-interacting protein );5;5;10,8
Q7L2H7;Q7L2H7;Eukaryotic translation initiation factor 3 subunit M;EIF3M;>EIF3M_HUMAN|Q7L2H7|Eukaryotic translation initiation factor 3 subunit M  (eIF3m ) (Fetal lung protein B5) (hFL-B5) (PCI domain-containing protein 1);2;2;7,8
"P60842;P38919";P60842;Eukaryotic initiation factor 4A-I;EIF4A1;>IF4A1_HUMAN|P60842|Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (3.6.4.13) (ATP-dependent RNA helicase eIF4A-1);15;7;39,9
Q14240;Q14240;Eukaryotic initiation factor 4A-II;EIF4A2;>IF4A2_HUMAN|Q14240|Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (3.6.4.13) (ATP-dependent RNA helicase eIF4A-2);13;5;36,4
"P06730;A6NMX2";P06730;Eukaryotic translation initiation factor 4E;EIF4E;>IF4E_HUMAN|P06730|Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);4;4;17,1
"Q04637;O43432";Q04637;Eukaryotic translation initiation factor 4 gamma 1;EIF4G1;>IF4G1_HUMAN|Q04637|Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220);9;9;6,2
Q15056;Q15056;Eukaryotic translation initiation factor 4H;EIF4H;>IF4H_HUMAN|Q15056|Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein);4;4;21,4
P55010;P55010;Eukaryotic translation initiation factor 5;EIF5;>IF5_HUMAN|P55010|Eukaryotic translation initiation factor 5 (eIF-5);7;7;17,2
"P63241;Q9GZV4;Q6IS14";"P63241;Q9GZV4;Q6IS14";"Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-2;Eukaryotic translation initiation factor 5A-1-like";EIF5A;">IF5A1_HUMAN|P63241|Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D);>IF5A2_HUMAN|Q9GZV4|Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2)";9;9;40,3
P56537;P56537;Eukaryotic translation initiation factor 6;EIF6;>IF6_HUMAN|P56537|Eukaryotic translation initiation factor 6  (eIF-6 ) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP));4;4;29
Q9H9T3;Q9H9T3;Elongator complex protein 3;ELP3;>ELP3_HUMAN|Q9H9T3|Elongator complex protein 3 (hELP3) (2.3.1.48);2;2;4,2
"O95834;O00423;Q6ZMW3";O95834;Echinoderm microtubule-associated protein-like 2;EML2;>EMAL2_HUMAN|O95834|Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2);22;21;43,6
O94919;O94919;Endonuclease domain-containing 1 protein;ENDOD1;>ENDD1_HUMAN|O94919|Endonuclease domain-containing 1 protein (3.1.30.-) (Precursor);4;4;10
"P06733;P13929;P09104";P06733;Alpha-enolase;ENO1;>ENOA_HUMAN|P06733|Alpha-enolase (4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein);21;21;50,2
Q9UHY7;Q9UHY7;Enolase-phosphatase E1;ENOPH1;>ENOPH_HUMAN|Q9UHY7|Enolase-phosphatase E1  (3.1.3.77 )  (2,3-diketo-5-methylthio-1-phosphopentane  phosphatase ) (MASA homolog );7;7;28
Q7L5Y1;Q7L5Y1;Mitochondrial enolase superfamily member 1;ENOSF1;>ENOF1_HUMAN|Q7L5Y1|Mitochondrial enolase superfamily member 1 (4.2.1.68 ) (Antisense RNA to thymidylate synthase) (rTS) (L-fuconate dehydratase);10;10;27,5
Q07075;Q07075;Glutamyl aminopeptidase;ENPEP;>AMPE_HUMAN|Q07075|Glutamyl aminopeptidase (EAP) (3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD249);31;31;31,1
O14638;O14638;"Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;Alkaline phosphodiesterase I;Nucleotide pyrophosphatase";ENPP3;>ENPP3_HUMAN|O14638|Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD203c) (Alkaline phosphodiesterase I) (3.1.4.1 ) (Nucleotide pyrophosp;6;6;9,3
Q6UWR7;Q6UWR7;Ectonucleotide pyrophosphatase/phosphodiesterase family member 6;ENPP6;>ENPP6_HUMAN|Q6UWR7|Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (E-NPP 6) (NPP-6) (3.1.4.-) (3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Glycerophosphocholine cholinephosphodiesterase) (GPC-Cpde) (Precursor);5;5;13,6
Q9Y5L3;Q9Y5L3;Ectonucleoside triphosphate diphosphohydrolase 2;ENTPD2;>ENTP2_HUMAN|Q9Y5L3|Ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) (3.6.1.-) (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2) (Ecto-ATPDase 2) (Ecto-ATPase 2);3;3;8,1
O75355;O75355;Ectonucleoside triphosphate diphosphohydrolase 3;ENTPD3;>ENTP3_HUMAN|O75355|Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6);6;6;13,8
P34913;P34913;"Bifunctional epoxide hydrolase 2;Cytosolic epoxide hydrolase 2;Lipid-phosphate phosphatase";EPHX2;>HYES_HUMAN|P34913|Bifunctional epoxide hydrolase 2 (Cytosolic epoxide hydrolase 2) (CEH) (3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH) (Lipid-phosphate phosphatase) (3.1.3.76);22;22;51,7
Q9Y6I3;Q9Y6I3;Epsin-1;EPN1;>EPN1_HUMAN|Q9Y6I3|Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1);4;3;6,8
P07814;P07814;"Bifunctional glutamate/proline--tRNA ligase;Glutamate--tRNA ligase;Proline--tRNA ligase";EPRS;>SYEP_HUMAN|P07814|Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) (Glutamate--tRNA ligase) (6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS);6;6;4,8
P42566;P42566;Epidermal growth factor receptor substrate 15;EPS15;>EPS15_HUMAN|P42566|Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p);4;4;5,5
Q12929;Q12929;Epidermal growth factor receptor kinase substrate 8;EPS8;>EPS8_HUMAN|Q12929|Epidermal growth factor receptor kinase substrate 8;37;37;58,2
Q8TE68;Q8TE68;Epidermal growth factor receptor kinase substrate 8-like protein 1;EPS8L1;>ES8L1_HUMAN|Q8TE68|Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1);30;30;45,4
Q9H6S3;Q9H6S3;Epidermal growth factor receptor kinase substrate 8-like protein 2;EPS8L2;>ES8L2_HUMAN|Q9H6S3|Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2);32;32;54,8
Q969X5;Q969X5;Endoplasmic reticulum-Golgi intermediate compartment protein 1;ERGIC1;>ERGI1_HUMAN|Q969X5|Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32);6;6;20,3
P10768;P10768;S-formylglutathione hydrolase;ESD;>ESTD_HUMAN|P10768|S-formylglutathione hydrolase (FGH) (3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (3.1.1.56);9;9;41,8
P62495;P62495;Eukaryotic peptide chain release factor subunit 1;ETF1;>ERF1_HUMAN|P62495|Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Protein Cl1) (TB3-1);8;8;17,8
Q92817;Q92817;Envoplakin;EVPL;>EVPL_HUMAN|Q92817|Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210);21;21;13,5
Q9NV70;Q9NV70;Exocyst complex component 1;EXOC1;>EXOC1_HUMAN|Q9NV70|Exocyst complex component 1 (Exocyst complex component Sec3);8;8;12,1
Q96KP1;Q96KP1;Exocyst complex component 2;EXOC2;>EXOC2_HUMAN|Q96KP1|Exocyst complex component 2 (Exocyst complex component Sec5);15;15;18,6
O60645;O60645;Exocyst complex component 3;EXOC3;>EXOC3_HUMAN|O60645|Exocyst complex component 3 (Exocyst complex component Sec6);9;9;13,1
Q96A65;Q96A65;Exocyst complex component 4;EXOC4;>EXOC4_HUMAN|Q96A65|Exocyst complex component 4 (Exocyst complex component Sec8);21;21;26,1
O00471;O00471;Exocyst complex component 5;EXOC5;>EXOC5_HUMAN|O00471|Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10);12;12;17,7
Q8TAG9;Q8TAG9;Exocyst complex component 6;EXOC6;>EXOC6_HUMAN|Q8TAG9|Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1);10;9;13,1
Q9Y2D4;Q9Y2D4;Exocyst complex component 6B;EXOC6B;>EXC6B_HUMAN|Q9Y2D4|Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2);4;3;5,4
Q9UPT5;Q9UPT5;Exocyst complex component 7;EXOC7;>EXOC7_HUMAN|Q9UPT5|Exocyst complex component 7 (Exocyst complex component Exo70);12;12;19,2
Q8IYI6;Q8IYI6;Exocyst complex component 8;EXOC8;>EXOC8_HUMAN|Q8IYI6|Exocyst complex component 8 (Exocyst complex 84 kDa subunit);13;13;18,3
P15311;P15311;Ezrin;EZR;>EZRI_HUMAN|P15311|Ezrin (Cytovillin) (Villin-2) (p81);47;33;65,4
Q9Y624;Q9Y624;Junctional adhesion molecule A;F11R;>JAM1_HUMAN|Q9Y624|Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD321) (Precursor);3;3;14
"P00734;CON__P00735";P00734;"Prothrombin;Activation peptide fragment 1;Activation peptide fragment 2;Thrombin light chain;Thrombin heavy chain";F2;>THRB_HUMAN|P00734|Prothrombin (3.4.21.5) (Coagulation factor II) (Activation peptide fragment 1) (Activation peptide fragment 2) (Thrombin light chain) (Thrombin heavy chain) (Precursor);6;6;12,1
P25116;P25116;Proteinase-activated receptor 1;F2R;>PAR1_HUMAN|P25116|Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor) (Precursor);3;3;9,9
P13726;P13726;Tissue factor;F3;>TF_HUMAN|P13726|Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD142) (Precursor);2;2;10,2
P07148;P07148;Fatty acid-binding protein, liver;FABP1;>FABPL_HUMAN|P07148|Fatty acid-binding  protein,  liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP);4;4;33,9
P05413;P05413;Fatty acid-binding protein, heart;FABP3;>FABPH_HUMAN|P05413|Fatty acid-binding  protein,  heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP) (Mammary-derived growth inhibitor) (MDGI) (Muscle fatty acid-binding protein) (M-FABP);8;8;65,4
"Q01469;A8MUU1";Q01469;Fatty acid-binding protein, epidermal;FABP5;>FABP5_HUMAN|Q01469|Fatty acid-binding  protein,  epidermal (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein 5) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP);9;9;66,7
P16930;P16930;Fumarylacetoacetase;FAH;>FAAA_HUMAN|P16930|Fumarylacetoacetase (FAA) (3.7.1.2 ) (Beta-diketonase) (Fumarylacetoacetate hydrolase);9;9;26
Q8IWE2;Q8IWE2;Protein NOXP20;FAM114A1;>NXP20_HUMAN|Q8IWE2|Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1);6;6;16,3
Q9Y4C2;Q9Y4C2;Protein FAM115A;FAM115A;>TCAF1_HUMAN|Q9Y4C2|TRPM8 channel-associated factor 1  (TRP channel-associated factor 1 );2;2;2,5
"Q9BZQ8;REV__Q9UHV5";Q9BZQ8;Protein Niban;FAM129A;>NIBAN_HUMAN|Q9BZQ8|Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A);33;33;40,7
Q96TA1;Q96TA1;Niban-like protein 1;FAM129B;>NIBL1_HUMAN|Q96TA1|Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B);20;20;30,8
Q8WW52;Q8WW52;Protein FAM151A;FAM151A;>F151A_HUMAN|Q8WW52|Protein FAM151A;9;9;15,2
Q92567;Q92567;Protein FAM168A;FAM168A;>F168A_HUMAN|Q92567|Protein FAM168A (Tongue cancer chemotherapy resistance-associated protein 1);5;5;31,6
A1KXE4;A1KXE4;Myelin-associated neurite-outgrowth inhibitor;FAM168B;>F168B_HUMAN|A1KXE4|Myelin-associated neurite-outgrowth inhibitor (Mani) (p20);2;2;21,5
Q15018;Q15018;BRISC complex subunit Abro1;FAM175B;>F175B_HUMAN|Q15018|BRISC complex subunit Abro1 (Abraxas brother protein 1 ) (Protein FAM175B);4;4;10,8
Q8N128;Q8N128;Protein FAM177A1;FAM177A1;>F177A_HUMAN|Q8N128|Protein FAM177A1;9;9;53,5
Q8TBF2;Q8TBF2;Prostamide/prostaglandin F synthase;FAM213B;>PGFS_HUMAN|Q8TBF2|Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (1.11.1.20) (Protein FAM213B);5;5;21,7
Q9H0Q0;Q9H0Q0;Protein FAM49A;FAM49A;>FA49A_HUMAN|Q9H0Q0|Protein FAM49A;3;2;12,1
Q9NUQ9;Q9NUQ9;Protein FAM49B;FAM49B;>FA49B_HUMAN|Q9NUQ9|Protein FAM49B (L1);6;5;24,4
Q8N5J2;Q8N5J2;Protein FAM63A;FAM63A;>MINY1_HUMAN|Q8N5J2|Ubiquitin carboxyl-terminal hydrolase MINDY-1  (3.4.19.12 ) (Deubiquitinating enzyme MINDY-1 ) (Protein FAM63A);6;6;17,3
Q8NBR6;Q8NBR6;Protein FAM63B;FAM63B;>MINY2_HUMAN|Q8NBR6|Ubiquitin carboxyl-terminal hydrolase MINDY-2  (3.4.19.12 ) (Deubiquitinating enzyme MINDY-2 ) (Protein FAM63B);4;3;8,5
Q6ZS17;Q6ZS17;Protein FAM65A;FAM65A;>FA65A_HUMAN|Q6ZS17|Protein FAM65A;11;11;10,2
Q96KN1;Q96KN1;Protein FAM84B;FAM84B;>FA84B_HUMAN|Q96KN1|Protein FAM84B (Breast cancer membrane protein 101) (Protein NSE2);3;3;14,8
Q658Y4;Q658Y4;Protein FAM91A1;FAM91A1;>F91A1_HUMAN|Q658Y4|Protein FAM91A1;2;2;2,7
Q6ZTR7;Q6ZTR7;Protein FAM92B;FAM92B;>FA92B_HUMAN|Q6ZTR7|Protein FAM92B;2;2;6,9
P49327;P49327;"Fatty acid synthase;[Acyl-carrier-protein] S-acetyltransferase;[Acyl-carrier-protein] S-malonyltransferase;3-oxoacyl-[acyl-carrier-protein] synthase;3-oxoacyl-[acyl-carrier-protein] reductase;3-hydroxyacyl-[acyl-carrier-protein] dehydratase;Enoyl-[acyl-carrier-protein] reductase;Oleoyl-[acyl-carrier-protein] hydrolase";FASN;>FAS_HUMAN|P49327|Fatty acid synthase (2.3.1.85) ([Acyl-carrier-protein] S-acetyltransferase) (2.3.1.38) ([Acyl-carrier-protein] S-malonyltransferase) (2.3.1.39) (3-oxoacyl-[acyl-carrier-protein] synthase) (2.3.1.41) (3-oxoacyl-[acyl-carrier-protein] reduc;96;96;47,6
P98095;P98095;Fibulin-2;FBLN2;>FBLN2_HUMAN|P98095|Fibulin-2 (FIBL-2) (Precursor);6;6;6,6
P09467;P09467;Fructose-1,6-bisphosphatase 1;FBP1;>F16P1_HUMAN|P09467| Fructose-1,6-bisphosphatase  1 (FBPase 1) (3.1.3.11)  (D-fructose-1,6-bisphosphate  1-phosphohydrolase 1) (Liver FBPase);20;17;62,1
"Q96IG2;Q9UKC9";Q96IG2;F-box/LRR-repeat protein 20;FBXL20;>FXL20_HUMAN|Q96IG2|F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like);8;8;20,9
Q96CD0;Q96CD0;F-box/LRR-repeat protein 8;FBXL8;>FBXL8_HUMAN|Q96CD0|F-box/LRR-repeat protein 8 (F-box and leucine-rich repeat protein 8) (F-box protein FBL8);5;5;17,9
Q96EF6;Q96EF6;F-box only protein 17;FBXO17;>FBX17_HUMAN|Q96EF6|F-box only protein 17 (F-box only protein 26);2;2;9,7
Q9Y6R7;Q9Y6R7;IgGFc-binding protein;FCGBP;>FCGBP_HUMAN|Q9Y6R7|IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) (Precursor);10;10;4,8
P14324;P14324;Farnesyl pyrophosphate synthase;FDPS;>FPPS_HUMAN|P14324|Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (2.5.1.10)  ((2E,6E)-farnesyl  diphosphate synthase) (Dimethylallyltranstransferase) (2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase);7;7;19,6
Q96AC1;Q96AC1;Fermitin family homolog 2;FERMT2;>FERM2_HUMAN|Q96AC1|Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1);5;4;7,8
Q9Y3D6;Q9Y3D6;Mitochondrial fission 1 protein;FIS1;>FIS1_HUMAN|Q9Y3D6|Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11);3;3;23,7
Q5T1M5;Q5T1M5;FK506-binding protein 15;FKBP15;>FKB15_HUMAN|Q5T1M5|FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL);5;5;5,4
P62942;P62942;Peptidyl-prolyl cis-trans isomerase FKBP1A;FKBP1A;>FKB1A_HUMAN|P62942|Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase);5;5;46,3
Q00688;Q00688;Peptidyl-prolyl cis-trans isomerase FKBP3;FKBP3;>FKBP3_HUMAN|Q00688|Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase);4;4;21,9
Q02790;Q02790;"Peptidyl-prolyl cis-trans isomerase FKBP4;Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed";FKBP4;>FKBP4_HUMAN|Q02790|Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (H;21;21;56,4
Q13451;Q13451;Peptidyl-prolyl cis-trans isomerase FKBP5;FKBP5;>FKBP5_HUMAN|Q13451|Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding;5;5;15,8
Q13045;Q13045;Protein flightless-1 homolog;FLII;>FLII_HUMAN|Q13045|Protein flightless-1 homolog;12;12;11,2
O75369;O75369;Filamin-B;FLNB;>FLNB_HUMAN|O75369|Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP);69;63;33,7
O75955;O75955;Flotillin-1;FLOT1;>FLOT1_HUMAN|O75955|Flotillin-1;20;20;50,1
Q14254;Q14254;Flotillin-2;FLOT2;>FLOT2_HUMAN|Q14254|Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1);19;19;49,8
Q9UPI3;Q9UPI3;Feline leukemia virus subgroup C receptor-related protein 2;FLVCR2;>FLVC2_HUMAN|Q9UPI3|Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter) (CCT);2;2;4,2
Q5T0N5;Q5T0N5;Formin-binding protein 1-like;FNBP1L;>FBP1L_HUMAN|Q5T0N5|Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1);7;7;13,4
P49354;P49354;Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha;FNTA;>FNTA_HUMAN|P49354|Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (2.5.1.58  ) (2.5.1.59 ) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltran;5;5;12,7
P49356;P49356;Protein farnesyltransferase subunit beta;FNTB;>FNTB_HUMAN|P49356|Protein farnesyltransferase subunit beta (FTase-beta) (2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta);2;2;4,1
"Q04609;Q9HBA9;Q9Y3Q0";"Q04609;Q9HBA9";"Glutamate carboxypeptidase 2;Putative N-acetylated-alpha-linked acidic dipeptidase";FOLH1;>FOLH1_HUMAN|Q04609|Glutamate carboxypeptidase 2 (3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mG;33;33;45,3
P15328;P15328;Folate receptor alpha;FOLR1;>FOLR1_HUMAN|P15328|Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate  receptor,  adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18) (Precursor);8;8;31,1
"P42685;Q9H3Y6;P08581;Q04912";P42685;Tyrosine-protein kinase FRK;FRK;>FRK_HUMAN|P42685|Tyrosine-protein kinase FRK (2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5);21;20;46,1
Q12841;Q12841;Follistatin-related protein 1;FSTL1;>FSTL1_HUMAN|Q12841|Follistatin-related protein 1 (Follistatin-like protein 1) (Precursor);6;6;24,4
O95954;O95954;"Formimidoyltransferase-cyclodeaminase;Glutamate formimidoyltransferase;Formimidoyltetrahydrofolate cyclodeaminase";FTCD;>FTCD_HUMAN|O95954|Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (LCHC1) (Glutamate formimidoyltransferase) (2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase) (Formimidoyltetrahydrofolate cyclodeam;6;6;12,9
P02794;P02794;"Ferritin heavy chain;Ferritin heavy chain, N-terminally processed";FTH1;>FRIH_HUMAN|P02794|Ferritin heavy chain (Ferritin H subunit) (1.16.3.1) (Cell proliferation-inducing gene 15 protein) (Ferritin heavy  chain,  N-terminally processed);11;11;64,5
P02792;P02792;Ferritin light chain;FTL;>FRIL_HUMAN|P02792|Ferritin light chain (Ferritin L subunit);9;9;50,9
P04066;P04066;Tissue alpha-L-fucosidase;FUCA1;>FUCO_HUMAN|P04066|Tissue alpha-L-fucosidase (3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1) (Precursor);7;7;18,2
Q8N0W3;Q8N0W3;L-fucose kinase;FUK;>FUK_HUMAN|Q8N0W3|L-fucose kinase (Fucokinase) (2.7.1.52);3;3;3
P11413;P11413;Glucose-6-phosphate 1-dehydrogenase;G6PD;>G6PD_HUMAN|P11413|Glucose-6-phosphate 1-dehydrogenase (G6PD) (1.1.1.49);17;17;40,8
P10253;P10253;"Lysosomal alpha-glucosidase;76 kDa lysosomal alpha-glucosidase;70 kDa lysosomal alpha-glucosidase";GAA;>LYAG_HUMAN|P10253|Lysosomal alpha-glucosidase (3.2.1.20) (Acid maltase) (Aglucosidase alfa) (76 kDa lysosomal alpha-glucosidase) (70 kDa lysosomal alpha-glucosidase) (Precursor);8;8;11,3
Q14376;Q14376;UDP-glucose 4-epimerase;GALE;>GALE_HUMAN|Q14376|UDP-glucose 4-epimerase  (5.1.3.2 ) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase ) (UDP-GalNAc 4-epimerase ) (UDP-N-acetylglucosamine 4-epimerase ) (UDP-GlcNAc 4-epimerase ) (5.1.3.7 ) (UDP-galactose 4-epimerase );4;4;12,1
P51570;P51570;Galactokinase;GALK1;>GALK1_HUMAN|P51570|Galactokinase (2.7.1.6) (Galactose kinase);8;8;20,7
Q01415;Q01415;N-acetylgalactosamine kinase;GALK2;>GALK2_HUMAN|Q01415|N-acetylgalactosamine kinase (2.7.1.157) (GalNAc kinase) (Galactokinase 2);6;6;10,9
Q96C23;Q96C23;Aldose 1-epimerase;GALM;>GALM_HUMAN|Q96C23|Aldose 1-epimerase (5.1.3.3) (Galactose mutarotase);3;3;11,4
P07902;P07902;Galactose-1-phosphate uridylyltransferase;GALT;>GALT_HUMAN|P07902|Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase);3;3;9,8
Q14353;Q14353;Guanidinoacetate N-methyltransferase;GAMT;>GAMT_HUMAN|Q14353|Guanidinoacetate N-methyltransferase (2.1.1.2);4;4;15,7
Q14697;Q14697;Neutral alpha-glucosidase AB;GANAB;>GANAB_HUMAN|Q14697|Neutral alpha-glucosidase AB (3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) (Precursor);4;4;4,9
"P04406;O14556";P04406;Glyceraldehyde-3-phosphate dehydrogenase;GAPDH;>G3P_HUMAN|P04406|Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (2.6.99.-);17;17;57,9
P41250;P41250;Glycine--tRNA ligase;GARS;>GARS_HUMAN|P41250|Glycine--tRNA ligase (3.6.1.17 ) (6.1.1.14 ) (Diadenosine tetraphosphate synthetase) (AP-4-A synthetase) (Glycyl-tRNA synthetase) (GlyRS);8;8;13,3
P22102;P22102;"Trifunctional purine biosynthetic protein adenosine-3;Phosphoribosylamine--glycine ligase;Phosphoribosylformylglycinamidine cyclo-ligase;Phosphoribosylglycinamide formyltransferase";GART;>PUR2_HUMAN|P22102|Trifunctional purine biosynthetic protein adenosine-3 (Phosphoribosylamine--glycine ligase) (6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase) (Phosphoribosylformylglycinamidine cyclo-ligase);6;6;7,7
Q04446;Q04446;1,4-alpha-glucan-branching enzyme;GBE1;>GLGB_HUMAN|Q04446| 1,4-alpha-glucan-branching  enzyme (2.4.1.18  ) (Brancher enzyme) (Glycogen-branching enzyme);11;11;19,1
Q92538;Q92538;Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1;GBF1;>GBF1_HUMAN|Q92538|Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1);14;14;9,8
P28676;P28676;Grancalcin;GCA;>GRAN_HUMAN|P28676|Grancalcin;10;10;47
P30047;P30047;GTP cyclohydrolase 1 feedback regulatory protein;GCHFR;>GFRP_HUMAN|P30047|GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein) (p35);3;3;70,2
P48506;P48506;Glutamate--cysteine ligase catalytic subunit;GCLC;>GSH1_HUMAN|P48506|Glutamate--cysteine ligase catalytic subunit (6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase);14;14;26,1
P48507;P48507;Glutamate--cysteine ligase regulatory subunit;GCLM;>GSH0_HUMAN|P48507|Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit);4;4;20,1
Q92616;Q92616;Translational activator GCN1;GCN1L1;>GCN1_HUMAN|Q92616|eIF-2-alpha kinase activator GCN1  (GCN1 eIF-2-alpha kinase activator homolog ) (GCN1-like protein 1 ) (General control of amino-acid synthesis 1-like protein 1 ) (Translational activator GCN1 ) (HsGCN1);14;14;6,6
P31150;P31150;Rab GDP dissociation inhibitor alpha;GDI1;>GDIA_HUMAN|P31150|Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4);24;16;62
P50395;P50395;Rab GDP dissociation inhibitor beta;GDI2;>GDIB_HUMAN|P50395|Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2);37;29;79,6
"Q06210;O94808";Q06210;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1;GFPT1;>GFPT1_HUMAN|Q06210|Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (2.6.1.16 ) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1);30;30;50,9
Q9BVM4;Q9BVM4;Gamma-glutamylaminecyclotransferase;GGACT;>GGACT_HUMAN|Q9BVM4|Gamma-glutamylaminecyclotransferase (GGACT) (2.3.2.4) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase);5;5;47,7
O75223;O75223;Gamma-glutamylcyclotransferase;GGCT;>GGCT_HUMAN|O75223|Gamma-glutamylcyclotransferase (2.3.2.4) (Cytochrome c-releasing factor 21);8;8;43,6
O95749;O95749;Geranylgeranyl pyrophosphate synthase;GGPS1;>GGPPS_HUMAN|O95749|Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (2.5.1.-)  ((2E,6E)-farnesyl  diphosphate synthase) (Dimethylallyltranstransferase) (2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (2.5.1.29) (Gerany;4;4;15,3
"P19440;A6NGU5;P36268;Q14390;B5MD39;Q9BX51";"P19440;A6NGU5;P36268";"Gamma-glutamyltranspeptidase 1;Gamma-glutamyltranspeptidase 1 heavy chain;Gamma-glutamyltranspeptidase 1 light chain;Putative gamma-glutamyltranspeptidase 3;Putative gamma-glutamyltranspeptidase 3 heavy chain;Putative gamma-glutamyltranspeptidase 3 light chain;Inactive gamma-glutamyltranspeptidase 2";GGT1;>GGT1_HUMAN|P19440|Gamma-glutamyltranspeptidase 1  (GGT 1) (2.3.2.2  ) (Gamma-glutamyltransferase 1) (Glutathione hydrolase 1) (3.4.19.13 ) (Leukotriene-C4 hydrolase) (3.4.19.14 ) (CD224) (Gamma-glutamyltranspeptidase 1 heavy chain) (Gamma-glutamyltranspep;22;22;32,2
"O14908;Q8TF64";O14908;PDZ domain-containing protein GIPC1;GIPC1;>GIPC1_HUMAN|O14908|PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2);7;7;24,3
"Q14409;P32189";"Q14409;P32189";"Putative glycerol kinase 3;Glycerol kinase";GK3P;">GLPK3_HUMAN|Q14409|Glycerol kinase 3  (GK 3) (Glycerokinase 3) (2.7.1.30) (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene ) (Glycerol  kinase,  testis specific 1);>GLPK_HUMAN|P32189|Glycerol kinase (GK) (Glycerokinase) (2.7.1.30) (ATP:";2;2;4,2
"P16278;Q6UWU2";P16278;Beta-galactosidase;GLB1;>BGAL_HUMAN|P16278|Beta-galactosidase (3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1) (Precursor);6;6;12,1
Q9H4G4;Q9H4G4;Golgi-associated plant pathogenesis-related protein 1;GLIPR2;>GAPR1_HUMAN|Q9H4G4|Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);10;10;79,9
Q04760;Q04760;Lactoylglutathione lyase;GLO1;>LGUL_HUMAN|Q04760|Lactoylglutathione lyase (4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase);12;12;81,5
Q9HC38;Q9HC38;Glyoxalase domain-containing protein 4;GLOD4;>GLOD4_HUMAN|Q9HC38|Glyoxalase domain-containing protein 4;13;13;41,5
P35754;P35754;Glutaredoxin-1;GLRX;>GLRX1_HUMAN|P35754|Glutaredoxin-1 (Thioltransferase-1) (TTase-1);5;5;50,9
O76003;O76003;Glutaredoxin-3;GLRX3;>GLRX3_HUMAN|O76003|Glutaredoxin-3 (PKC-interacting cousin of thioredoxin ) (PICOT ) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2);4;4;14
Q9NZD2;Q9NZD2;Glycolipid transfer protein;GLTP;>GLTP_HUMAN|Q9NZD2|Glycolipid transfer protein (GLTP);7;7;29,7
O60547;O60547;GDP-mannose 4,6 dehydratase;GMDS;>GMDS_HUMAN|O60547|GDP-mannose  4,6  dehydratase (4.2.1.47) (GDP-D-mannose dehydratase) (GMD);9;9;29,3
"P60983;O60234";P60983;Glia maturation factor beta;GMFB;>GMFB_HUMAN|P60983|Glia maturation factor beta (GMF-beta);4;4;26,1
Q96IJ6;Q96IJ6;Mannose-1-phosphate guanyltransferase alpha;GMPPA;>GMPPA_HUMAN|Q96IJ6|Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha);15;15;41,2
Q9Y5P6;Q9Y5P6;Mannose-1-phosphate guanyltransferase beta;GMPPB;>GMPPB_HUMAN|Q9Y5P6|Mannose-1-phosphate guanyltransferase beta (2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta);10;10;35,6
"P36959;Q9P0U4";P36959;GMP reductase 1;GMPR;>GMPR1_HUMAN|P36959|GMP reductase 1  (GMPR 1 ) (1.7.1.7 ) (Guanosine 5-monophosphate oxidoreductase 1 ) (Guanosine monophosphate reductase 1 );13;12;47,2
Q9P2T1;Q9P2T1;GMP reductase 2;GMPR2;>GMPR2_HUMAN|Q9P2T1|GMP reductase 2  (GMPR 2 ) (1.7.1.7 ) (Guanosine 5-monophosphate oxidoreductase 2 ) (Guanosine monophosphate reductase 2 );8;7;27
P29992;P29992;Guanine nucleotide-binding protein subunit alpha-11;GNA11;>GNA11_HUMAN|P29992|Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha);20;13;53,2
Q14344;Q14344;Guanine nucleotide-binding protein subunit alpha-13;GNA13;>GNA13_HUMAN|Q14344|Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13);21;20;61
P30679;P30679;Guanine nucleotide-binding protein subunit alpha-15;GNA15;>GNA15_HUMAN|P30679|Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16);3;3;9,6
P63096;P63096;Guanine nucleotide-binding protein G(i) subunit alpha-1;GNAI1;>GNAI1_HUMAN|P63096|Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein);15;8;41,5
P04899;P04899;Guanine nucleotide-binding protein G(i) subunit alpha-2;GNAI2;>GNAI2_HUMAN|P04899|Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein);19;12;53,8
"P08754;P19087;P11488;A8MTJ3";P08754;Guanine nucleotide-binding protein G(k) subunit alpha;GNAI3;>GNAI3_HUMAN|P08754|Guanine nucleotide-binding protein G(k) subunit alpha  (G(i) alpha-3);14;7;37
P09471;P09471;Guanine nucleotide-binding protein G(o) subunit alpha;GNAO1;>GNAO_HUMAN|P09471|Guanine nucleotide-binding protein G(o) subunit alpha;6;4;22
"P50148;Q03113";P50148;Guanine nucleotide-binding protein G(q) subunit alpha;GNAQ;>GNAQ_HUMAN|P50148|Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q);18;11;53,2
"P63092;Q5JWF2;P38405";"P63092;Q5JWF2";"Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas";GNAS;">GNAS2_HUMAN|P63092|Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein);>GNAS1_HUMAN|Q5JWF2|Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating ";16;15;39,1
P19086;P19086;Guanine nucleotide-binding protein G(z) subunit alpha;GNAZ;>GNAZ_HUMAN|P19086|Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha);5;4;16,6
"P62873;P16520";P62873;Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1;GNB1;>GBB1_HUMAN|P62873|Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1);15;9;60,3
P62879;P62879;Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2;GNB2;>GBB2_HUMAN|P62879|Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2);13;4;45,6
P63244;P63244;"Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed";GNB2L1;>RACK1_HUMAN|P63244|Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer onc;14;14;52,4
Q9Y223;Q9Y223;"Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase;UDP-N-acetylglucosamine 2-epimerase (hydrolyzing);N-acetylmannosamine kinase";GNE;>GLCNE_HUMAN|Q9Y223|Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) (UDP-N-acetylglucosamine 2-epimerase (hydrolyzing)) (3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylgluc;7;7;13,6
P50151;P50151;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10;GNG10;>GBG10_HUMAN|P50151|Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 (Precursor);3;3;69,1
Q9UBI6;Q9UBI6;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12;GNG12;>GBG12_HUMAN|Q9UBI6|Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 (Precursor);7;7;80,6
P50150;P50150;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4;GNG4;>GBG4_HUMAN|P50150|Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 (Precursor);2;2;41,3
P63218;P63218;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5;GNG5;>GBG5_HUMAN|P63218|Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 (Precursor);4;4;77,9
O60262;O60262;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7;GNG7;>GBG7_HUMAN|O60262|Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 (Precursor);4;4;69,1
P36915;P36915;Guanine nucleotide-binding protein-like 1;GNL1;>GNL1_HUMAN|P36915|Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1);4;4;7,4
Q14749;Q14749;Glycine N-methyltransferase;GNMT;>GNMT_HUMAN|Q14749|Glycine N-methyltransferase (2.1.1.20);7;7;31,5
P46926;P46926;Glucosamine-6-phosphate isomerase 1;GNPDA1;>GNPI1_HUMAN|P46926|Glucosamine-6-phosphate isomerase 1 (3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin);11;8;54,3
Q96EK6;Q96EK6;Glucosamine 6-phosphate N-acetyltransferase;GNPNAT1;>GNA1_HUMAN|Q96EK6|Glucosamine 6-phosphate N-acetyltransferase (2.3.1.4  ) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase);5;5;34,8
"Q7Z5G4;Q2TAP0";Q7Z5G4;Golgin subfamily A member 7;GOLGA7;>GOGA7_HUMAN|Q7Z5G4|Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa);3;3;24,8
Q9H4A6;Q9H4A6;Golgi phosphoprotein 3;GOLPH3;>GOLP3_HUMAN|Q9H4A6|Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS);3;3;12,4
P17174;P17174;Aspartate aminotransferase, cytoplasmic;GOT1;>AATC_HUMAN|P17174|Aspartate  aminotransferase,  cytoplasmic (cAspAT) (2.6.1.1) (2.6.1.3) (Cysteine  aminotransferase,  cytoplasmic) (Cysteine  transaminase,  cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A);18;18;52,5
P55259;P55259;Pancreatic secretory granule membrane major glycoprotein GP2;GP2;>GP2_HUMAN|P55259|Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75) (Precursor);11;11;21,8
P21695;P21695;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic;GPD1;>GPDA_HUMAN|P21695|Glycerol-3-phosphate dehydrogenase  [NAD(+)],  cytoplasmic (GPD-C) (GPDH-C) (1.1.1.8);10;9;34,1
Q8N335;Q8N335;Glycerol-3-phosphate dehydrogenase 1-like protein;GPD1L;>GPD1L_HUMAN|Q8N335|Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (1.1.1.8);17;16;45,9
"P06744;Q8N196";P06744;Glucose-6-phosphate isomerase;GPI;>G6PI_HUMAN|P06744|Glucose-6-phosphate isomerase (GPI) (5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36);19;14;40,3
Q86SQ4;Q86SQ4;G-protein coupled receptor 126;GPR126;>AGRG6_HUMAN|Q86SQ4|Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor ) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor ) (ADGRG6 N-terminal fragment) (ADGRG6-NTF) (ADGRG6 C-termina;3;3;2,9
Q8IZP9;Q8IZP9;G-protein coupled receptor 64;GPR64;>AGRG2_HUMAN|Q8IZP9|Adhesion G-protein coupled receptor G2  (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6) (Precursor);3;3;3,4
Q8NFJ5;Q8NFJ5;Retinoic acid-induced protein 3;GPRC5A;>RAI3_HUMAN|Q8NFJ5|Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1 ) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1);9;9;26,1
Q9NZH0;Q9NZH0;G-protein coupled receptor family C group 5 member B;GPRC5B;>GPC5B_HUMAN|Q9NZH0|G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein) (RAIG-2) (Precursor);6;6;17,9
Q9NQ84;Q9NQ84;G-protein coupled receptor family C group 5 member C;GPRC5C;>GPC5C_HUMAN|Q9NQ84|G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3) (Precursor);12;12;30,8
Q13098;Q13098;COP9 signalosome complex subunit 1;GPS1;>CSN1_HUMAN|Q13098|COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH);6;6;13,4
P07203;P07203;Glutathione peroxidase 1;GPX1;>GPX1_HUMAN|P07203|Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (1.11.1.9) (Cellular glutathione peroxidase);9;9;60,6
P36969;P36969;Phospholipid hydroperoxide glutathione peroxidase, mitochondrial;GPX4;>GPX4_HUMAN|P36969|Phospholipid hydroperoxide glutathione  peroxidase,  mitochondrial (PHGPx) (1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (Precursor);11;11;48,2
P62993;P62993;Growth factor receptor-bound protein 2;GRB2;>GRB2_HUMAN|P62993|Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2);13;13;58,1
Q9UBQ7;Q9UBQ7;Glyoxylate reductase/hydroxypyruvate reductase;GRHPR;>GRHPR_HUMAN|Q9UBQ7|Glyoxylate reductase/hydroxypyruvate reductase (1.1.1.79) (1.1.1.81);16;16;52,7
P28799;P28799;"Granulins;Acrogranin;Paragranulin;Granulin-1;Granulin-2;Granulin-3;Granulin-4;Granulin-5;Granulin-6;Granulin-7";GRN;>GRN_HUMAN|P28799|Granulins (Proepithelin) (PEPI) (Acrogranin) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Progranulin) (Paragranulin) (Granulin-1) (Granulin G) (Granulin-2) (Granulin F) (Granulin-3) (Granulin B) (Granulin-4) (Granulin A) (Granulin-;4;4;7,9
Q5TC63;Q5TC63;Growth hormone-regulated TBC protein 1;GRTP1;>GRTP1_HUMAN|Q5TC63|Growth hormone-regulated TBC protein 1 (TBC1 domain family member 6);5;5;17,9
P57764;P57764;Gasdermin-D;GSDMD;>GSDMD_HUMAN|P57764|Gasdermin-D (Gasdermin domain-containing protein 1)  (Gasdermin-D,  N-terminal ) (GSDMD-NT)  (Gasdermin-D,  C-terminal ) (GSDMD-CT);2;2;4,5
P49840;P49840;Glycogen synthase kinase-3 alpha;GSK3A;>GSK3A_HUMAN|P49840|Glycogen synthase kinase-3 alpha (GSK-3 alpha) (2.7.11.26) (Serine/threonine-protein kinase GSK3A) (2.7.11.1);6;5;16,8
P49841;P49841;Glycogen synthase kinase-3 beta;GSK3B;>GSK3B_HUMAN|P49841|Glycogen synthase kinase-3 beta (GSK-3 beta) (2.7.11.26) (Serine/threonine-protein kinase GSK3B) (2.7.11.1);5;4;16,4
"P06396;CON__Q3SX14;REV__Q6TDU7";"P06396;CON__Q3SX14";Gelsolin;GSN;">GELS_HUMAN|P06396|Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin) (Precursor);>Q3SX14 TREMBL:Q3SX14 (Bos taurus) Similar to Gelsolin";24;24;31,5
"P15170;Q8IYD1";"P15170;Q8IYD1";"Eukaryotic peptide chain release factor GTP-binding subunit ERF3A;Eukaryotic peptide chain release factor GTP-binding subunit ERF3B";GSPT1;">ERF3A_HUMAN|P15170|Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog);>ERF3B_HUMAN|Q8IYD1|Eukaryotic peptide chain release factor GTP-";11;11;27,5
P00390;P00390;Glutathione reductase, mitochondrial;GSR;>GSHR_HUMAN|P00390|Glutathione  reductase,  mitochondrial (GR) (GRase) (1.8.1.7) (Precursor);19;19;46
P48637;P48637;Glutathione synthetase;GSS;>GSHB_HUMAN|P48637|Glutathione synthetase (GSH synthetase) (GSH-S) (6.3.2.3) (Glutathione synthase);17;17;35,2
"P09210;Q16772;Q7RTV2";"P09210;Q16772";"Glutathione S-transferase A2;Glutathione S-transferase A3";GSTA2;">GSTA2_HUMAN|P09210|Glutathione S-transferase A2 (2.5.1.18) (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2);>GSTA3_HUMAN|Q16772|Glutathione S-transferase A3 (2.5.1.18) (GST class-alpha member 3) (Glutathione S-transferase A3-3)";13;2;44,6
P09488;P09488;Glutathione S-transferase Mu 1;GSTM1;>GSTM1_HUMAN|P09488|Glutathione S-transferase Mu 1 (2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4);17;2;62,8
P28161;P28161;Glutathione S-transferase Mu 2;GSTM2;>GSTM2_HUMAN|P28161|Glutathione S-transferase Mu 2 (2.5.1.18) (GST class-mu 2) (GSTM2-2);15;6;61,5
P21266;P21266;Glutathione S-transferase Mu 3;GSTM3;>GSTM3_HUMAN|P21266|Glutathione S-transferase Mu 3 (2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3);20;18;70,7
P78417;P78417;Glutathione S-transferase omega-1;GSTO1;>GSTO1_HUMAN|P78417|Glutathione S-transferase omega-1 (GSTO-1) (2.5.1.18  ) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (1.8.5.1  ) (Monomethylarsonic acid reductase) (MMA(V) reductase) (1.20.4.2 ) (S;12;12;48,1
P09211;P09211;Glutathione S-transferase P;GSTP1;>GSTP1_HUMAN|P09211|Glutathione S-transferase P (2.5.1.18) (GST class-pi) (GSTP1-1);10;10;67,1
P30711;P30711;Glutathione S-transferase theta-1;GSTT1;>GSTT1_HUMAN|P30711|Glutathione S-transferase theta-1 (2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1);13;12;42,9
"P0CG30;P0CG29";"P0CG30;P0CG29";"Glutathione S-transferase theta-2B;Glutathione S-transferase theta-2";GSTT2B;">GSTT2_HUMAN|P0CG30|Glutathione S-transferase theta-2B (2.5.1.18) (GST class-theta-2) (Glutathione S-transferase theta-2);>GST2_HUMAN|P0CG29|Glutathione S-transferase theta-2 (2.5.1.18) (GST class-theta-2)";5;4;25
O43708;O43708;Maleylacetoacetate isomerase;GSTZ1;>MAAI_HUMAN|O43708|Maleylacetoacetate isomerase (MAAI) (5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (2.5.1.18);3;3;17,6
O00178;O00178;GTP-binding protein 1;GTPBP1;>GTPB1_HUMAN|O00178|GTP-binding protein 1 (G-protein 1) (GP-1) (GP1);2;2;3,7
Q96NT3;Q96NT3;Protein GUCD1;GUCD1;>GUCD1_HUMAN|Q96NT3|Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4);6;6;21,2
"P13807;P54840";P13807;Glycogen [starch] synthase, muscle;GYS1;>GYS1_HUMAN|P13807|Glycogen [starch]  synthase,  muscle (2.4.1.11);5;5;6,9
Q16775;Q16775;Hydroxyacylglutathione hydrolase, mitochondrial;HAGH;>GLO2_HUMAN|Q16775|Hydroxyacylglutathione  hydrolase,  mitochondrial  (3.1.2.6) (Glyoxalase II) (Glx II) (Precursor);6;6;23,7
P12081;P12081;Histidine--tRNA ligase, cytoplasmic;HARS;>SYHC_HUMAN|P12081|Histidine--tRNA  ligase,  cytoplasmic (6.1.1.21) (Histidyl-tRNA synthetase) (HisRS);4;4;8,8
"P69905;P02008";P69905;Hemoglobin subunit alpha;HBA1;>HBA_HUMAN|P69905|Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain);7;3;63,4
P68871;P68871;"Hemoglobin subunit beta;LVV-hemorphin-7;Spinorphin";HBB;>HBB_HUMAN|P68871|Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) (LVV-hemorphin-7) (Spinorphin);11;6;88,4
"P02042;CON__Q3SX09;CON__P02070;P69892;P69891;P02100";P02042;Hemoglobin subunit delta;HBD;>HBD_HUMAN|P02042|Hemoglobin subunit delta (Delta-globin) (Hemoglobin delta chain);7;2;53,7
Q7Z4H3;Q7Z4H3;HD domain-containing protein 2;HDDC2;>HDDC2_HUMAN|Q7Z4H3|HD domain-containing protein 2 (Hepatitis C virus NS5A-transactivated protein 2) (HCV NS5A-transactivated protein 2);4;4;25
Q08623;Q08623;Pseudouridine-5-monophosphatase;HDHD1;>HDHD1_HUMAN|Q08623|Pseudouridine-5-phosphatase  (3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5-monophosphatase) (5-PsiMPas;2;2;11,4
Q9H0R4;Q9H0R4;Haloacid dehalogenase-like hydrolase domain-containing protein 2;HDHD2;>HDHD2_HUMAN|Q9H0R4|Haloacid dehalogenase-like hydrolase domain-containing protein 2;4;4;19,3
Q00341;Q00341;Vigilin;HDLBP;>VIGLN_HUMAN|Q00341|Vigilin (High density lipoprotein-binding protein) (HDL-binding protein);11;11;9,5
Q9NRV9;Q9NRV9;Heme-binding protein 1;HEBP1;>HEBP1_HUMAN|Q9NRV9|Heme-binding protein 1 (p22HBP);7;7;43,9
Q9Y5Z4;Q9Y5Z4;Heme-binding protein 2;HEBP2;>HEBP2_HUMAN|Q9Y5Z4|Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);8;8;44,9
Q9Y4D8;Q9Y4D8;Probable E3 ubiquitin-protein ligase HECTD4;HECTD4;>HECD4_HUMAN|Q9Y4D8|Probable E3 ubiquitin-protein ligase HECTD4 (2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4);2;2;0,5
Q5GLZ8;Q5GLZ8;Probable E3 ubiquitin-protein ligase HERC4;HERC4;>HERC4_HUMAN|Q5GLZ8|Probable E3 ubiquitin-protein ligase HERC4 (2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4);3;3;3,5
P06865;P06865;Beta-hexosaminidase subunit alpha;HEXA;>HEXA_HUMAN|P06865|Beta-hexosaminidase subunit alpha (3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) (Precursor);3;3;6,4
P07686;P07686;"Beta-hexosaminidase subunit beta;Beta-hexosaminidase subunit beta chain B;Beta-hexosaminidase subunit beta chain A";HEXB;>HEXB_HUMAN|P07686|Beta-hexosaminidase subunit beta (3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) (Beta-hexosaminidase subuni;7;7;14,7
Q93099;Q93099;Homogentisate 1,2-dioxygenase;HGD;>HGD_HUMAN|Q93099|Homogentisate  1,2-dioxygenase  (1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase);17;17;54,8
O14964;O14964;Hepatocyte growth factor-regulated tyrosine kinase substrate;HGS;>HGS_HUMAN|O14964|Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs ) (Protein pp110);9;9;12,7
Q8IV36;Q8IV36;Protein HID1;HID1;>HID1_HUMAN|Q8IV36|Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog);17;17;24,1
P49773;P49773;Histidine triad nucleotide-binding protein 1;HINT1;>HINT1_HUMAN|P49773|Histidine triad nucleotide-binding protein 1 (3.-.-.-) (Adenosine 5-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1);8;8;83,3
Q9NQE9;Q9NQE9;Histidine triad nucleotide-binding protein 3;HINT3;>HINT3_HUMAN|Q9NQE9|Histidine triad nucleotide-binding protein 3 (HINT-3) (3.-.-.-);6;6;53,3
P62805;P62805;Histone H4;HIST1H4A;>H4_HUMAN|P62805|Histone H4;5;5;50,5
"P10316;P01891";"P10316;P01891";"HLA class I histocompatibility antigen, A-69 alpha chain;HLA class I histocompatibility antigen, A-68 alpha chain";HLA-A;">1A69_HUMAN|P10316|HLA class I histocompatibility  antigen,  A-69 alpha chain (Aw-69) (HLA class I histocompatibility  antigen,  A-28 alpha chain) (MHC class I antigen A*69) (Precursor);>1A68_HUMAN|P01891|HLA class I histocompatibility  antigen,  A-68 alph";15;0;52,9
"P30453;P16190;P16189;P30457;P30450;P18462";"P30453;P16190;P16189;P30457;P30450;P18462";"HLA class I histocompatibility antigen, A-34 alpha chain;HLA class I histocompatibility antigen, A-33 alpha chain;HLA class I histocompatibility antigen, A-31 alpha chain;HLA class I histocompatibility antigen, A-66 alpha chain;HLA class I histocompatibility antigen, A-26 alpha chain;HLA class I histocompatibility antigen, A-25 alpha chain";HLA-A;">1A34_HUMAN|P30453|HLA class I histocompatibility  antigen,  A-34 alpha chain (Aw-34) (HLA class I histocompatibility  antigen,  A-10 alpha chain) (MHC class I antigen A*34) (Precursor);>1A33_HUMAN|P16190|HLA class I histocompatibility  antigen,  A-33 alph";10;0;34,2
"Q07000;P30508;Q29963;P30501;P30510;Q29960;P01893";"Q07000;P30508;Q29963;P30501;P30510;Q29960";"HLA class I histocompatibility antigen, Cw-15 alpha chain;HLA class I histocompatibility antigen, Cw-12 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-2 alpha chain;HLA class I histocompatibility antigen, Cw-14 alpha chain;HLA class I histocompatibility antigen, Cw-16 alpha chain";HLA-C;">1C15_HUMAN|Q07000|HLA class I histocompatibility  antigen,  Cw-15 alpha chain (MHC class I antigen Cw*15) (Precursor);>1C12_HUMAN|P30508|HLA class I histocompatibility  antigen,  Cw-12 alpha chain (MHC class I antigen Cw*12) (Precursor);>1C06_HUMAN|Q29963";9;0;32
P28068;P28068;HLA class II histocompatibility antigen, DM beta chain;HLA-DMB;>DMB_HUMAN|P28068|HLA class II histocompatibility  antigen,  DM beta chain (MHC class II antigen DMB) (Really interesting new gene 7 protein) (Precursor);5;5;19,8
"P01903;P01906";P01903;HLA class II histocompatibility antigen, DR alpha chain;HLA-DRA;>DRA_HUMAN|P01903|HLA class II histocompatibility  antigen,  DR alpha chain (MHC class II antigen DRA) (Precursor);3;3;15,7
"Q30154;Q29974;P04229;Q9GIY3";"Q30154;Q29974;P04229;Q9GIY3";"HLA class II histocompatibility antigen, DR beta 5 chain;HLA class II histocompatibility antigen, DRB1-16 beta chain;HLA class II histocompatibility antigen, DRB1-1 beta chain;HLA class II histocompatibility antigen, DRB1-14 beta chain";HLA-DRB5;">DRB5_HUMAN|Q30154|HLA class II histocompatibility  antigen,  DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5) (Precursor);>2B1G_HUMAN|Q29974|HLA class II histocompatibility  antigen,  DRB1-16 beta chain (MHC class II antigen DRB1";3;0;19,9
Q01581;Q01581;Hydroxymethylglutaryl-CoA synthase, cytoplasmic;HMGCS1;>HMCS1_HUMAN|Q01581|Hydroxymethylglutaryl-CoA  synthase,  cytoplasmic (HMG-CoA synthase) (2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase);9;9;20,8
Q9H910;Q9H910;Hematological and neurological expressed 1-like protein;HN1L;>HN1L_HUMAN|Q9H910|Hematological and neurological expressed 1-like protein (HN1-like protein);4;4;30
P50135;P50135;Histamine N-methyltransferase;HNMT;>HNMT_HUMAN|P50135|Histamine N-methyltransferase (HMT) (2.1.1.8 );6;6;26,4
P61978;P61978;Heterogeneous nuclear ribonucleoprotein K;HNRNPK;>HNRPK_HUMAN|P61978|Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP);5;5;13,4
Q9NSB8;Q9NSB8;Homer protein homolog 2;HOMER2;>HOME2_HUMAN|Q9NSB8|Homer protein homolog 2 (Homer-2) (Cupidin);12;11;39,3
Q9UJC3;Q9UJC3;Protein Hook homolog 1;HOOK1;>HOOK1_HUMAN|Q9UJC3|Protein Hook homolog 1 (h-hook1) (hHK1);6;6;12
"P37235;P84074";"P37235;P84074";"Hippocalcin-like protein 1;Neuron-specific calcium-binding protein hippocalcin";HPCAL1;">HPCL1_HUMAN|P37235|Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3);>HPCA_HUMAN|P84074|Neuron-specific calcium-binding protein hippocalcin (Calcium-binding protein BDR-2)";7;4;39,9
P32754;P32754;4-hydroxyphenylpyruvate dioxygenase;HPD;>HPPD_HUMAN|P32754|4-hydroxyphenylpyruvate dioxygenase (1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase);4;4;12,2
P15428;P15428;15-hydroxyprostaglandin dehydrogenase [NAD(+)];HPGD;>PGDH_HUMAN|P15428|15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1);7;7;33,1
"P05981;Q9BZJ3;Q15661;P20231;A6NIE9";P05981;"Serine protease hepsin;Serine protease hepsin non-catalytic chain;Serine protease hepsin catalytic chain";HPN;>HEPS_HUMAN|P05981|Serine protease hepsin (3.4.21.106  ) (Transmembrane protease serine 1) (Serine protease hepsin non-catalytic chain) (Serine protease hepsin catalytic chain);8;8;20,9
P00492;P00492;Hypoxanthine-guanine phosphoribosyltransferase;HPRT1;>HPRT_HUMAN|P00492|Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (2.4.2.8);8;8;42,2
P02790;P02790;Hemopexin;HPX;>HEMO_HUMAN|P02790|Hemopexin (Beta-1B-glycoprotein) (Precursor);3;3;8,7
P01112;P01112;"GTPase HRas;GTPase HRas, N-terminally processed";HRAS;>RASH_HUMAN|P01112|GTPase HRas (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) (GTPase  HRas,  N-terminally processed) (Precursor);9;3;48,1
"CON__Q86YZ3;Q86YZ3";"CON__Q86YZ3;Q86YZ3";Hornerin;HRNR;">Q86YZ3 SWISS-PROT:Q86YZ3 Tax_Id=9606 Gene_Symbol=HRNR Hornerin;>HORN_HUMAN|Q86YZ3|Hornerin";3;3;6,3
Q53T59;Q53T59;HCLS1-binding protein 3;HS1BP3;>H1BP3_HUMAN|Q53T59|HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3);6;6;19,9
"P07900;Q14568;Q58FG0;Q58FG1";P07900;Heat shock protein HSP 90-alpha;HSP90AA1;>HS90A_HUMAN|P07900|Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38);41;25;51,1
"P08238;Q58FF7;Q58FF6";P08238;Heat shock protein HSP 90-beta;HSP90AB1;>HS90B_HUMAN|P08238|Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84);43;21;55,1
Q58FF8;Q58FF8;Putative heat shock protein HSP 90-beta 2;HSP90AB2P;>H90B2_HUMAN|Q58FF8|Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b) (Heat shock protein 90Bb);11;2;23,6
"P14625;Q58FF3";P14625;Endoplasmin;HSP90B1;>ENPL_HUMAN|P14625|Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog) (Precursor);13;11;15,4
"O43301;Q96MM6";O43301;Heat shock 70 kDa protein 12A;HSPA12A;>HS12A_HUMAN|O43301|Heat shock 70 kDa protein 12A;8;8;15
P54652;P54652;Heat shock-related 70 kDa protein 2;HSPA2;>HSP72_HUMAN|P54652|Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2);23;8;33,3
P34932;P34932;Heat shock 70 kDa protein 4;HSPA4;>HSP74_HUMAN|P34932|Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2);28;26;40,1
P11021;P11021;78 kDa glucose-regulated protein;HSPA5;>GRP78_HUMAN|P11021|78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) (Precursor);10;8;18,7
P11142;P11142;Heat shock cognate 71 kDa protein;HSPA8;>HSP7C_HUMAN|P11142|Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1);39;24;53,9
P04792;P04792;Heat shock protein beta-1;HSPB1;>HSPB1_HUMAN|P04792|Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27);16;16;60,5
Q92598;Q92598;Heat shock protein 105 kDa;HSPH1;>HS105_HUMAN|Q92598|Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein);16;13;21,9
Q9BUP3;Q9BUP3;Oxidoreductase HTATIP2;HTATIP2;>HTAI2_HUMAN|Q9BUP3|Oxidoreductase HTATIP2 (1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2);7;7;33,5
Q7Z6Z7;Q7Z6Z7;E3 ubiquitin-protein ligase HUWE1;HUWE1;>HUWE1_HUMAN|Q7Z6Z7|E3 ubiquitin-protein ligase HUWE1 (2.3.2.26) (ARF-binding protein 1) (ARF-BP1)  (HECT,  UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (Hec;12;12;3,6
Q2TAA2;Q2TAA2;Isoamyl acetate-hydrolyzing esterase 1 homolog;IAH1;>IAH1_HUMAN|Q2TAA2|Isoamyl acetate-hydrolyzing esterase 1 homolog (3.1.-.-);3;3;14,9
P41252;P41252;Isoleucine--tRNA ligase, cytoplasmic;IARS;>SYIC_HUMAN|P41252|Isoleucine--tRNA  ligase,  cytoplasmic (6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS);5;5;4,5
Q05084;Q05084;Islet cell autoantigen 1;ICA1;>ICA69_HUMAN|Q05084|Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69);5;5;11,8
Q9UPZ9;Q9UPZ9;Serine/threonine-protein kinase ICK;ICK;>ICK_HUMAN|Q9UPZ9|Serine/threonine-protein kinase ICK (2.7.11.1 ) (Intestinal cell kinase) (hICK) (Laryngeal cancer kinase 2) (LCK2) (MAK-related kinase) (MRK);2;2;6,3
P14735;P14735;Insulin-degrading enzyme;IDE;>IDE_HUMAN|P14735|Insulin-degrading enzyme (3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin);10;10;11
O75874;O75874;Isocitrate dehydrogenase [NADP] cytoplasmic;IDH1;>IDHC_HUMAN|O75874|Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase);24;23;56
P78318;P78318;Immunoglobulin-binding protein 1;IGBP1;>IGBP1_HUMAN|P78318|Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/2006 regulatory subunit) (Renal carcinoma antigen NY-REN-16);2;2;6,2
P11717;P11717;Cation-independent mannose-6-phosphate receptor;IGF2R;>MPRI_HUMAN|P11717|Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6;5;5;2,1
P01876;P01876;Ig alpha-1 chain C region;IGHA1;>IGHA1_HUMAN|P01876|Immunoglobulin heavy constant alpha 1   (Ig alpha-1 chain C region ) (Ig alpha-1 chain C region BUR ) (Ig alpha-1 chain C region TRO );10;8;40,5
"P0DOX5;P01857";"P0DOX5;P01857";Ig gamma-1 chain C region;IGHG1;">IGG1_HUMAN|P0DOX5|Immunoglobulin gamma-1 heavy chain  (Immunoglobulin gamma-1 heavy chain NIE );>IGHG1_HUMAN|P01857|Immunoglobulin heavy constant gamma 1   (Ig gamma-1 chain C region ) (Ig gamma-1 chain C region EU  ) (Ig gamma-1 chain C region KOL ) (Ig ";10;5;33,4
P01859;P01859;Ig gamma-2 chain C region;IGHG2;>IGHG2_HUMAN|P01859|Immunoglobulin heavy constant gamma 2   (Ig gamma-2 chain C region ) (Ig gamma-2 chain C region DOT ) (Ig gamma-2 chain C region TIL ) (Ig gamma-2 chain C region ZIE  );9;3;40,5
"P01871;P04220";"P01871;P04220";"Ig mu chain C region;Ig mu heavy chain disease protein";IGHM;">IGHM_HUMAN|P01871|Immunoglobulin heavy constant mu   (Ig mu chain C region ) (Ig mu chain C region GAL ) (Ig mu chain C region OU );>MUCB_HUMAN|P04220|Ig mu heavy chain disease protein (BOT)";7;3;19,9
P01591;P01591;Immunoglobulin J chain;IGJ;>IGJ_HUMAN|P01591|Immunoglobulin J chain (Joining chain of multimeric IgA and IgM ) (Precursor);5;5;32,7
P01834;P01834;Ig kappa chain C region;IGKC;>IGKC_HUMAN|P01834|Immunoglobulin kappa constant   (Ig kappa chain C region ) (Ig kappa chain C region AG ) (Ig kappa chain C region CUM ) (Ig kappa chain C region EU ) (Ig kappa chain C region OU ) (Ig kappa chain C region ROY ) (Ig kappa chain C region T;6;2;73,8
"P0DOY3;P0DOY2;P0CF74";"P0DOY3;P0DOY2;P0CF74";Ig lambda-6 chain C region;IGLC6;">IGLC3_HUMAN|P0DOY3|Immunoglobulin lambda constant 3   (Ig lambda chain C region DOT ) (Ig lambda chain C region NEWM ) (Ig lambda-3 chain C regions );>IGLC2_HUMAN|P0DOY2|Immunoglobulin lambda constant 2   (Ig lambda chain C region Kern ) (Ig lambda chain ";4;1;55,7
"P0DOX8;B9A064;P0CG04";"P0DOX8;B9A064;P0CG04";"Immunoglobulin lambda-like polypeptide 5;Ig lambda-1 chain C regions";IGLL5;">IGL1_HUMAN|P0DOX8|Immunoglobulin lambda-1 light chain  (Immunoglobulin lambda-1 light chain MCG );>IGLL5_HUMAN|B9A064|Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1) (Precursor);>IGLC1_HUMAN|P0CG04|Immunoglobulin l";4;2;27,3
Q969P0;Q969P0;Immunoglobulin superfamily member 8;IGSF8;>IGSF8_HUMAN|Q969P0|Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD316);4;4;9,3
Q86SU0;Q86SU0;Immunoglobulin-like domain-containing receptor 1;ILDR1;>ILDR1_HUMAN|Q86SU0|Immunoglobulin-like domain-containing receptor 1 (Precursor);3;3;6,2
Q13418;Q13418;Integrin-linked protein kinase;ILK;>ILK_HUMAN|Q13418|Integrin-linked protein kinase (2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK);10;10;25,4
P29218;P29218;Inositol monophosphatase 1;IMPA1;>IMPA1_HUMAN|P29218|Inositol monophosphatase 1 (IMP 1) (IMPase 1) (3.1.3.25  ) (D-galactose 1-phosphate phosphatase ) (3.1.3.94 ) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1);7;7;28,9
Q9P2X3;Q9P2X3;Protein IMPACT;IMPACT;>IMPCT_HUMAN|Q9P2X3|Protein IMPACT (Imprinted and ancient gene protein homolog);3;3;12,8
"P12268;P20839";P12268;Inosine-5-monophosphate dehydrogenase 2;IMPDH2;>IMDH2_HUMAN|P12268|Inosine-5-monophosphate dehydrogenase 2  (IMP dehydrogenase 2 ) (IMPD 2 ) (IMPDH 2 ) (1.1.1.205 ) (IMPDH-II);6;6;17,5
Q8NI35;Q8NI35;InaD-like protein;INADL;>INADL_HUMAN|Q8NI35|InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions);32;31;25,1
Q27J81;Q27J81;Inverted formin-2;INF2;>INF2_HUMAN|Q27J81|Inverted formin-2 (HBEBP2-binding protein C);11;11;12
O15327;O15327;Type II inositol 3,4-bisphosphate 4-phosphatase;INPP4B;>INP4B_HUMAN|O15327|Type II inositol  3,4-bisphosphate  4-phosphatase (3.1.3.66) (Inositol polyphosphate 4-phosphatase type II);4;4;6
Q14642;Q14642;Type I inositol 1,4,5-trisphosphate 5-phosphatase;INPP5A;>I5P1_HUMAN|Q14642|Type I inositol  1,4,5-trisphosphate  5-phosphatase (5PTase) (3.1.3.56) (Precursor);8;8;18
Q9NRR6;Q9NRR6;72 kDa inositol polyphosphate 5-phosphatase;INPP5E;>INP5E_HUMAN|Q9NRR6|72 kDa inositol polyphosphate 5-phosphatase (3.1.3.36 ) (Phosphatidylinositol  4,5-bisphosphate  5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV) (Precursor);3;3;5,4
O00410;O00410;Importin-5;IPO5;>IPO5_HUMAN|O00410|Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5);13;12;15,6
O95373;O95373;Importin-7;IPO7;>IPO7_HUMAN|O95373|Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7);7;7;7,8
"P46940;Q86VI3";P46940;Ras GTPase-activating-like protein IQGAP1;IQGAP1;>IQGA1_HUMAN|P46940|Ras GTPase-activating-like protein IQGAP1 (p195);50;48;36,7
Q13576;Q13576;Ras GTPase-activating-like protein IQGAP2;IQGAP2;>IQGA2_HUMAN|Q13576|Ras GTPase-activating-like protein IQGAP2;32;30;21,1
Q96CN7;Q96CN7;Isochorismatase domain-containing protein 1;ISOC1;>ISOC1_HUMAN|Q96CN7|Isochorismatase domain-containing protein 1;7;7;28,2
P53990;P53990;IST1 homolog;IST1;>IST1_HUMAN|P53990|IST1 homolog (hIST1) (Putative MAPK-activating protein PM28);17;17;35,2
Q96J02;Q96J02;E3 ubiquitin-protein ligase Itchy homolog;ITCH;>ITCH_HUMAN|Q96J02|E3 ubiquitin-protein ligase Itchy homolog (Itch) (2.3.2.26) (Atrophin-1-interacting protein 4) (AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1) (NAPP1);23;19;28,8
Q8TB96;Q8TB96;T-cell immunomodulatory protein;ITFG1;>TIP_HUMAN|Q8TB96|T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin ) (Precursor);9;9;16,7
P56199;P56199;Integrin alpha-1;ITGA1;>ITA1_HUMAN|P56199|Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD49a) (Precursor);3;3;3,7
P26006;P26006;"Integrin alpha-3;Integrin alpha-3 heavy chain;Integrin alpha-3 light chain";ITGA3;>ITA3_HUMAN|P26006|Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD49c) (Integrin alpha-3 heavy chain) (Integrin alpha-3 light chain) (Precursor);10;10;9,7
P06756;P06756;"Integrin alpha-V;Integrin alpha-V heavy chain;Integrin alpha-V light chain";ITGAV;>ITAV_HUMAN|P06756|Integrin alpha-V (Vitronectin receptor subunit alpha) (CD51) (Integrin alpha-V heavy chain) (Integrin alpha-V light chain) (Precursor);22;22;23,6
P05556;P05556;Integrin beta-1;ITGB1;>ITB1_HUMAN|P05556|Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD29) (Precursor);17;17;21,4
P05106;P05106;Integrin beta-3;ITGB3;>ITB3_HUMAN|P05106|Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD61) (Precursor);11;11;17,5
P18084;P18084;Integrin beta-5;ITGB5;>ITB5_HUMAN|P18084|Integrin beta-5 (Precursor);5;5;8,3
P26012;P26012;Integrin beta-8;ITGB8;>ITB8_HUMAN|P26012|Integrin beta-8 (Precursor);5;5;7,5
Q9Y287;Q9Y287;"Integral membrane protein 2B;BRI2, membrane form;BRI2 intracellular domain;BRI2C, soluble form;Bri23 peptide";ITM2B;>ITM2B_HUMAN|Q9Y287|Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri)  (BRI2,  membrane form) (Mature BRI2) (mBRI2) (BRI2 intracellular domain) (BRI2 ICD)  (BRI2C,  soluble form) (Bri23 peptide) (Bri2-23;7;7;36,1
Q9NQX7;Q9NQX7;"Integral membrane protein 2C;CT-BRI3";ITM2C;>ITM2C_HUMAN|Q9NQX7|Integral membrane protein 2C (Cerebral protein 14) (Transmembrane protein BRI3) (CT-BRI3);3;3;19,1
O60229;O60229;Kalirin;KALRN;>KALRN_HUMAN|O60229|Kalirin  (2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);5;5;1,9
Q15046;Q15046;Lysine--tRNA ligase;KARS;>SYK_HUMAN|Q15046|Lysine--tRNA ligase (6.1.1.6) (Lysyl-tRNA synthetase) (LysRS);4;4;5,4
P48048;P48048;ATP-sensitive inward rectifier potassium channel 1;KCNJ1;>KCNJ1_HUMAN|P48048|ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium  channel,  inwardly rectifying subfamily J member 1);5;5;13,6
Q9Y257;Q9Y257;Potassium channel subfamily K member 6;KCNK6;>KCNK6_HUMAN|Q9Y257|Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence);2;2;7,7
Q96CX2;Q96CX2;BTB/POZ domain-containing protein KCTD12;KCTD12;>KCD12_HUMAN|Q96CX2|BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain);7;7;28,3
P50053;P50053;Ketohexokinase;KHK;>KHK_HUMAN|P50053|Ketohexokinase  (2.7.1.3 ) (Hepatic fructokinase);8;8;26,8
Q12768;Q12768;WASH complex subunit strumpellin;KIAA0196;>WASC5_HUMAN|Q12768|WASH complex subunit 5  (Strumpellin) (WASH complex subunit strumpellin );8;8;8,2
O60268;O60268;Uncharacterized protein KIAA0513;KIAA0513;>K0513_HUMAN|O60268|Uncharacterized protein KIAA0513;12;12;29,9
Q2M389;Q2M389;WASH complex subunit 7;KIAA1033;>WASC4_HUMAN|Q2M389|WASH complex subunit 4  (Strumpellin and WASH-interacting protein ) (SWIP ) (WASH complex subunit SWIP );10;10;9,7
Q6UXG2;Q6UXG2;UPF0577 protein KIAA1324;KIAA1324;>K1324_HUMAN|Q6UXG2|UPF0577 protein KIAA1324 (Estrogen-induced gene 121 protein) (Precursor);12;12;14,8
Q9P206;Q9P206;Uncharacterized protein KIAA1522;KIAA1522;>K1522_HUMAN|Q9P206|Uncharacterized protein KIAA1522;11;11;15,7
A0MZ66;A0MZ66;Shootin-1;KIAA1598;>SHOT1_HUMAN|A0MZ66|Shootin-1  (Shootin1 );13;13;22,7
Q9BY89;Q9BY89;Uncharacterized protein KIAA1671;KIAA1671;>K1671_HUMAN|Q9BY89|Uncharacterized protein KIAA1671;2;2;1,7
Q96FN5;Q96FN5;Kinesin-like protein KIF12;KIF12;>KIF12_HUMAN|Q96FN5|Kinesin-like protein KIF12;33;33;55,3
"Q9NQT8;Q9H1H9";Q9NQT8;Kinesin-like protein KIF13B;KIF13B;>KI13B_HUMAN|Q9NQT8|Kinesin-like protein KIF13B (Kinesin-like protein GAKIN);14;13;9,1
"Q12756;O60333";Q12756;Kinesin-like protein KIF1A;KIF1A;>KIF1A_HUMAN|Q12756|Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104);7;6;4,5
"Q7Z4S6;Q2M1P5;Q86VH2;O75037";Q7Z4S6;Kinesin-like protein KIF21A;KIF21A;>KI21A_HUMAN|Q7Z4S6|Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62);9;9;8,1
O00139;O00139;Kinesin-like protein KIF2A;KIF2A;>KIF2A_HUMAN|O00139|Kinesin-like protein KIF2A (Kinesin-2) (hK2);5;5;7,9
O15066;O15066;"Kinesin-like protein KIF3B;Kinesin-like protein KIF3B, N-terminally processed";KIF3B;>KIF3B_HUMAN|O15066|Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) (Kinesin-like protein  KIF3B,  N-terminally processed);5;4;8,4
P33176;P33176;Kinesin-1 heavy chain;KIF5B;>KINH_HUMAN|P33176|Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC);43;33;51,2
"O60282;Q86Y91;Q969V6";O60282;Kinesin heavy chain isoform 5C;KIF5C;>KIF5C_HUMAN|O60282|Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2);41;30;48,8
Q96J84;Q96J84;Kin of IRRE-like protein 1;KIRREL;>KIRR1_HUMAN|Q96J84|Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1) (Precursor);5;5;9,5
Q07866;Q07866;Kinesin light chain 1;KLC1;>KLC1_HUMAN|Q07866|Kinesin light chain 1 (KLC 1);17;9;33,2
Q9H0B6;Q9H0B6;Kinesin light chain 2;KLC2;>KLC2_HUMAN|Q9H0B6|Kinesin light chain 2 (KLC 2);26;19;47,4
"Q9NSK0;Q6P597";Q9NSK0;Kinesin light chain 4;KLC4;>KLC4_HUMAN|Q9NSK0|Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8);24;20;44,3
P20151;P20151;Kallikrein-2;KLK2;>KLK2_HUMAN|P20151|Kallikrein-2 (3.4.21.35) (Glandular kallikrein-1) (hGK-1) (Tissue kallikrein-2) (Precursor);5;4;24,5
P07288;P07288;Prostate-specific antigen;KLK3;>KLK3_HUMAN|P07288|Prostate-specific antigen (PSA) (3.4.21.77) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase) (Precursor);13;12;82
"P01042;CON__P01045-1;CON__Q2KJ62;CON__P01044-1";P01042;"Kininogen-1;Kininogen-1 heavy chain;T-kinin;Bradykinin;Lysyl-bradykinin;Kininogen-1 light chain;Low molecular weight growth-promoting factor";KNG1;>KNG1_HUMAN|P01042|Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) (Kininogen-1 heavy chain) (T-kinin) (Ile-Ser-Bradykinin) (Bradykinin) (Kallidin I) (Lysyl;8;8;11,6
"O00629;O00505";O00629;Importin subunit alpha-3;KPNA4;>IMA3_HUMAN|O00629|Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4);5;5;12,9
"O60684;O15131";"O60684;O15131";"Importin subunit alpha-7;Importin subunit alpha-6";KPNA6;">IMA7_HUMAN|O60684|Importin subunit alpha-7 (Karyopherin subunit alpha-6);>IMA6_HUMAN|O15131|Importin subunit alpha-6 (Karyopherin subunit alpha-5)";5;2;13,6
Q14974;Q14974;Importin subunit beta-1;KPNB1;>IMB1_HUMAN|Q14974|Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97);23;23;31,3
P01116;P01116;"GTPase KRas;GTPase KRas, N-terminally processed";KRAS;>RASK_HUMAN|P01116|GTPase KRas (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) (GTPase  KRas,  N-terminally processed) (Precursor);6;3;37
O00522;O00522;Krev interaction trapped protein 1;KRIT1;>KRIT1_HUMAN|O00522|Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein);4;4;6,8
P11279;P11279;Lysosome-associated membrane glycoprotein 1;LAMP1;>LAMP1_HUMAN|P11279|Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD107a) (Precursor);10;10;18,7
P13473;P13473;Lysosome-associated membrane glycoprotein 2;LAMP2;>LAMP2_HUMAN|P13473|Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96 ) (CD107b) (Precursor);6;6;13,2
Q6IAA8;Q6IAA8;Ragulator complex protein LAMTOR1;LAMTOR1;>LTOR1_HUMAN|Q6IAA8|Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho);3;3;22,4
Q9UHA4;Q9UHA4;Ragulator complex protein LAMTOR3;LAMTOR3;>LTOR3_HUMAN|Q9UHA4|Ragulator complex protein LAMTOR3 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3) (MEK-binding partner 1) (Mp1) (Mitogen-activated protein kinase kinase 1-interacting protein 1) (Mitogen-activated protein kinase scaffol;3;3;49,2
O43504;O43504;Ragulator complex protein LAMTOR5;LAMTOR5;>LTOR5_HUMAN|O43504|Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein) (HBV X-interacting protein) (HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5);2;2;33
O43813;O43813;LanC-like protein 1;LANCL1;>LANC1_HUMAN|O43813|LanC-like protein 1 (40 kDa erythrocyte membrane protein) (p40);11;11;30,6
Q9NS86;Q9NS86;LanC-like protein 2;LANCL2;>LANC2_HUMAN|Q9NS86|LanC-like protein 2 (Testis-specific adriamycin sensitivity protein);10;10;26,4
P28838;P28838;Cytosol aminopeptidase;LAP3;>AMPL_HUMAN|P28838|Cytosol aminopeptidase (3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (3.4.11.5) (Prolyl aminopeptidase);15;15;38,7
Q9P2J5;Q9P2J5;Leucine--tRNA ligase, cytoplasmic;LARS;>SYLC_HUMAN|Q9P2J5|Leucine--tRNA  ligase,  cytoplasmic (6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS);7;7;6,5
Q14847;Q14847;LIM and SH3 domain protein 1;LASP1;>LASP1_HUMAN|Q14847|LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50);7;7;28,7
A4D1U4;A4D1U4;Protein LCHN;LCHN;>LCHN_HUMAN|A4D1U4|Protein LCHN;2;2;6,2
P80188;P80188;Neutrophil gelatinase-associated lipocalin;LCN2;>NGAL_HUMAN|P80188|Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin LCN2) (p25) (Precursor);4;4;27,8
P13796;P13796;Plastin-2;LCP1;>PLSL_HUMAN|P13796|Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1);33;27;55,2
P00338;P00338;L-lactate dehydrogenase A chain;LDHA;>LDHA_HUMAN|P00338|L-lactate dehydrogenase A chain (LDH-A) (1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59);13;12;38
"P07195;Q6ZMR3";P07195;L-lactate dehydrogenase B chain;LDHB;>LDHB_HUMAN|P07195|L-lactate dehydrogenase B chain (LDH-B) (1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46);18;17;43,4
P09382;P09382;Galectin-1;LGALS1;>LEG1_HUMAN|P09382|Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating prot;6;6;58,5
P17931;P17931;Galectin-3;LGALS3;>LEG3_HUMAN|P17931|Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen);11;11;38,4
Q08380;Q08380;Galectin-3-binding protein;LGALS3BP;>LG3BP_HUMAN|Q08380|Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K) (Precursor);13;13;30,3
O00214;O00214;Galectin-8;LGALS8;>LEG8_HUMAN|O00214|Galectin-8  (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1 ) (PCTA-1 );6;6;16,7
Q3ZCW2;Q3ZCW2;Galectin-related protein;LGALSL;>LEGL_HUMAN|Q3ZCW2|Galectin-related protein (Lectin galactoside-binding-like protein);2;2;11
P42702;P42702;Leukemia inhibitory factor receptor;LIFR;>LIFR_HUMAN|P42702|Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD118) (Precursor);7;7;8,1
"P48059;Q7Z4I7";P48059;LIM and senescent cell antigen-like-containing domain protein 1;LIMS1;>LIMS1_HUMAN|P48059|LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48);3;3;12
"Q9NUP9;O14910";Q9NUP9;Protein lin-7 homolog C;LIN7C;>LIN7C_HUMAN|Q9NUP9|Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3);8;8;49,7
Q99732;Q99732;Lipopolysaccharide-induced tumor necrosis factor-alpha factor;LITAF;>LITAF_HUMAN|Q99732|Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein);2;2;11,2
P49257;P49257;Protein ERGIC-53;LMAN1;>LMAN1_HUMAN|P49257|Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1) (Precursor);2;2;6,5
Q12907;Q12907;Vesicular integral-membrane protein VIP36;LMAN2;>LMAN2_HUMAN|Q12907|Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36) (Precursor);7;7;25,6
Q8IWU2;Q8IWU2;Serine/threonine-protein kinase LMTK2;LMTK2;>LMTK2_HUMAN|Q8IWU2|Serine/threonine-protein kinase LMTK2 (2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-pr;12;12;10,8
Q9UBY5;Q9UBY5;Lysophosphatidic acid receptor 3;LPAR3;>LPAR3_HUMAN|Q9UBY5|Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7);3;3;13
Q93052;Q93052;Lipoma-preferred partner;LPP;>LPP_HUMAN|Q93052|Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma);10;10;26,6
Q8TBJ4;Q8TBJ4;Lipid phosphate phosphatase-related protein type 1;LPPR1;>PLPR1_HUMAN|Q8TBJ4|Phospholipid phosphatase-related protein type 1  (Lipid phosphate phosphatase-related protein type 1 ) (Plasticity-related gene 3 protein ) (PRG-3 );5;5;20,9
"P50851;Q8NFP9";P50851;Lipopolysaccharide-responsive and beige-like anchor protein;LRBA;>LRBA_HUMAN|P50851|Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein);18;18;7,4
P98164;P98164;Low-density lipoprotein receptor-related protein 2;LRP2;>LRP2_HUMAN|P98164|Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) (Precursor);29;29;7,5
Q5VZK9;Q5VZK9;Leucine-rich repeat-containing protein 16A;LRRC16A;>CARL1_HUMAN|Q5VZK9|F-actin-uncapping protein LRRC16A  (CARMIL homolog ) (Capping protein regulator and myosin 1 linker protein 1 ) (Capping  protein,  Arp2/3 and myosin-I linker homolog 1 ) (Capping  protein,  Arp2/3 and myosin-I linker protein 1 ) (Leuci;5;5;3,2
Q8N1G4;Q8N1G4;Leucine-rich repeat-containing protein 47;LRRC47;>LRC47_HUMAN|Q8N1G4|Leucine-rich repeat-containing protein 47;13;13;21,6
Q8N9N7;Q8N9N7;Leucine-rich repeat-containing protein 57;LRRC57;>LRC57_HUMAN|Q8N9N7|Leucine-rich repeat-containing protein 57;8;8;34,7
Q32MZ4;Q32MZ4;Leucine-rich repeat flightless-interacting protein 1;LRRFIP1;>LRRF1_HUMAN|Q32MZ4|Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein);11;10;20,7
Q6UWE0;Q6UWE0;E3 ubiquitin-protein ligase LRSAM1;LRSAM1;>LRSM1_HUMAN|Q6UWE0|E3 ubiquitin-protein ligase LRSAM1  (2.3.2.27  ) (Leucine-rich repeat and sterile alpha motif-containing protein 1 ) (RING-type E3 ubiquitin transferase LRSAM1 ) (Tsg101-associated ligase ) (hTAL );7;7;10,9
Q13449;Q13449;Limbic system-associated membrane protein;LSAMP;>LSAMP_HUMAN|Q13449|Limbic system-associated membrane protein (LSAMP) (IgLON family member 3) (Precursor);3;3;11,8
Q86X29;Q86X29;Lipolysis-stimulated lipoprotein receptor;LSR;>LSR_HUMAN|Q86X29|Lipolysis-stimulated lipoprotein receptor;7;7;14
P48449;P48449;Lanosterol synthase;LSS;>ERG7_HUMAN|P48449|Lanosterol synthase (5.4.99.7)  (2,3-epoxysqualene--lanosterol  cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC);9;9;13,8
P09960;P09960;Leukotriene A-4 hydrolase;LTA4H;>LKHA4_HUMAN|P09960|Leukotriene A-4 hydrolase (LTA-4 hydrolase) (3.3.2.6) (Leukotriene A(4) hydrolase);24;24;47,3
P02788;P02788;"Lactotransferrin;Lactoferricin-H;Kaliocin-1;Lactoferroxin-A;Lactoferroxin-B;Lactoferroxin-C";LTF;>TRFL_HUMAN|P02788|Lactotransferrin (Lactoferrin) (3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) (Lactoferricin-H) (Lfcin-H) (Kaliocin-1) (Lactoferroxin-A) (Lactoferroxin-B) (Lactoferroxin-C) (Precursor);28;26;44,6
Q9BS40;Q9BS40;Latexin;LXN;>LXN_HUMAN|Q9BS40|Latexin (Endogenous carboxypeptidase inhibitor) (ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor) (TCI);3;3;16,7
Q14210;Q14210;Lymphocyte antigen 6D;LY6D;>LY6D_HUMAN|Q14210|Lymphocyte antigen 6D (Ly-6D) (E48 antigen) (Precursor);2;2;18,8
"P07948;P08631";P07948;Tyrosine-protein kinase Lyn;LYN;>LYN_HUMAN|P07948|Tyrosine-protein kinase Lyn (2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn);16;14;36,3
O75608;O75608;Acyl-protein thioesterase 1;LYPLA1;>LYPA1_HUMAN|O75608|Acyl-protein thioesterase 1 (APT-1) (hAPT1) (3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);4;4;20
O95372;O95372;Acyl-protein thioesterase 2;LYPLA2;>LYPA2_HUMAN|O95372|Acyl-protein thioesterase 2 (APT-2) (3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II);5;5;22,9
Q5VWZ2;Q5VWZ2;Lysophospholipase-like protein 1;LYPLAL1;>LYPL1_HUMAN|Q5VWZ2|Lysophospholipase-like protein 1 (3.1.2.-);8;8;41,8
P61626;P61626;Lysozyme C;LYZ;>LYSC_HUMAN|P61626|Lysozyme C (3.2.1.17)  (1,4-beta-N-acetylmuramidase  C) (Precursor);3;3;27
Q8WXG6;Q8WXG6;MAP kinase-activating death domain protein;MADD;>MADD_HUMAN|Q8WXG6|MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor);20;20;16
Q969L2;Q969L2;Protein MAL2;MAL2;>MAL2_HUMAN|Q969L2|Protein MAL2;2;2;18,2
"P33908;O60476";P33908;Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA;MAN1A1;>MA1A1_HUMAN|P33908|Mannosyl-oligosaccharide  1,2-alpha-mannosidase  IA (3.2.1.113 ) (Man(9)-alpha-mannosidase) (Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing  alpha-1,2-mannosidase  IA)  (Alpha-1,2-mannosidase  IA);3;3;5,4
Q02750;Q02750;Dual specificity mitogen-activated protein kinase kinase 1;MAP2K1;>MP2K1_HUMAN|Q02750|Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1);10;7;23,2
P36507;P36507;Dual specificity mitogen-activated protein kinase kinase 2;MAP2K2;>MP2K2_HUMAN|P36507|Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (2.7.12.2 ) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2);13;9;37,2
P45985;P45985;Dual specificity mitogen-activated protein kinase kinase 4;MAP2K4;>MP2K4_HUMAN|P45985|Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kina;3;3;10,3
P28482;P28482;Mitogen-activated protein kinase 1;MAPK1;>MK01_HUMAN|P28482|Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2);15;12;50
"P27361;P31152;Q16659";P27361;Mitogen-activated protein kinase 3;MAPK3;>MK03_HUMAN|P27361|Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase;6;3;19,3
"P45984;P53779";"P45984;P53779";"Mitogen-activated protein kinase 9;Mitogen-activated protein kinase 10";MAPK9;">MK09_HUMAN|P45984|Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2);>MK10_HUMAN|P53779|Mitogen-activated protein";2;2;5
"Q15691;Q9UPY8";Q15691;Microtubule-associated protein RP/EB family member 1;MAPRE1;>MARE1_HUMAN|Q15691|Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1);8;8;30,2
P29966;P29966;Myristoylated alanine-rich C-kinase substrate;MARCKS;>MARCS_HUMAN|P29966|Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C  substrate,  80 kDa  protein,  light chain) (80K-L protein) (PKCSL);13;13;56
P49006;P49006;MARCKS-related protein;MARCKSL1;>MRP_HUMAN|P49006|MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS);6;6;41
P56192;P56192;Methionine--tRNA ligase, cytoplasmic;MARS;>SYMC_HUMAN|P56192|Methionine--tRNA  ligase,  cytoplasmic (6.1.1.10) (Methionyl-tRNA synthetase) (MetRS);6;6;8,1
O00187;O00187;"Mannan-binding lectin serine protease 2;Mannan-binding lectin serine protease 2 A chain;Mannan-binding lectin serine protease 2 B chain";MASP2;>MASP2_HUMAN|O00187|Mannan-binding lectin serine protease 2 (3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) (Mannan-binding lectin serine protease 2 A chain) (Mannan-binding lectin serine prot;6;6;7,9
"P31153;Q00266";P31153;S-adenosylmethionine synthase isoform type-2;MAT2A;>METK2_HUMAN|P31153|S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (2.5.1.6  ) (Methionine adenosyltransferase 2) (MAT 2 ) (Methionine adenosyltransferase II) (MAT-II);15;15;42,3
Q9NZL9;Q9NZL9;Methionine adenosyltransferase 2 subunit beta;MAT2B;>MAT2B_HUMAN|Q9NZL9|Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase);7;7;29
P02144;P02144;Myoglobin;MB;>MYG_HUMAN|P02144|Myoglobin;4;4;24,7
P02686;P02686;Myelin basic protein;MBP;>MBP_HUMAN|P02686|Myelin basic protein (MBP) (Myelin A1 protein) (Myelin membrane encephalitogenic protein);2;2;9,9
Q9ULC4;Q9ULC4;Malignant T-cell-amplified sequence 1;MCTS1;>MCTS1_HUMAN|Q9ULC4|Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies);5;5;39,8
P40925;P40925;Malate dehydrogenase, cytoplasmic;MDH1;>MDHC_HUMAN|P40925|Malate  dehydrogenase,  cytoplasmic (1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (1.1.1.96);14;14;44,6
P53582;P53582;Methionine aminopeptidase 1;METAP1;>MAP11_HUMAN|P53582|Methionine aminopeptidase 1  (MAP 1 ) (MetAP 1 ) (3.4.11.18 ) (Peptidase M 1 );3;3;9,6
Q08431;Q08431;"Lactadherin;Lactadherin short form;Medin";MFGE8;>MFGM_HUMAN|Q08431|Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Lactadherin short form) (Medin) (Precursor);5;5;18,6
P08582;P08582;Melanotransferrin;MFI2;>TRFM_HUMAN|P08582|Melanotransferrin  (Melanoma-associated antigen p97) (CD228) (Precursor);27;27;48
"O43451;Q2M2H8";O43451;"Maltase-glucoamylase, intestinal;Maltase;Glucoamylase";MGAM;>MGA_HUMAN|O43451| Maltase-glucoamylase,  intestinal (Maltase) (3.2.1.20) (Alpha-glucosidase) (Glucoamylase) (3.2.1.3) (Glucan  1,4-alpha-glucosidase);39;38;25,1
"O60291;Q96PX1";O60291;E3 ubiquitin-protein ligase MGRN1;MGRN1;>MGRN1_HUMAN|O60291|E3 ubiquitin-protein ligase MGRN1 (2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1 );8;8;20,8
Q8TDZ2;Q8TDZ2;Protein-methionine sulfoxide oxidase MICAL1;MICAL1;>MICA1_HUMAN|Q8TDZ2|[F-actin]-methionine sulfoxide oxidase MICAL1 (1.14.13.225 ) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains);3;3;3,8
Q9BRT3;Q9BRT3;Migration and invasion enhancer 1;MIEN1;>MIEN1_HUMAN|Q9BRT3|Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35) (Precursor);4;4;25,2
P14174;P14174;Macrophage migration inhibitory factor;MIF;>MIF_HUMAN|P14174|Macrophage migration inhibitory factor (MIF) (5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (5.3.3.12) (Phenylpyruvate tautomerase);2;2;17,4
"Q8N4C8;O95819;Q9UKE5";Q8N4C8;Misshapen-like kinase 1;MINK1;>MINK1_HUMAN|Q8N4C8|Misshapen-like kinase 1 (2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6);11;11;8,5
Q8WV92;Q8WV92;MIT domain-containing protein 1;MITD1;>MITD1_HUMAN|Q8WV92|MIT domain-containing protein 1;14;14;59
P55196;P55196;Afadin;MLLT4;>AFAD_HUMAN|P55196|Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor );4;4;3,2
Q9BV36;Q9BV36;Melanophilin;MLPH;>MELPH_HUMAN|Q9BV36|Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a) (SlaC2-a) (Synaptotagmin-like protein 2a);28;28;63
Q9BVC4;Q9BVC4;Target of rapamycin complex subunit LST8;MLST8;>LST8_HUMAN|Q9BVC4|Target of rapamycin complex subunit LST8 (TORC subunit LST8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (Mammalian lethal with SEC13 protein 8) (mLST8);2;2;8
P08473;P08473;Neprilysin;MME;>NEP_HUMAN|P08473|Neprilysin (3.4.24.11  ) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD10);48;48;58
Q9H8S9;Q9H8S9;MOB kinase activator 1A;MOB1A;>MOB1A_HUMAN|Q9H8S9|MOB kinase activator 1A (Mob1 alpha) (Mob1A) (Mob1 homolog 1B) (Mps one binder kinase activator-like 1B);5;1;22,7
O96033;O96033;Molybdopterin synthase sulfur carrier subunit;MOCS2;>MOC2A_HUMAN|O96033|Molybdopterin synthase sulfur carrier subunit  (MOCO1-A) (Molybdenum cofactor synthesis protein 2 small subunit ) (Molybdenum cofactor synthesis protein 2A ) (MOCS2A ) (Molybdopterin-synthase small subunit) (Sulfur carrier protein MOCS2;3;3;30,7
Q7Z3U7;Q7Z3U7;Protein MON2 homolog;MON2;>MON2_HUMAN|Q7Z3U7|Protein MON2 homolog (Protein SF21);27;27;16,1
O75970;O75970;Multiple PDZ domain protein;MPDZ;>MPDZ_HUMAN|O75970|Multiple PDZ domain protein (Multi-PDZ domain protein 1);13;12;7,8
P34949;P34949;Mannose-6-phosphate isomerase;MPI;>MPI_HUMAN|P34949|Mannose-6-phosphate isomerase (5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI);7;7;26,5
"P05164;P11678";P05164;"Myeloperoxidase;Myeloperoxidase;89 kDa myeloperoxidase;84 kDa myeloperoxidase;Myeloperoxidase light chain;Myeloperoxidase heavy chain";MPO;>PERM_HUMAN|P05164|Myeloperoxidase (MPO) (1.11.2.2 ) (Myeloperoxidase) (89 kDa myeloperoxidase) (84 kDa myeloperoxidase) (Myeloperoxidase light chain) (Myeloperoxidase heavy chain) (Precursor);4;4;6,6
"Q8N3R9;P08908";Q8N3R9;MAGUK p55 subfamily member 5;MPP5;>MPP5_HUMAN|Q8N3R9|MAGUK p55 subfamily member 5;24;24;43,3
P25325;P25325;3-mercaptopyruvate sulfurtransferase;MPST;>THTM_HUMAN|P25325|3-mercaptopyruvate sulfurtransferase (MST) (2.8.1.2);11;11;43,8
Q96AM1;Q96AM1;Mas-related G-protein coupled receptor member F;MRGPRF;>MRGRF_HUMAN|Q96AM1|Mas-related G-protein coupled receptor member F (Mas-related gene F protein) (G-protein coupled receptor 140) (G-protein coupled receptor 168);2;2;7,6
Q9BV20;Q9BV20;Methylthioribose-1-phosphate isomerase;MRI1;>MTNA_HUMAN|Q9BV20|Methylthioribose-1-phosphate isomerase  (M1Pi ) (MTR-1-P isomerase ) (5.3.1.23 ) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase ) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like pro;6;6;22,8
Q8NDA8;Q8NDA8;Maestro heat-like repeat-containing protein family member 1;MROH1;>MROH1_HUMAN|Q8NDA8|Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A);6;6;3,9
P08118;P08118;Beta-microseminoprotein;MSMB;>MSMB_HUMAN|P08118|Beta-microseminoprotein (Immunoglobulin-binding factor) (IGBF) (PN44) (Prostate secreted seminal plasma protein) (Prostate secretory protein of 94 amino acids) (PSP-94) (PSP94) (Seminal plasma beta-inhibin) (Precursor);1;1;7,9
P26038;P26038;Moesin;MSN;>MOES_HUMAN|P26038|Moesin  (Membrane-organizing extension spike protein);45;30;57,2
Q9UJ68;Q9UJ68;Mitochondrial peptide methionine sulfoxide reductase;MSRA;>MSRA_HUMAN|Q9UJ68|Mitochondrial peptide methionine sulfoxide reductase (1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase) (PMSR) (Precursor);8;8;50,6
"P02795;P80297;P13640;CON__P67983;Q8N339;P04732";"P02795;P80297;P13640";"Metallothionein-2;Metallothionein-1X;Metallothionein-1G";MT2A;">MT2_HUMAN|P02795|Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II);>MT1X_HUMAN|P80297|Metallothionein-1X (MT-1X) (Metallothionein-IX) (MT-IX);>MT1G_HUMAN|P13640|Metallothionein-1G (MT-1G) (Metallothionein-1K) (MT-1K) (Metallothion";3;2;65,6
Q13126;Q13126;S-methyl-5-thioadenosine phosphorylase;MTAP;>MTAP_HUMAN|Q13126|S-methyl-5-thioadenosine phosphorylase  (2.4.2.28 ) (5-methylthioadenosine phosphorylase ) (MTA phosphorylase ) (MTAP ) (MTAPase );4;4;17,7
P11586;P11586;"C-1-tetrahydrofolate synthase, cytoplasmic;Methylenetetrahydrofolate dehydrogenase;Methenyltetrahydrofolate cyclohydrolase;Formyltetrahydrofolate synthetase;C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed";MTHFD1;>C1TC_HUMAN|P11586|C-1-tetrahydrofolate  synthase,  cytoplasmic (C1-THF synthase) (Methylenetetrahydrofolate dehydrogenase) (1.5.1.5) (Methenyltetrahydrofolate cyclohydrolase) (3.5.4.9) (Formyltetrahydrofolate synthetase) (6.3.4.3) (C-1-tetrahydrofolate  s;20;20;24,1
P49914;P49914;5-formyltetrahydrofolate cyclo-ligase;MTHFS;>MTHFS_HUMAN|P49914|5-formyltetrahydrofolate cyclo-ligase (6.3.3.2)  (5,10-methenyl-tetrahydrofolate  synthetase) (MTHFS) (Methenyl-THF synthetase);2;2;10,3
Q13496;Q13496;Myotubularin;MTM1;>MTM1_HUMAN|Q13496|Myotubularin  (Phosphatidylinositol-3,5-bisphosphate  3-phosphatase) (3.1.3.95 ) (Phosphatidylinositol-3-phosphate phosphatase) (3.1.3.64  );3;3;5
P58546;P58546;Myotrophin;MTPN;>MTPN_HUMAN|P58546|Myotrophin (Protein V-1);5;5;50,8
P15941;P15941;"Mucin-1;Mucin-1 subunit alpha;Mucin-1 subunit beta";MUC1;>MUC1_HUMAN|P15941|Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epitheli;9;9;8,4
Q9UKN1;Q9UKN1;Mucin-12;MUC12;>MUC12_HUMAN|Q9UKN1|Mucin-12 (MUC-12) (Mucin-11) (MUC-11) (Precursor);9;9;1,5
Q9H3R2;Q9H3R2;Mucin-13;MUC13;>MUC13_HUMAN|Q9H3R2|Mucin-13 (MUC-13) (Down-regulated in colon cancer 1) (Precursor);2;2;6,2
Q99102;Q99102;"Mucin-4;Mucin-4 alpha chain;Mucin-4 beta chain";MUC4;>MUC4_HUMAN|Q99102|Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) (Mucin-4 alpha chain) (Ascites sialoglycoprotein 1) (ASGP-1) (Mucin-4 beta chain) (Ascites sialoglycoprotein 2) ;14;14;8,6
P98088;P98088;Mucin-5AC;MUC5AC;>MUC5A_HUMAN|P98088|Mucin-5AC  (MUC-5AC ) (Gastric mucin ) (Lewis B blood group antigen ) (LeB ) (Major airway glycoprotein ) (Mucin-5 subtype  AC,  tracheobronchial) (Tracheobronchial mucin ) (TBM ) (Precursor);9;7;4,5
Q9HC84;Q9HC84;Mucin-5B;MUC5B;>MUC5B_HUMAN|Q9HC84|Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype  B,  tracheobronchial) (Sublingual gland mucin) (Precursor);37;35;10,3
Q96EY5;Q96EY5;Multivesicular body subunit 12A;MVB12A;>MB12A_HUMAN|Q96EY5|Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A);8;8;46,5
Q9H7P6;Q9H7P6;Multivesicular body subunit 12B;MVB12B;>MB12B_HUMAN|Q9H7P6|Multivesicular body subunit 12B (ESCRT-I complex subunit MVB12B) (Protein FAM125B);6;6;30,4
P53602;P53602;Diphosphomevalonate decarboxylase;MVD;>MVD1_HUMAN|P53602|Diphosphomevalonate decarboxylase (4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase);5;5;12,8
Q03426;Q03426;Mevalonate kinase;MVK;>KIME_HUMAN|Q03426|Mevalonate kinase (MK) (2.7.1.36);5;5;19,2
Q14764;Q14764;Major vault protein;MVP;>MVP_HUMAN|Q14764|Major vault protein (MVP) (Lung resistance-related protein);5;5;7,3
Q9BRK3;Q9BRK3;Matrix-remodeling-associated protein 8;MXRA8;>MXRA8_HUMAN|Q9BRK3|Matrix remodeling-associated protein 8 (Limitrin) (Precursor);11;11;24,9
Q99417;Q99417;C-Myc-binding protein;MYCBP;>MYCBP_HUMAN|Q99417|C-Myc-binding protein (Associate of Myc 1) (AMY-1);3;3;28,2
P35580;P35580;Myosin-10;MYH10;>MYH10_HUMAN|P35580|Myosin-10 (Cellular myosin heavy  chain,  type B) (Myosin heavy chain 10) (Myosin heavy  chain,  non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB);30;15;18,6
Q7Z406;Q7Z406;Myosin-14;MYH14;>MYH14_HUMAN|Q7Z406|Myosin-14 (Myosin heavy chain 14) (Myosin heavy  chain,  non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C);21;15;12,3
"P35579;REV__Q9UKV3;P12883;P13535;Q9UKX3;P13533;P12882;P11055;Q9UKX2;A7E2Y1";P35579;Myosin-9;MYH9;>MYH9_HUMAN|P35579|Myosin-9 (Cellular myosin heavy  chain,  type A) (Myosin heavy chain 9) (Myosin heavy  chain,  non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA);80;65;48,9
"P19105;O14950;P24844";"P19105;O14950;P24844";"Myosin regulatory light chain 12A;Myosin regulatory light chain 12B;Myosin regulatory light polypeptide 9";MYL12A;">ML12A_HUMAN|P19105|Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain  2,  nonsarcomeric) (Myosin regulatory light chain MRLC3);>ML12B_HUMAN|O14950|Myosin regulatory light";8;8;51,5
"P60660;P14649";P60660;Myosin light polypeptide 6;MYL6;>MYL6_HUMAN|P60660|Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6);8;8;55,6
"O43795;Q9UBC5";O43795;Unconventional myosin-Ib;MYO1B;>MYO1B_HUMAN|O43795|Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa);21;21;21,7
"O00159;Q8N1T3;O00160";O00159;Unconventional myosin-Ic;MYO1C;>MYO1C_HUMAN|O00159|Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb);44;44;46,8
"O94832;B0I1T2";O94832;Unconventional myosin-Id;MYO1D;>MYO1D_HUMAN|O94832|Unconventional myosin-Id;47;47;49,5
Q12965;Q12965;Unconventional myosin-Ie;MYO1E;>MYO1E_HUMAN|Q12965|Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E);6;6;6,9
Q9Y4I1;Q9Y4I1;Unconventional myosin-Va;MYO5A;>MYO5A_HUMAN|Q9Y4I1|Unconventional myosin-Va (Dilute myosin heavy  chain,  non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin);9;3;4,9
Q9ULV0;Q9ULV0;Unconventional myosin-Vb;MYO5B;>MYO5B_HUMAN|Q9ULV0|Unconventional myosin-Vb;12;8;6,8
Q9NQX4;Q9NQX4;Unconventional myosin-Vc;MYO5C;>MYO5C_HUMAN|Q9NQX4|Unconventional myosin-Vc;42;37;25,5
Q9UM54;Q9UM54;Unconventional myosin-VI;MYO6;>MYO6_HUMAN|Q9UM54|Unconventional myosin-VI (Unconventional myosin-6);29;29;26,3
"Q9NZM1;O75923";Q9NZM1;Myoferlin;MYOF;>MYOF_HUMAN|Q9NZM1|Myoferlin (Fer-1-like protein 3);72;72;41,9
Q8NFW9;Q8NFW9;Rab effector MyRIP;MYRIP;>MYRIP_HUMAN|Q8NFW9|Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c);4;4;5,4
Q13564;Q13564;NEDD8-activating enzyme E1 regulatory subunit;NAE1;>ULA1_HUMAN|Q13564|NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein  1,  59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1);4;4;11,2
Q9UJ70;Q9UJ70;N-acetyl-D-glucosamine kinase;NAGK;>NAGK_HUMAN|Q9UJ70|N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (2.7.1.59) (GlcNAc kinase);13;13;48,8
P54802;P54802;"Alpha-N-acetylglucosaminidase;Alpha-N-acetylglucosaminidase 82 kDa form;Alpha-N-acetylglucosaminidase 77 kDa form";NAGLU;>ANAG_HUMAN|P54802|Alpha-N-acetylglucosaminidase (3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) (Alpha-N-acetylglucosaminidase 82 kDa form) (Alpha-N-acetylglucosaminidase 77 kDa form) (Precursor);7;7;12,9
P43490;P43490;Nicotinamide phosphoribosyltransferase;NAMPT;>NAMPT_HUMAN|P43490|Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin);21;21;47,3
Q9NR45;Q9NR45;Sialic acid synthase;NANS;>SIAS_HUMAN|Q9NR45|Sialic acid synthase (N-acetylneuraminate synthase) (2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase);13;13;43,2
P55209;P55209;Nucleosome assembly protein 1-like 1;NAP1L1;>NP1L1_HUMAN|P55209|Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNRP) (Precursor);6;4;17,4
Q99733;Q99733;Nucleosome assembly protein 1-like 4;NAP1L4;>NP1L4_HUMAN|Q99733|Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2);9;7;26,9
"P54920;Q9H115";P54920;Alpha-soluble NSF attachment protein;NAPA;>SNAA_HUMAN|P54920|Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha);21;21;70,5
Q99747;Q99747;Gamma-soluble NSF attachment protein;NAPG;>SNAG_HUMAN|Q99747|Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma);16;16;45,8
Q6XQN6;Q6XQN6;Nicotinate phosphoribosyltransferase;NAPRT;>PNCB_HUMAN|Q6XQN6|Nicotinate phosphoribosyltransferase (NAPRTase) (6.3.4.21) (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1);12;12;25,3
O96009;O96009;Napsin-A;NAPSA;>NAPSA_HUMAN|O96009|Napsin-A (3.4.23.-) (Aspartyl protease 4) (ASP4) (Asp 4) (Napsin-1) (TA01/TA02) (Precursor);6;6;13,3
O43776;O43776;Asparagine--tRNA ligase, cytoplasmic;NARS;>SYNC_HUMAN|O43776|Asparagine--tRNA  ligase,  cytoplasmic (6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS);15;15;29,9
P18440;P18440;Arylamine N-acetyltransferase 1;NAT1;>ARY1_HUMAN|P18440|Arylamine N-acetyltransferase 1 (2.3.1.5) (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase) (MNAT) (N-acetyltransferase type 1) (NAT-1);3;3;11
O43639;O43639;Cytoplasmic protein NCK2;NCK2;>NCK2_HUMAN|O43639|Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta);4;4;12,9
"Q9Y2A7;P55160";Q9Y2A7;Nck-associated protein 1;NCKAP1;>NCKP1_HUMAN|Q9Y2A7|Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1);29;29;25,7
Q92542;Q92542;Nicastrin;NCSTN;>NICA_HUMAN|Q92542|Nicastrin (Precursor);10;10;13,4
Q92597;Q92597;Protein NDRG1;NDRG1;>NDRG1_HUMAN|Q92597|Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42);10;10;44,2
Q9UN36;Q9UN36;Protein NDRG2;NDRG2;>NDRG2_HUMAN|Q9UN36|Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613);6;6;23,7
Q9UGV2;Q9UGV2;Protein NDRG3;NDRG3;>NDRG3_HUMAN|Q9UGV2|Protein NDRG3 (N-myc downstream-regulated gene 3 protein);9;9;36,3
"Q96PU5;Q9HAU4;Q9P2P5;Q76N89";Q96PU5;E3 ubiquitin-protein ligase NEDD4-like;NEDD4L;>NED4L_HUMAN|Q96PU5|E3 ubiquitin-protein ligase NEDD4-like (2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2);23;21;28,3
"P12036;Q16352;P07196;P07197";P12036;Neurofilament heavy polypeptide;NEFH;>NFH_HUMAN|P12036|Neurofilament heavy polypeptide (NF-H) (200 kDa neurofilament protein) (Neurofilament triplet H protein);17;14;19,2
P35240;P35240;Merlin;NF2;>MERL_HUMAN|P35240|Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin);9;9;16,1
O94856;O94856;Neurofascin;NFASC;>NFASC_HUMAN|O94856|Neurofascin (Precursor);8;8;7,6
Q8NBF2;Q8NBF2;NHL repeat-containing protein 2;NHLRC2;>NHLC2_HUMAN|Q8NBF2|NHL repeat-containing protein 2;9;9;17,2
Q86X76;Q86X76;Nitrilase homolog 1;NIT1;>NIT1_HUMAN|Q86X76|Nitrilase homolog 1 (3.5.-.-);9;9;29,4
Q9NQR4;Q9NQR4;Omega-amidase NIT2;NIT2;>NIT2_HUMAN|Q9NQR4|Omega-amidase NIT2 (3.5.1.3) (Nitrilase homolog 2);15;15;70,3
P15531;P15531;Nucleoside diphosphate kinase A;NME1;>NDKA_HUMAN|P15531|Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein);8;4;57,2
"P22392;O60361";"P22392;O60361";"Nucleoside diphosphate kinase B;Putative nucleoside diphosphate kinase";NME2;">NDKB_HUMAN|P22392|Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (2.7.13.3) (nm23-H2);>NDK8_HUMAN|O60361|Putative nucleoside diphosphate kinase (NDK) (NDP ki";9;5;63,8
Q9HBL8;Q9HBL8;NmrA-like family domain-containing protein 1;NMRAL1;>NMRL1_HUMAN|Q9HBL8|NmrA-like family domain-containing protein 1;4;4;16,4
O60936;O60936;Nucleolar protein 3;NOL3;>NOL3_HUMAN|O60936|Nucleolar protein 3  (Apoptosis repressor with CARD ) (Muscle-enriched cytoplasmic protein ) (Myp ) (Nucleolar protein of 30 kDa ) (Nop30 );5;5;39,9
P61916;P61916;Epididymal secretory protein E1;NPC2;>NPC2_HUMAN|P61916|Epididymal secretory protein E1 (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein) (Precursor);3;3;30,5
Q9NQX5;Q9NQX5;Neural proliferation differentiation and control protein 1;NPDC1;>NPDC1_HUMAN|Q9NQX5|Neural proliferation differentiation and control protein 1 (NPDC-1) (Precursor);4;4;16,6
"P55786;A6NEC2";P55786;Puromycin-sensitive aminopeptidase;NPEPPS;>PSA_HUMAN|P55786|Puromycin-sensitive aminopeptidase (PSA) (3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);29;29;33,7
O60500;O60500;Nephrin;NPHS1;>NPHN_HUMAN|O60500|Nephrin (Renal glomerulus-specific cell adhesion receptor) (Precursor);15;15;15,1
Q9NP85;Q9NP85;Podocin;NPHS2;>PODO_HUMAN|Q9NP85|Podocin;10;10;39,7
Q6UXI9;Q6UXI9;Nephronectin;NPNT;>NPNT_HUMAN|Q6UXI9|Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like) (Precursor);11;11;25,3
P17342;P17342;Atrial natriuretic peptide receptor 3;NPR3;>ANPRC_HUMAN|P17342|Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) (Precursor);5;5;10,5
P16083;P16083;Ribosyldihydronicotinamide dehydrogenase [quinone];NQO2;>NQO2_HUMAN|P16083|Ribosyldihydronicotinamide dehydrogenase [quinone] (1.10.5.1 ) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2);5;5;22,9
P01111;P01111;GTPase NRas;NRAS;>RASN_HUMAN|P01111|GTPase NRas (Transforming protein N-Ras) (Precursor);7;2;39,2
O43847;O43847;Nardilysin;NRD1;>NRDC_HUMAN|O43847|Nardilysin (3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase ) (Precursor);8;8;7,8
"P46459;Q969G3";P46459;Vesicle-fusing ATPase;NSF;>NSF_HUMAN|P46459|Vesicle-fusing ATPase (3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF);23;23;31,6
Q9UNZ2;Q9UNZ2;NSFL1 cofactor p47;NSFL1C;>NSF1C_HUMAN|Q9UNZ2|NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47);7;7;21,9
Q8TCD5;Q8TCD5;5(3)-deoxyribonucleotidase, cytosolic type;NT5C;>NT5C_HUMAN|Q8TCD5| 5(3)-deoxyribonucleotidase,  cytosolic type (3.1.3.-) (Cytosolic  5,3-pyrimidine  nucleotidase) (Deoxy-5-nucleotidase 1) (dNT-1);4;4;23,4
P49902;P49902;Cytosolic purine 5-nucleotidase;NT5C2;>5NTC_HUMAN|P49902|Cytosolic purine 5-nucleotidase (3.1.3.5) (Cytosolic 5-nucleotidase II);7;7;18,2
Q5TFE4;Q5TFE4;5-nucleotidase domain-containing protein 1;NT5DC1;>NT5D1_HUMAN|Q5TFE4|5-nucleotidase domain-containing protein 1 (3.1.3.-);4;4;10,8
P21589;P21589;5-nucleotidase;NT5E;>5NTD_HUMAN|P21589|5-nucleotidase (5-NT) (3.1.3.5) (Ecto-5-nucleotidase) (CD73) (Precursor);11;11;23,5
"P53384;REV__Q8N7X0";P53384;Cytosolic Fe-S cluster assembly factor NUBP1;NUBP1;>NUBP1_HUMAN|P53384|Cytosolic Fe-S cluster assembly factor NUBP1  (Nucleotide-binding protein 1 ) (NBP 1 );3;3;14,1
Q02818;Q02818;Nucleobindin-1;NUCB1;>NUCB1_HUMAN|Q02818|Nucleobindin-1 (CALNUC) (Precursor);4;4;12,1
Q9Y266;Q9Y266;Nuclear migration protein nudC;NUDC;>NUDC_HUMAN|Q9Y266|Nuclear migration protein nudC (Nuclear distribution protein C homolog);5;5;19,9
Q8WVJ2;Q8WVJ2;NudC domain-containing protein 2;NUDCD2;>NUDC2_HUMAN|Q8WVJ2|NudC domain-containing protein 2;3;3;19,1
P50583;P50583;Bis(5-nucleosyl)-tetraphosphatase [asymmetrical];NUDT2;>AP4A_HUMAN|P50583|Bis(5-nucleosyl)-tetraphosphatase [asymmetrical] (3.6.1.17) (Diadenosine  5,5-P1,P4-tetraphosphate  asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (;4;4;31,3
O95989;O95989;Diphosphoinositol polyphosphate phosphohydrolase 1;NUDT3;>NUDT3_HUMAN|O95989|Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (3.6.1.52) (Diadenosine  5,5-P1,P6-hexaphosphate  hydrolase 1) (3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3);3;2;18
Q9NZJ9;Q9NZJ9;Diphosphoinositol polyphosphate phosphohydrolase 2;NUDT4;>NUDT4_HUMAN|Q9NZJ9|Diphosphoinositol polyphosphate phosphohydrolase 2 (DIPP-2) (3.6.1.52) (Diadenosine  5,5-P1,P6-hexaphosphate  hydrolase 2) (3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 4) (Nudix motif 4);5;2;38,3
Q9UKK9;Q9UKK9;ADP-sugar pyrophosphatase;NUDT5;>NUDT5_HUMAN|Q9UKK9|ADP-sugar pyrophosphatase (3.6.1.13  ) (8-oxo-dGDP phosphatase) (3.6.1.58  ) (Nuclear ATP-synthesis protein NUDIX5 ) (2.7.7.96 ) (Nucleoside diphosphate-linked moiety X motif 5 ) (Nudix motif 5 ) (hNUDT5 ) (YSA1H );6;6;26
P61970;P61970;Nuclear transport factor 2;NUTF2;>NTF2_HUMAN|P61970|Nuclear transport factor 2  (NTF-2) (Placental protein 15 ) (PP15 );5;5;56,7
Q6DKJ4;Q6DKJ4;Nucleoredoxin;NXN;>NXN_HUMAN|Q6DKJ4|Nucleoredoxin (1.8.1.8);3;3;11,3
P29728;P29728;2-5-oligoadenylate synthase 2;OAS2;>OAS2_HUMAN|P29728|2-5-oligoadenylate synthase 2 ((2-5)oligo(A) synthase 2) (2-5A synthase 2) (2.7.7.84) (p69 OAS / p71 OAS) (p69OAS / p71OAS);3;3;4,2
Q8TAD7;Q8TAD7;Overexpressed in colon carcinoma 1 protein;OCC1;>OCC1_HUMAN|Q8TAD7|Overexpressed in colon carcinoma 1 protein (OCC-1) (AGD3);3;3;57,1
Q01968;Q01968;Inositol polyphosphate 5-phosphatase OCRL-1;OCRL;>OCRL_HUMAN|Q01968|Inositol polyphosphate 5-phosphatase OCRL-1 (3.1.3.36) (Lowe oculocerebrorenal syndrome protein);5;5;6,2
Q9NTK5;Q9NTK5;Obg-like ATPase 1;OLA1;>OLA1_HUMAN|Q9NTK5|Obg-like ATPase 1  (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9);7;7;21,5
O14841;O14841;5-oxoprolinase;OPLAH;>OPLA_HUMAN|O14841|5-oxoprolinase (3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase);19;19;19,4
P02763;P02763;Alpha-1-acid glycoprotein 1;ORM1;>A1AG1_HUMAN|P02763|Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1) (Precursor);7;5;40,8
P19652;P19652;Alpha-1-acid glycoprotein 2;ORM2;>A1AG2_HUMAN|P19652|Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2) (Precursor);6;4;29,4
"P22059;Q969R2";P22059;Oxysterol-binding protein 1;OSBP;>OSBP1_HUMAN|P22059|Oxysterol-binding protein 1;13;13;23,3
Q96SU4;Q96SU4;Oxysterol-binding protein-related protein 9;OSBPL9;>OSBL9_HUMAN|Q96SU4|Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9);2;2;2,7
Q92882;Q92882;Osteoclast-stimulating factor 1;OSTF1;>OSTF1_HUMAN|Q92882|Osteoclast-stimulating factor 1;4;4;26,6
Q96FW1;Q96FW1;Ubiquitin thioesterase OTUB1;OTUB1;>OTUB1_HUMAN|Q96FW1|Ubiquitin thioesterase OTUB1 (3.4.19.12 ) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1);10;10;44,3
O95747;O95747;Serine/threonine-protein kinase OSR1;OXSR1;>OXSR1_HUMAN|O95747|Serine/threonine-protein kinase OSR1 (2.7.11.1) (Oxidative stress-responsive 1 protein);13;10;27,5
Q99571;Q99571;P2X purinoceptor 4;P2RX4;>P2RX4_HUMAN|Q99571|P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);9;9;30,4
P07237;P07237;Protein disulfide-isomerase;P4HB;>PDIA1_HUMAN|P07237|Protein disulfide-isomerase (PDI) (5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55) (Precursor);11;11;21,7
Q9UQ80;Q9UQ80;Proliferation-associated protein 2G4;PA2G4;>PA2G4_HUMAN|Q9UQ80|Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1);3;3;8,6
"P11940;Q9H361;Q13310;Q4VXU2;Q5JQF8;Q96DU9";P11940;Polyadenylate-binding protein 1;PABPC1;>PABP1_HUMAN|P11940|Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1);13;13;24,1
"Q9UNF0;Q9BY11";Q9UNF0;Protein kinase C and casein kinase substrate in neurons protein 2;PACSIN2;>PACN2_HUMAN|Q9UNF0|Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II);16;16;36,8
Q9UKS6;Q9UKS6;Protein kinase C and casein kinase substrate in neurons protein 3;PACSIN3;>PACN3_HUMAN|Q9UKS6|Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511);18;18;48,3
P43034;P43034;Platelet-activating factor acetylhydrolase IB subunit alpha;PAFAH1B1;>LIS1_HUMAN|P43034|Platelet-activating factor acetylhydrolase IB subunit alpha  (Lissencephaly-1 protein ) (LIS-1 ) (PAF acetylhydrolase 45 kDa subunit ) (PAF-AH 45 kDa subunit ) (PAF-AH alpha ) (PAFAH alpha );15;15;41,2
P68402;P68402;Platelet-activating factor acetylhydrolase IB subunit beta;PAFAH1B2;>PA1B2_HUMAN|P68402|Platelet-activating factor acetylhydrolase IB subunit beta (3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta);5;5;29,3
Q15102;Q15102;Platelet-activating factor acetylhydrolase IB subunit gamma;PAFAH1B3;>PA1B3_HUMAN|Q15102|Platelet-activating factor acetylhydrolase IB subunit gamma (3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma);8;8;39
P22234;P22234;"Multifunctional protein ADE2;Phosphoribosylaminoimidazole-succinocarboxamide synthase;Phosphoribosylaminoimidazole carboxylase";PAICS;>PUR6_HUMAN|P22234|Multifunctional protein ADE2 (Phosphoribosylaminoimidazole-succinocarboxamide synthase) (6.3.2.6) (SAICAR synthetase) (Phosphoribosylaminoimidazole carboxylase) (4.1.1.21) (AIR carboxylase) (AIRC);10;10;27,1
Q9H074;Q9H074;Polyadenylate-binding protein-interacting protein 1;PAIP1;>PAIP1_HUMAN|Q9H074|Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1);6;6;10,6
Q13153;Q13153;Serine/threonine-protein kinase PAK 1;PAK1;>PAK1_HUMAN|Q13153|Serine/threonine-protein kinase PAK 1 (2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK);5;4;11,2
"Q13177;O75914";Q13177;"Serine/threonine-protein kinase PAK 2;PAK-2p27;PAK-2p34";PAK2;>PAK2_HUMAN|Q13177|Serine/threonine-protein kinase PAK 2 (2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) (PAK-2p27) (p27) (PAK-2p34) (p34) (C-t-PAK2);8;7;23,7
O96013;O96013;Serine/threonine-protein kinase PAK 4;PAK4;>PAK4_HUMAN|O96013|Serine/threonine-protein kinase PAK 4 (2.7.11.1) (p21-activated kinase 4) (PAK-4);9;9;21,7
Q9NVE7;Q9NVE7;Pantothenate kinase 4;PANK4;>PANK4_HUMAN|Q9NVE7|Pantothenate kinase 4 (hPanK4) (2.7.1.33) (Pantothenic acid kinase 4);5;5;7,1
"Q9BYG5;Q9NPB6;Q9BYG4";Q9BYG5;Partitioning defective 6 homolog beta;PARD6B;>PAR6B_HUMAN|Q9BYG5|Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B);6;6;19,4
Q99497;Q99497;Protein DJ-1;PARK7;>PARK7_HUMAN|Q99497|Protein DJ-1  (DJ-1) (Oncogene DJ1 ) (Parkinson disease protein 7 ) (Parkinsonism-associated deglycase ) (Protein deglycase DJ-1 ) (3.1.2.- ) (3.5.1.124 ) (Precursor);13;13;59,8
Q9NVD7;Q9NVD7;Alpha-parvin;PARVA;>PARVA_HUMAN|Q9NVD7|Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2);4;4;13,7
Q9BVG4;Q9BVG4;Protein PBDC1;PBDC1;>PBDC1_HUMAN|Q9BVG4|Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1);4;4;23,6
P30039;P30039;Phenazine biosynthesis-like domain-containing protein;PBLD;>PBLD_HUMAN|P30039|Phenazine biosynthesis-like domain-containing protein (5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue);10;10;45,1
P61457;P61457;Pterin-4-alpha-carbinolamine dehydratase;PCBD1;>PHS_HUMAN|P61457|Pterin-4-alpha-carbinolamine dehydratase (PHS) (4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimul;5;4;49
Q15365;Q15365;Poly(rC)-binding protein 1;PCBP1;>PCBP1_HUMAN|Q15365|Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3);14;9;61,2
"Q15366;P57721;P57723";Q15366;Poly(rC)-binding protein 2;PCBP2;>PCBP2_HUMAN|Q15366|Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2);10;5;38,9
P35558;P35558;Phosphoenolpyruvate carboxykinase, cytosolic [GTP];PCK1;>PCKGC_HUMAN|P35558|Phosphoenolpyruvate  carboxykinase,  cytosolic [GTP] (PEPCK-C) (4.1.1.32);12;10;22,3
P22061;P22061;Protein-L-isoaspartate(D-aspartate) O-methyltransferase;PCMT1;>PIMT_HUMAN|P22061|Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase);7;7;33,9
Q9UHG3;Q9UHG3;Prenylcysteine oxidase 1;PCYOX1;>PCYOX_HUMAN|Q9UHG3|Prenylcysteine oxidase 1 (1.8.3.5) (Prenylcysteine lyase) (Precursor);3;3;5,7
Q99447;Q99447;Ethanolamine-phosphate cytidylyltransferase;PCYT2;>PCY2_HUMAN|Q99447|Ethanolamine-phosphate cytidylyltransferase (2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase);5;5;17,2
Q13442;Q13442;28 kDa heat- and acid-stable phosphoprotein;PDAP1;>HAP28_HUMAN|Q13442|28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1);3;3;23,2
Q9BUL8;Q9BUL8;Programmed cell death protein 10;PDCD10;>PDC10_HUMAN|Q9BUL8|Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15);10;10;45,3
O75340;O75340;Programmed cell death protein 6;PDCD6;>PDCD6_HUMAN|O75340|Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog ) (ALG-2 );12;12;55
Q8WUM4;Q8WUM4;Programmed cell death 6-interacting protein;PDCD6IP;>PDC6I_HUMAN|Q8WUM4|Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95);63;63;67,4
Q9HCR9;Q9HCR9;Dual 3,5-cyclic-AMP and -GMP phosphodiesterase 11A;PDE11A;>PDE11_HUMAN|Q9HCR9|Dual  3,5-cyclic-AMP  and #NAME phosphodiesterase 11A (3.1.4.35) (3.1.4.53) (cAMP and cGMP phosphodiesterase 11A);5;5;6,9
Q6L8Q7;Q6L8Q7;2,5-phosphodiesterase 12;PDE12;>PDE12_HUMAN|Q6L8Q7| 2,5-phosphodiesterase  12 (2-PDE) (2-PDE) (3.1.4.-) (Mitochondrial deadenylase) (3.1.13.4) (Precursor);2;2;6,1
O60658;O60658;High affinity cAMP-specific and IBMX-insensitive 3,5-cyclic phosphodiesterase 8A;PDE8A;>PDE8A_HUMAN|O60658|High affinity cAMP-specific and IBMX-insensitive  3,5-cyclic  phosphodiesterase 8A (3.1.4.53 );7;6;9,5
O76083;O76083;High affinity cGMP-specific 3,5-cyclic phosphodiesterase 9A;PDE9A;>PDE9A_HUMAN|O76083|High affinity cGMP-specific  3,5-cyclic  phosphodiesterase 9A  (3.1.4.35  );6;6;9,3
P09619;P09619;Platelet-derived growth factor receptor beta;PDGFRB;>PGFRB_HUMAN|P09619|Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived;10;10;9,9
P30101;P30101;Protein disulfide-isomerase A3;PDIA3;>PDIA3_HUMAN|P30101|Protein disulfide-isomerase A3 (5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum residen;9;9;20,4
Q96HC4;Q96HC4;PDZ and LIM domain protein 5;PDLIM5;>PDLI5_HUMAN|Q96HC4|PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein);18;18;35,9
O00764;O00764;Pyridoxal kinase;PDXK;>PDXK_HUMAN|O00764|Pyridoxal kinase (2.7.1.35) (Pyridoxine kinase);8;8;31,4
"Q5T2W1;A8MUH7";"Q5T2W1;A8MUH7";"Na(+)/H(+) exchange regulatory cofactor NHE-RF3;Putative PDZ domain-containing protein 1P";PDZK1;>NHRF3_HUMAN|Q5T2W1|Na(+)/H(+) exchange regulatory cofactor NHE-RF3 (NHERF-3) (CFTR-associated protein of 70 kDa) (Na(+)/H(+) exchanger regulatory factor 3) (Na/Pi cotransporter C-terminal-associated protein 1) (NaPi-Cap1) (PDZ domain-containing protein 1);25;25;54,7
Q13113;Q13113;PDZK1-interacting protein 1;PDZK1IP1;>PDZ1I_HUMAN|Q13113|PDZK1-interacting protein 1 (17 kDa membrane-associated protein) (Protein DD96);4;4;34,2
Q15121;Q15121;Astrocytic phosphoprotein PEA-15;PEA15;>PEA15_HUMAN|Q15121|Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED);5;5;44,6
P30086;P30086;"Phosphatidylethanolamine-binding protein 1;Hippocampal cholinergic neurostimulating peptide";PEBP1;>PEBP1_HUMAN|P30086|Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) (Hippocampal cholinergic neurostimulating peptide) (HCNP);13;13;82,4
Q9UBV8;Q9UBV8;Peflin;PEF1;>PEF1_HUMAN|Q9UBV8|Peflin  (PEF protein with a long N-terminal hydrophobic domain ) (Penta-EF hand domain-containing protein 1 );7;7;19,4
Q9BRX2;Q9BRX2;Protein pelota homolog;PELO;>PELO_HUMAN|Q9BRX2|Protein pelota homolog (3.1.-.-);3;3;8,3
P12955;P12955;Xaa-Pro dipeptidase;PEPD;>PEPD_HUMAN|P12955|Xaa-Pro dipeptidase (X-Pro dipeptidase) (3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase);14;14;33,9
Q9UHV9;Q9UHV9;Prefoldin subunit 2;PFDN2;>PFD2_HUMAN|Q9UHV9|Prefoldin subunit 2;3;3;22,7
Q99471;Q99471;Prefoldin subunit 5;PFDN5;>PFD5_HUMAN|Q99471|Prefoldin subunit 5 (C-Myc-binding protein Mm-1) (Myc modulator 1);3;3;24,7
O15212;O15212;Prefoldin subunit 6;PFDN6;>PFD6_HUMAN|O15212|Prefoldin subunit 6 (Protein Ke2);5;5;43,4
"O60825;Q16877;Q16875";O60825;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2;6-phosphofructo-2-kinase;Fructose-2,6-bisphosphatase";PFKFB2;>F262_HUMAN|O60825| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase  2  (6PF-2-K/Fru-2,6-P2ase  2) (PFK/FBPase 2)  (6PF-2-K/Fru-2,6-P2ase  heart-type isozyme) (6-phosphofructo-2-kinase) (2.7.1.105)  (Fructose-2,6-bisphosphatase)  (3.1.3.46);8;6;15,4
P17858;P17858;ATP-dependent 6-phosphofructokinase, liver type;PFKL;>PFKAL_HUMAN|P17858|ATP-dependent  6-phosphofructokinase,  liver type  (ATP-PFK ) (PFK-L) (2.7.1.11 ) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase );20;17;29,2
Q01813;Q01813;ATP-dependent 6-phosphofructokinase, platelet type;PFKP;>PFKAP_HUMAN|Q01813|ATP-dependent  6-phosphofructokinase,  platelet type  (ATP-PFK ) (PFK-P) (2.7.1.11 ) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase );6;4;9,4
"P07737;CON__P02584";P07737;Profilin-1;PFN1;>PROF1_HUMAN|P07737|Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I);11;11;72,1
P35080;P35080;Profilin-2;PFN2;>PROF2_HUMAN|P35080|Profilin-2 (Profilin II);6;6;43,6
"P18669;P15259;Q8N0Y7";P18669;Phosphoglycerate mutase 1;PGAM1;>PGAM1_HUMAN|P18669|Phosphoglycerate mutase 1 (5.4.2.11 ) (5.4.2.4 ) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B);13;13;53,9
P52209;P52209;6-phosphogluconate dehydrogenase, decarboxylating;PGD;>6PGD_HUMAN|P52209|6-phosphogluconate  dehydrogenase,  decarboxylating (1.1.1.44);21;21;52
P53609;P53609;Geranylgeranyl transferase type-1 subunit beta;PGGT1B;>PGTB1_HUMAN|P53609|Geranylgeranyl transferase type-1 subunit beta (2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta);4;4;10,3
"P00558;P07205";P00558;Phosphoglycerate kinase 1;PGK1;>PGK1_HUMAN|P00558|Phosphoglycerate kinase 1 (2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2);29;29;73,4
O95336;O95336;6-phosphogluconolactonase;PGLS;>6PGL_HUMAN|O95336|6-phosphogluconolactonase (6PGL) (3.1.1.31);11;11;49,6
P36871;P36871;Phosphoglucomutase-1;PGM1;>PGM1_HUMAN|P36871|Phosphoglucomutase-1 (PGM 1) (5.4.2.2  ) (Glucose phosphomutase 1);20;20;40,6
Q96G03;Q96G03;Phosphoglucomutase-2;PGM2;>PGM2_HUMAN|Q96G03|Phosphoglucomutase-2 (PGM 2) (5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (5.4.2.7);9;9;19
O95394;O95394;Phosphoacetylglucosamine mutase;PGM3;>AGM1_HUMAN|O95394|Phosphoacetylglucosamine mutase  (PAGM) (5.4.2.3  ) (Acetylglucosamine phosphomutase ) (N-acetylglucosamine-phosphate mutase ) (Phosphoglucomutase-3 ) (PGM 3);24;24;45,9
Q8IZ21;Q8IZ21;Phosphatase and actin regulator 4;PHACTR4;>PHAR4_HUMAN|Q8IZ21|Phosphatase and actin regulator 4;5;5;8,7
O43175;O43175;D-3-phosphoglycerate dehydrogenase;PHGDH;>SERA_HUMAN|O43175|D-3-phosphoglycerate dehydrogenase (3-PGDH) (1.1.1.95 ) (2-oxoglutarate reductase ) (1.1.1.399 ) (Malate dehydrogenase ) (1.1.1.37 );22;22;46,9
Q93100;Q93100;Phosphorylase b kinase regulatory subunit beta;PHKB;>KPBB_HUMAN|Q93100|Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta);2;2;2,4
Q9NRX4;Q9NRX4;14 kDa phosphohistidine phosphatase;PHPT1;>PHP14_HUMAN|Q9NRX4|14 kDa phosphohistidine phosphatase  (3.9.1.3  ) (Phosphohistidine phosphatase 1 ) (PHPT1 ) (Protein histidine phosphatase ) (PHP ) (Protein janus-A homolog);4;4;47,2
Q5SRE7;Q5SRE7;Phytanoyl-CoA dioxygenase domain-containing protein 1;PHYHD1;>PHYD1_HUMAN|Q5SRE7|Phytanoyl-CoA dioxygenase domain-containing protein 1 (1.-.-.-);4;4;18,9
Q9BTU6;Q9BTU6;Phosphatidylinositol 4-kinase type 2-alpha;PI4K2A;>P4K2A_HUMAN|Q9BTU6|Phosphatidylinositol 4-kinase type 2-alpha (2.7.1.67  ) (Phosphatidylinositol 4-kinase type II-alpha);2;2;4,2
"P42356;A4QPH2;Q8N8J0";P42356;Phosphatidylinositol 4-kinase alpha;PI4KA;>PI4KA_HUMAN|P42356|Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (2.7.1.67 );17;17;10,6
Q9NRD5;Q9NRD5;PRKCA-binding protein;PICK1;>PICK1_HUMAN|Q9NRD5|PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein);4;4;9,6
P01833;P01833;"Polymeric immunoglobulin receptor;Secretory component";PIGR;>PIGR_HUMAN|P01833|Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) (Secretory component) (Precursor);15;15;23,7
"P42338;O00329";P42338;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform;PIK3CB;>PK3CB_HUMAN|P42338|Phosphatidylinositol  4,5-bisphosphate  3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (2.7.1.153) (Phosphatidylinositol  4,5-bisphosphate  3-kinase 110 kDa cataly;3;3;2,8
P27986;P27986;Phosphatidylinositol 3-kinase regulatory subunit alpha;PIK3R1;>P85A_HUMAN|P27986|Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-;2;2;3,5
"P78356;P48426";"P78356;P48426";"Phosphatidylinositol 5-phosphate 4-kinase type-2 beta;Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha";PIP4K2B;>PI42B_HUMAN|P78356|Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II ;2;2;7,5
Q8TBX8;Q8TBX8;Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma;PIP4K2C;>PI42C_HUMAN|Q8TBX8|Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma);3;3;7,6
Q9GZP4;Q9GZP4;PITH domain-containing protein 1;PITHD1;>PITH1_HUMAN|Q9GZP4|PITH domain-containing protein 1;6;6;33,2
Q00169;Q00169;Phosphatidylinositol transfer protein alpha isoform;PITPNA;>PIPNA_HUMAN|Q00169|Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha);13;11;49,3
P48739;P48739;Phosphatidylinositol transfer protein beta isoform;PITPNB;>PIPNB_HUMAN|P48739|Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta);11;9;44,6
Q13563;Q13563;Polycystin-2;PKD2;>PKD2_HUMAN|Q13563|Polycystin-2 (PC2 ) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin ) (R48321) (Transient receptor potential cation channel subfamily P member 2  );14;14;18,1
P08F94;P08F94;Fibrocystin;PKHD1;>PKHD1_HUMAN|P08F94|Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin) (Precursor);12;12;3,9
P14618;P14618;Pyruvate kinase PKM;PKM;>KPYM_HUMAN|P14618|Pyruvate kinase PKM (2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58);34;33;73,1
Q16513;Q16513;Serine/threonine-protein kinase N2;PKN2;>PKN2_HUMAN|Q16513|Serine/threonine-protein kinase N2 (2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2);6;6;9,6
P14555;P14555;Phospholipase A2, membrane associated;PLA2G2A;>PA2GA_HUMAN|P14555|Phospholipase  A2,  membrane associated (3.1.1.4 ) (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2) (NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A) (Precursor);4;4;29,9
Q13018;Q13018;"Secretory phospholipase A2 receptor;Soluble secretory phospholipase A2 receptor";PLA2R1;>PLA2R_HUMAN|Q13018|Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) (Soluble secretory phospholipase A2 receptor) (Soluble PLA2-R) (Soluble PLA2R;17;17;14,8
Q9NQ66;Q9NQ66;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1;PLCB1;>PLCB1_HUMAN|Q9NQ66|1-phosphatidylinositol  4,5-bisphosphate  phosphodiesterase beta-1 (3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1);8;8;8,2
Q01970;Q01970;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;PLCB3;>PLCB3_HUMAN|Q01970|1-phosphatidylinositol  4,5-bisphosphate  phosphodiesterase beta-3 (3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3);8;8;7,3
Q15147;Q15147;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4;PLCB4;>PLCB4_HUMAN|Q15147|1-phosphatidylinositol  4,5-bisphosphate  phosphodiesterase beta-4 (3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4);3;3;2,7
"P51178;Q4KWH8";P51178;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1;PLCD1;>PLCD1_HUMAN|P51178|1-phosphatidylinositol  4,5-bisphosphate  phosphodiesterase delta-1 (3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1);18;18;27,9
P16885;P16885;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2;PLCG2;>PLCG2_HUMAN|P16885|1-phosphatidylinositol  4,5-bisphosphate  phosphodiesterase gamma-2 (3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2);13;13;12,4
Q8IV08;Q8IV08;Phospholipase D3;PLD3;>PLD3_HUMAN|Q8IV08|Phospholipase D3 (PLD 3) (3.1.4.4) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3);9;9;25,7
Q96CS7;Q96CS7;Pleckstrin homology domain-containing family B member 2;PLEKHB2;>PKHB2_HUMAN|Q96CS7|Pleckstrin homology domain-containing family B member 2 (PH domain-containing family B member 2) (Evectin-2);4;4;18,5
"P00747;CON__P06868";P00747;"Plasminogen;Plasmin heavy chain A;Activation peptide;Angiostatin;Plasmin heavy chain A, short form;Plasmin light chain B";PLG;>PLMN_HUMAN|P00747|Plasminogen (3.4.21.7) (Plasmin heavy chain A) (Activation peptide) (Angiostatin) (Plasmin heavy chain  A,  short form) (Plasmin light chain B) (Precursor);18;18;28,3
O60664;O60664;Perilipin-3;PLIN3;>PLIN3_HUMAN|O60664|Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17);15;15;46,5
P60201;P60201;Myelin proteolipid protein;PLP1;>MYPR_HUMAN|P60201|Myelin proteolipid protein (PLP) (Lipophilin);2;2;7,6
Q14651;Q14651;Plastin-1;PLS1;>PLSI_HUMAN|Q14651|Plastin-1 (Intestine-specific plastin) (I-plastin);9;6;16,7
P13797;P13797;Plastin-3;PLS3;>PLST_HUMAN|P13797|Plastin-3 (T-plastin);15;7;28,3
O15162;O15162;Phospholipid scramblase 1;PLSCR1;>PLS1_HUMAN|O15162|Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (MmTRA1b);6;6;24,5
Q9NRY6;Q9NRY6;Phospholipid scramblase 3;PLSCR3;>PLS3_HUMAN|Q9NRY6|Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3);3;3;17,3
Q9NRQ2;Q9NRQ2;Phospholipid scramblase 4;PLSCR4;>PLS4_HUMAN|Q9NRQ2|Phospholipid scramblase 4 (PL scramblase 4) (Ca(2+)-dependent phospholipid scramblase 4) (Cell growth-inhibiting gene 43 protein) (TRA1);6;6;18,5
"O15031;O60486";O15031;Plexin-B2;PLXNB2;>PLXB2_HUMAN|O15031|Plexin-B2 (MM1) (Precursor);12;11;8,2
Q8IYS1;Q8IYS1;Peptidase M20 domain-containing protein 2;PM20D2;>P20D2_HUMAN|Q8IYS1|Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2);5;5;12,6
O15305;O15305;Phosphomannomutase 2;PMM2;>PMM2_HUMAN|O15305|Phosphomannomutase 2 (PMM 2) (5.4.2.8);4;4;18,7
Q15126;Q15126;Phosphomevalonate kinase;PMVK;>PMVK_HUMAN|Q15126|Phosphomevalonate kinase (PMKase) (hPMK) (2.7.4.2);4;4;24,5
Q8N490;Q8N490;Probable hydrolase PNKD;PNKD;>PNKD_HUMAN|Q8N490|Probable hydrolase PNKD (3.-.-.-) (Myofibrillogenesis regulator 1) (MR-1) (Paroxysmal nonkinesiogenic dyskinesia protein) (Trans-activated by hepatitis C virus core protein 2);5;5;13,8
P00491;P00491;Purine nucleoside phosphorylase;PNP;>PNPH_HUMAN|P00491|Purine nucleoside phosphorylase (PNP) (2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase);11;11;51,2
Q9NVS9;Q9NVS9;Pyridoxine-5-phosphate oxidase;PNPO;>PNPO_HUMAN|Q9NVS9|Pyridoxine-5-phosphate oxidase (1.4.3.5) (Pyridoxamine-phosphate oxidase);3;3;12,3
O00592;O00592;Podocalyxin;PODXL;>PODXL_HUMAN|O00592|Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) (Precursor);11;11;16,8
Q15181;Q15181;Inorganic pyrophosphatase;PPA1;>IPYR_HUMAN|Q15181|Inorganic pyrophosphatase (3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase);9;9;50,5
O14494;O14494;Lipid phosphate phosphohydrolase 1;PPAP2A;>PLPP1_HUMAN|O14494|Phospholipid phosphatase 1  (3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a);8;8;34,9
Q9HAB8;Q9HAB8;Phosphopantothenate--cysteine ligase;PPCS;>PPCS_HUMAN|Q9HAB8|Phosphopantothenate--cysteine ligase (6.3.2.5) (Phosphopantothenoylcysteine synthetase) (PPC synthetase);8;8;25,1
"P62937;P0DN26;A0A0B4J2A2;A0A075B759;Q9Y536;F5H284;P0DN37";P62937;"Peptidyl-prolyl cis-trans isomerase A;Peptidyl-prolyl cis-trans isomerase A, N-terminally processed";PPIA;>PPIA_HUMAN|P62937|Peptidyl-prolyl cis-trans isomerase A (PPIase A) (5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) (Peptidyl-prolyl cis-trans isomerase  A,  N-terminally processed);12;12;73,3
P23284;P23284;Peptidyl-prolyl cis-trans isomerase B;PPIB;>PPIB_HUMAN|P23284|Peptidyl-prolyl cis-trans isomerase B (PPIase B) (5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) (Precursor);5;5;26,9
Q9Y3C6;Q9Y3C6;Peptidyl-prolyl cis-trans isomerase-like 1;PPIL1;>PPIL1_HUMAN|Q9Y3C6|Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (5.2.1.8) (Rotamase PPIL1);2;2;14,5
Q9H2H8;Q9H2H8;Peptidyl-prolyl cis-trans isomerase-like 3;PPIL3;>PPIL3_HUMAN|Q9H2H8|Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3);3;3;27,3
O60437;O60437;Periplakin;PPL;>PEPL_HUMAN|O60437|Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein);18;18;12,3
P35813;P35813;Protein phosphatase 1A;PPM1A;>PPM1A_HUMAN|P35813|Protein phosphatase 1A (3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA);13;11;43,7
O75688;O75688;Protein phosphatase 1B;PPM1B;>PPM1B_HUMAN|O75688|Protein phosphatase 1B (3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta);6;4;15,7
"Q9ULR3;Q5JR12";Q9ULR3;Protein phosphatase 1H;PPM1H;>PPM1H_HUMAN|Q9ULR3|Protein phosphatase 1H (3.1.3.16);9;9;25,3
Q9Y570;Q9Y570;Protein phosphatase methylesterase 1;PPME1;>PPME1_HUMAN|Q9Y570|Protein phosphatase methylesterase 1 (PME-1) (3.1.1.89);9;9;26,2
P62140;P62140;Serine/threonine-protein phosphatase PP1-beta catalytic subunit;PPP1CB;>PP1B_HUMAN|P62140|Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (3.1.3.16) (3.1.3.53);13;4;46,2
Q15435;Q15435;Protein phosphatase 1 regulatory subunit 7;PPP1R7;>PP1R7_HUMAN|Q15435|Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22);15;15;43,6
P67775;P67775;Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform;PPP2CA;>PP2AA_HUMAN|P67775|Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (3.1.3.16) (Replication protein C) (RP-C);13;2;44,7
"P62714;P60510";P62714;Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform;PPP2CB;>PP2AB_HUMAN|P62714|Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (3.1.3.16);13;2;44,7
"P30153;P30154";P30153;Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform;PPP2R1A;>2AAA_HUMAN|P30153|Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha);23;23;47,7
"P63151;Q66LE6;Q00005;Q9Y2T4";"P63151;Q66LE6";"Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform;Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform";PPP2R2A;">2ABA_HUMAN|P63151|Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha);>2ABD_HUMAN|Q66LE6|";8;8;20,6
Q15257;Q15257;Serine/threonine-protein phosphatase 2A activator;PPP2R4;>PTPA_HUMAN|Q15257|Serine/threonine-protein phosphatase 2A activator (5.2.1.8)  (PP2A,  subunit  B,  PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosp;9;9;33,5
"Q14738;Q13362;Q15173";Q14738;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform;PPP2R5D;>2A5D_HUMAN|Q14738|Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta);9;8;17,6
Q16537;Q16537;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform;PPP2R5E;>2A5E_HUMAN|Q16537|Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon);4;3;10,1
"Q08209;P16298;P48454";Q08209;Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;PPP3CA;>PP2BA_HUMAN|Q08209|Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform);12;12;24,6
P63098;P63098;Calcineurin subunit B type 1;PPP3R1;>CANB1_HUMAN|P63098|Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1);2;2;12,9
P53041;P53041;Serine/threonine-protein phosphatase 5;PPP5C;>PPP5_HUMAN|P53041|Serine/threonine-protein phosphatase 5 (PP5) (3.1.3.16) (Protein phosphatase T) (PP-T) (PPT);4;4;10
Q5H9R7;Q5H9R7;Serine/threonine-protein phosphatase 6 regulatory subunit 3;PPP6R3;>PP6R3_HUMAN|Q5H9R7|Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL);3;3;4
P50897;P50897;Palmitoyl-protein thioesterase 1;PPT1;>PPT1_HUMAN|P50897|Palmitoyl-protein thioesterase 1 (PPT-1) (3.1.2.22) (Palmitoyl-protein hydrolase 1) (Precursor);2;2;7,8
P42785;P42785;Lysosomal Pro-X carboxypeptidase;PRCP;>PCP_HUMAN|P42785|Lysosomal Pro-X carboxypeptidase (3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP) (Precursor);7;7;14,9
Q06830;Q06830;Peroxiredoxin-1;PRDX1;>PRDX1_HUMAN|Q06830|Peroxiredoxin-1 (1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2);18;14;71,9
P32119;P32119;Peroxiredoxin-2;PRDX2;>PRDX2_HUMAN|P32119|Peroxiredoxin-2 (1.11.1.15) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);16;15;61,6
Q13162;Q13162;Peroxiredoxin-4;PRDX4;>PRDX4_HUMAN|Q13162|Peroxiredoxin-4 (1.11.1.15) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Precursor);6;3;21
P30044;P30044;Peroxiredoxin-5, mitochondrial;PRDX5;>PRDX5_HUMAN|P30044| Peroxiredoxin-5,  mitochondrial (1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase ;10;10;56,5
P30041;P30041;Peroxiredoxin-6;PRDX6;>PRDX6_HUMAN|P30041|Peroxiredoxin-6 (1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (3.1.1.-) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx;25;25;83,9
P48147;P48147;Prolyl endopeptidase;PREP;>PPCE_HUMAN|P48147|Prolyl endopeptidase (PE) (3.4.21.26) (Post-proline cleaving enzyme);20;20;34,6
Q13131;Q13131;5-AMP-activated protein kinase catalytic subunit alpha-1;PRKAA1;>AAPK1_HUMAN|Q13131|5-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (2.7.11.1 ) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (2.7.11.27 ) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (2.7.11.31 ) (Tau-prote;3;2;5,7
"P17612;P22612";P17612;cAMP-dependent protein kinase catalytic subunit alpha;PRKACA;>KAPCA_HUMAN|P17612|cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (2.7.11.11);13;5;32,2
P22694;P22694;cAMP-dependent protein kinase catalytic subunit beta;PRKACB;>KAPCB_HUMAN|P22694|cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (2.7.11.11);12;4;26,5
"P54619;Q9UGJ0";P54619;5-AMP-activated protein kinase subunit gamma-1;PRKAG1;>AAKG1_HUMAN|P54619|5-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg);7;7;22,1
P10644;P10644;"cAMP-dependent protein kinase type I-alpha regulatory subunit;cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed";PRKAR1A;>KAP0_HUMAN|P10644|cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1) (cAMP-dependent protein kinase type I-alpha regulatory  subunit,  N-terminally processed);7;7;22,8
P13861;P13861;cAMP-dependent protein kinase type II-alpha regulatory subunit;PRKAR2A;>KAP2_HUMAN|P13861|cAMP-dependent protein kinase type II-alpha regulatory subunit;23;21;65,3
P31323;P31323;cAMP-dependent protein kinase type II-beta regulatory subunit;PRKAR2B;>KAP3_HUMAN|P31323|cAMP-dependent protein kinase type II-beta regulatory subunit;10;8;33
"P17252;P05771;P05129";P17252;Protein kinase C alpha type;PRKCA;>KPCA_HUMAN|P17252|Protein kinase C alpha type (PKC-A) (PKC-alpha) (2.7.11.13);5;5;10
"Q05655;Q04759";Q05655;"Protein kinase C delta type;Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit";PRKCD;>KPCD_HUMAN|Q05655|Protein kinase C delta type (2.7.11.13 ) (Tyrosine-protein kinase PRKCD) (2.7.10.2) (nPKC-delta) (Protein kinase C delta type regulatory subunit) (Protein kinase C delta type catalytic subunit) (Sphingosine-dependent protein kinase-1) (S;16;16;28,7
P41743;P41743;Protein kinase C iota type;PRKCI;>KPCI_HUMAN|P41743|Protein kinase C iota type (2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota);7;6;14,4
Q05513;Q05513;Protein kinase C zeta type;PRKCZ;>KPCZ_HUMAN|Q05513|Protein kinase C zeta type (2.7.11.13) (nPKC-zeta);3;2;5,9
"Q15139;O94806;Q9BZL6;Q00532;Q92772;Q8IVW4;O76039;Q9NRP7";"Q15139;O94806";"Serine/threonine-protein kinase D1;Serine/threonine-protein kinase D3";PRKD1;">KPCD1_HUMAN|Q15139|Serine/threonine-protein kinase D1 (2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu);>KPCD3_HUMAN|O94806|Serine/threonine-protein kinase D3 (2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-n";7;7;9,5
"Q13237;Q13976";Q13237;cGMP-dependent protein kinase 2;PRKG2;>KGP2_HUMAN|Q13237|cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (2.7.11.12) (cGMP-dependent protein kinase II) (cGKII);25;25;34,6
Q99873;Q99873;Protein arginine N-methyltransferase 1;PRMT1;>ANM1_HUMAN|Q99873|Protein arginine N-methyltransferase 1 (2.1.1.319  ) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4);4;4;15
O14744;O14744;"Protein arginine N-methyltransferase 5;Protein arginine N-methyltransferase 5, N-terminally processed";PRMT5;>ANM5_HUMAN|O14744|Protein arginine N-methyltransferase 5 (2.1.1.320 ) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) (Protein arginine N-me;6;6;8,6
P04156;P04156;Major prion protein;PRNP;>PRIO_HUMAN|P04156|Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD230) (Precursor);2;2;7,9
Q9UNN8;Q9UNN8;Endothelial protein C receptor;PROCR;>EPCR_HUMAN|Q9UNN8|Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD201) (Precursor);3;3;14,7
O43490;O43490;Prominin-1;PROM1;>PROM1_HUMAN|O43490|Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD133) (Precursor);33;33;40,9
Q8N271;Q8N271;Prominin-2;PROM2;>PROM2_HUMAN|Q8N271|Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2) (Precursor);24;24;30,1
O94903;O94903;Proline synthase co-transcribed bacterial homolog protein;PROSC;>PROSC_HUMAN|O94903|Proline synthase co-transcribed bacterial homolog protein;7;7;28
P60891;P60891;Ribose-phosphate pyrophosphokinase 1;PRPS1;>PRPS1_HUMAN|P60891|Ribose-phosphate pyrophosphokinase 1 (2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase I) (PRS-I);9;2;31,8
P11908;P11908;Ribose-phosphate pyrophosphokinase 2;PRPS2;>PRPS2_HUMAN|P11908|Ribose-phosphate pyrophosphokinase 2 (2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II);9;2;32,7
O60256;O60256;Phosphoribosyl pyrophosphate synthase-associated protein 2;PRPSAP2;>KPRB_HUMAN|O60256|Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41);7;6;26
Q16651;Q16651;"Prostasin;Prostasin light chain;Prostasin heavy chain";PRSS8;>PRSS8_HUMAN|Q16651|Prostasin (3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) (Prostasin light chain) (Prostasin heavy chain) (Precursor);6;6;33,5
Q86TP1;Q86TP1;Protein prune homolog;PRUNE;>PRUN1_HUMAN|Q86TP1|Exopolyphosphatase PRUNE1 (3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune);2;2;4,6
Q8WUY3;Q8WUY3;Protein prune homolog 2;PRUNE2;>PRUN2_HUMAN|Q8WUY3|Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1);9;9;3,4
P07602;P07602;"Prosaposin;Saposin-A;Saposin-B-Val;Saposin-B;Saposin-C;Saposin-D";PSAP;>SAP_HUMAN|P07602|Prosaposin (Proactivator polypeptide) (Saposin-A) (Protein A) (Saposin-B-Val) (Saposin-B) (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator) (Saposin-C) (A1 activator) ;11;11;24,4
Q9Y617;Q9Y617;Phosphoserine aminotransferase;PSAT1;>SERC_HUMAN|Q9Y617|Phosphoserine aminotransferase (2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT);14;14;43,2
O43653;O43653;Prostate stem cell antigen;PSCA;>PSCA_HUMAN|O43653|Prostate stem cell antigen (Precursor);3;3;22,8
"P49768;P49810";P49768;"Presenilin-1;Presenilin-1 NTF subunit;Presenilin-1 CTF subunit;Presenilin-1 CTF12";PSEN1;>PSN1_HUMAN|P49768|Presenilin-1 (PS-1) (3.4.23.-  ) (Protein S182) (Presenilin-1 NTF subunit) (Presenilin-1 CTF subunit) (Presenilin-1 CTF12) (PS1-CTF12);4;4;13,5
P25786;P25786;Proteasome subunit alpha type-1;PSMA1;>PSA1_HUMAN|P25786|Proteasome subunit alpha type-1 (3.4.25.1 ) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain);14;14;49,4
P25787;P25787;Proteasome subunit alpha type-2;PSMA2;>PSA2_HUMAN|P25787|Proteasome subunit alpha type-2 (3.4.25.1 ) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3);5;5;23,1
P25788;P25788;Proteasome subunit alpha type-3;PSMA3;>PSA3_HUMAN|P25788|Proteasome subunit alpha type-3 (3.4.25.1 ) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8);10;10;34,9
P25789;P25789;Proteasome subunit alpha type-4;PSMA4;>PSA4_HUMAN|P25789|Proteasome subunit alpha type-4 (3.4.25.1 ) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L);8;8;32,2
P28066;P28066;Proteasome subunit alpha type-5;PSMA5;>PSA5_HUMAN|P28066|Proteasome subunit alpha type-5 (3.4.25.1 ) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain);8;8;46,9
P60900;P60900;Proteasome subunit alpha type-6;PSMA6;>PSA6_HUMAN|P60900|Proteasome subunit alpha type-6 (3.4.25.1 ) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain);10;10;49,2
"O14818;Q8TAA3";O14818;Proteasome subunit alpha type-7;PSMA7;>PSA7_HUMAN|O14818|Proteasome subunit alpha type-7 (3.4.25.1 ) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7);7;7;35,1
P20618;P20618;Proteasome subunit beta type-1;PSMB1;>PSB1_HUMAN|P20618|Proteasome subunit beta type-1 (3.4.25.1 ) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain) (Precursor);8;8;37,3
P49721;P49721;Proteasome subunit beta type-2;PSMB2;>PSB2_HUMAN|P49721|Proteasome subunit beta type-2 (3.4.25.1 ) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I);5;5;18,4
P49720;P49720;Proteasome subunit beta type-3;PSMB3;>PSB3_HUMAN|P49720|Proteasome subunit beta type-3 (3.4.25.1 ) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain);4;4;17,6
P28070;P28070;Proteasome subunit beta type-4;PSMB4;>PSB4_HUMAN|P28070|Proteasome subunit beta type-4 (3.4.25.1 ) (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3) (Precursor);5;5;19,7
P28074;P28074;Proteasome subunit beta type-5;PSMB5;>PSB5_HUMAN|P28074|Proteasome subunit beta type-5 (3.4.25.1 ) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X) (Precursor);6;6;22,1
P28072;P28072;Proteasome subunit beta type-6;PSMB6;>PSB6_HUMAN|P28072|Proteasome subunit beta type-6 (3.4.25.1 ) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y) (Precursor);3;3;13
Q99436;Q99436;Proteasome subunit beta type-7;PSMB7;>PSB7_HUMAN|Q99436|Proteasome subunit beta type-7 (3.4.25.1 ) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z) (Precursor);4;4;15,2
P28062;P28062;Proteasome subunit beta type-8;PSMB8;>PSB8_HUMAN|P28062|Proteasome subunit beta type-8 (3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 p;3;3;11,6
P35998;P35998;26S protease regulatory subunit 7;PSMC2;>PRS7_HUMAN|P35998|26S protease regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1);15;15;37,9
P17980;P17980;26S protease regulatory subunit 6A;PSMC3;>PRS6A_HUMAN|P17980|26S protease regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1);9;9;31,2
P43686;P43686;26S protease regulatory subunit 6B;PSMC4;>PRS6B_HUMAN|P43686|26S protease regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7) (TBP-7);7;7;23
"P62195;Q8NB90";P62195;26S protease regulatory subunit 8;PSMC5;>PRS8_HUMAN|P62195|26S protease regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG);9;9;25,9
P62333;P62333;26S protease regulatory subunit 10B;PSMC6;>PRS10_HUMAN|P62333|26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42);11;11;31,9
Q99460;Q99460;26S proteasome non-ATPase regulatory subunit 1;PSMD1;>PSMD1_HUMAN|Q99460|26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112);11;11;17,1
O75832;O75832;26S proteasome non-ATPase regulatory subunit 10;PSMD10;>PSD10_HUMAN|O75832|26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK));3;3;21,7
O00231;O00231;26S proteasome non-ATPase regulatory subunit 11;PSMD11;>PSD11_HUMAN|O00231|26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5);12;12;33,9
O00232;O00232;26S proteasome non-ATPase regulatory subunit 12;PSMD12;>PSD12_HUMAN|O00232|26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55);12;12;31,8
Q9UNM6;Q9UNM6;26S proteasome non-ATPase regulatory subunit 13;PSMD13;>PSD13_HUMAN|Q9UNM6|26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5);12;12;30,9
O00487;O00487;26S proteasome non-ATPase regulatory subunit 14;PSMD14;>PSDE_HUMAN|O00487|26S proteasome non-ATPase regulatory subunit 14 (3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1);4;4;14,5
Q13200;Q13200;26S proteasome non-ATPase regulatory subunit 2;PSMD2;>PSMD2_HUMAN|Q13200|26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2);11;11;15,9
O43242;O43242;26S proteasome non-ATPase regulatory subunit 3;PSMD3;>PSMD3_HUMAN|O43242|26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58);10;10;21
P55036;P55036;26S proteasome non-ATPase regulatory subunit 4;PSMD4;>PSMD4_HUMAN|P55036|26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein);4;3;19,9
Q16401;Q16401;26S proteasome non-ATPase regulatory subunit 5;PSMD5;>PSMD5_HUMAN|Q16401|26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B);10;10;25,2
Q15008;Q15008;26S proteasome non-ATPase regulatory subunit 6;PSMD6;>PSMD6_HUMAN|Q15008|26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regul;9;9;26,5
P51665;P51665;26S proteasome non-ATPase regulatory subunit 7;PSMD7;>PSMD7_HUMAN|P51665|26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40);8;8;30,6
P48556;P48556;26S proteasome non-ATPase regulatory subunit 8;PSMD8;>PSMD8_HUMAN|P48556|26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31);4;4;10
O00233;O00233;26S proteasome non-ATPase regulatory subunit 9;PSMD9;>PSMD9_HUMAN|O00233|26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27);3;3;17,5
Q06323;Q06323;Proteasome activator complex subunit 1;PSME1;>PSME1_HUMAN|Q06323|Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alph;14;14;64,7
Q9UL46;Q9UL46;Proteasome activator complex subunit 2;PSME2;>PSME2_HUMAN|Q9UL46|Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta);12;12;56,1
Q96BW5;Q96BW5;Phosphotriesterase-related protein;PTER;>PTER_HUMAN|Q96BW5|Phosphotriesterase-related protein (3.1.-.-) (Parathion hydrolase-related protein) (hPHRP);5;5;14,6
P41222;P41222;Prostaglandin-H2 D-isomerase;PTGDS;>PTGDS_HUMAN|P41222|Prostaglandin-H2 D-isomerase (5.3.99.2) (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2) (Precursor);4;4;24,7
Q15185;Q15185;Prostaglandin E synthase 3;PTGES3;>TEBP_HUMAN|Q15185|Prostaglandin E synthase 3 (5.3.99.3 ) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23);7;7;43,8
Q14914;Q14914;Prostaglandin reductase 1;PTGR1;>PTGR1_HUMAN|Q14914|Prostaglandin reductase 1 (PRG-1) (1.3.1.-) (15-oxoprostaglandin 13-reductase) (1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (1.3.1.74);13;13;43,2
Q8N8N7;Q8N8N7;Prostaglandin reductase 2;PTGR2;>PTGR2_HUMAN|Q8N8N7|Prostaglandin reductase 2 (PRG-2) (1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 1);7;7;24,5
P06454;P06454;"Prothymosin alpha;Prothymosin alpha, N-terminally processed;Thymosin alpha-1";PTMA;>PTMA_HUMAN|P06454|Prothymosin alpha (Prothymosin  alpha,  N-terminally processed) (Thymosin alpha-1);3;3;23,4
P20962;P20962;Parathymosin;PTMS;>PTMS_HUMAN|P20962|Parathymosin;4;4;23,5
Q12974;Q12974;Protein tyrosine phosphatase type IVA 2;PTP4A2;>TP4A2_HUMAN|Q12974|Protein tyrosine phosphatase type IVA 2 (3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2) (Precursor);7;4;55,1
Q06124;Q06124;Tyrosine-protein phosphatase non-receptor type 11;PTPN11;>PTN11_HUMAN|Q06124|Tyrosine-protein phosphatase non-receptor type 11 (3.1.3.48  ) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3);12;12;21,8
Q12923;Q12923;Tyrosine-protein phosphatase non-receptor type 13;PTPN13;>PTN13_HUMAN|Q12923|Tyrosine-protein phosphatase non-receptor type 13 (3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1);43;43;23,8
Q9H3S7;Q9H3S7;Tyrosine-protein phosphatase non-receptor type 23;PTPN23;>PTN23_HUMAN|Q9H3S7|Tyrosine-protein phosphatase non-receptor type 23 (3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14);16;16;11,6
P26045;P26045;Tyrosine-protein phosphatase non-receptor type 3;PTPN3;>PTN3_HUMAN|P26045|Tyrosine-protein phosphatase non-receptor type 3 (3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1);2;2;2,6
P29350;P29350;Tyrosine-protein phosphatase non-receptor type 6;PTPN6;>PTN6_HUMAN|P29350|Tyrosine-protein phosphatase non-receptor type 6 (3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1);10;10;19,7
P18433;P18433;Receptor-type tyrosine-protein phosphatase alpha;PTPRA;>PTPRA_HUMAN|P18433|Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (3.1.3.48) (Precursor);2;2;4,1
P23468;P23468;Receptor-type tyrosine-protein phosphatase delta;PTPRD;>PTPRD_HUMAN|P23468|Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (3.1.3.48) (Precursor);11;1;7,4
Q12913;Q12913;Receptor-type tyrosine-protein phosphatase eta;PTPRJ;>PTPRJ_HUMAN|Q12913|Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD148) (Precursor);35;35;29,3
"Q16827;P23467";Q16827;Receptor-type tyrosine-protein phosphatase O;PTPRO;>PTPRO_HUMAN|Q16827|Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2) (Precursor);14;14;14,7
Q13332;Q13332;Receptor-type tyrosine-protein phosphatase S;PTPRS;>PTPRS_HUMAN|Q13332|Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (3.1.3.48  ) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma) (Precursor);12;4;8,3
Q6GMV3;Q6GMV3;Putative peptidyl-tRNA hydrolase PTRHD1;PTRHD1;>PTRD1_HUMAN|Q6GMV3|Putative peptidyl-tRNA hydrolase PTRHD1 (3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1);3;3;25
P53801;P53801;Pituitary tumor-transforming gene 1 protein-interacting protein;PTTG1IP;>PTTG_HUMAN|P53801|Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor) (Precursor);4;4;20,6
P20472;P20472;Parvalbumin alpha;PVALB;>PRVA_HUMAN|P20472|Parvalbumin alpha;4;4;32,7
Q92692;Q92692;Nectin-2;PVRL2;>NECT2_HUMAN|Q92692|Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin cell adhesion molecule 2 ) (Poliovirus receptor-related protein 2) (CD112) (Precursor);4;4;8,6
Q53H96;Q53H96;Pyrroline-5-carboxylate reductase 3;PYCRL;>P5CR3_HUMAN|Q53H96|Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (1.5.1.2 ) (Pyrroline-5-carboxylate reductase-like protein);4;4;17,9
P11216;P11216;Glycogen phosphorylase, brain form;PYGB;>PYGB_HUMAN|P11216|Glycogen  phosphorylase,  brain form  (2.4.1.1 );38;31;49,7
P06737;P06737;Glycogen phosphorylase, liver form;PYGL;>PYGL_HUMAN|P06737|Glycogen  phosphorylase,  liver form (2.4.1.1);14;9;19,8
P47897;P47897;Glutamine--tRNA ligase;QARS;>SYQ_HUMAN|P47897|Glutamine--tRNA ligase (6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS);11;11;17,5
P09417;P09417;Dihydropteridine reductase;QDPR;>DHPR_HUMAN|P09417|Dihydropteridine reductase (1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1);10;10;54,5
Q15274;Q15274;Nicotinate-nucleotide pyrophosphorylase [carboxylating];QPRT;>NADC_HUMAN|Q15274|Nicotinate-nucleotide pyrophosphorylase [carboxylating] (2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase) (QPRTase);6;6;24,2
P61026;P61026;Ras-related protein Rab-10;RAB10;>RAB10_HUMAN|P61026|Ras-related protein Rab-10;15;13;52,5
"Q15907;P62491";"Q15907;P62491";"Ras-related protein Rab-11B;Ras-related protein Rab-11A";RAB11B;">RB11B_HUMAN|Q15907|Ras-related protein Rab-11B (GTP-binding protein YPT3) (Precursor);>RB11A_HUMAN|P62491|Ras-related protein Rab-11A (Rab-11) (YL8) (Precursor)";14;13;56,4
"Q6WKZ4;Q7L804";Q6WKZ4;Rab11 family-interacting protein 1;RAB11FIP1;>RFIP1_HUMAN|Q6WKZ4|Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein);6;6;5,6
Q9BXF6;Q9BXF6;Rab11 family-interacting protein 5;RAB11FIP5;>RFIP5_HUMAN|Q9BXF6|Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11);4;4;7,2
Q6IQ22;Q6IQ22;Ras-related protein Rab-12;RAB12;>RAB12_HUMAN|Q6IQ22|Ras-related protein Rab-12;2;2;9
P51153;P51153;Ras-related protein Rab-13;RAB13;>RAB13_HUMAN|P51153|Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein) (Precursor);9;6;45,8
P61106;P61106;Ras-related protein Rab-14;RAB14;>RAB14_HUMAN|P61106|Ras-related protein Rab-14;15;15;73
Q9H0T7;Q9H0T7;Ras-related protein Rab-17;RAB17;>RAB17_HUMAN|Q9H0T7|Ras-related protein Rab-17;3;3;16,5
Q9NP72;Q9NP72;Ras-related protein Rab-18;RAB18;>RAB18_HUMAN|Q9NP72|Ras-related protein Rab-18 (Precursor);13;13;66,5
A4D1S5;A4D1S5;Ras-related protein Rab-19;RAB19;>RAB19_HUMAN|A4D1S5|Ras-related protein Rab-19;6;5;30,9
P62820;P62820;Ras-related protein Rab-1A;RAB1A;>RAB1A_HUMAN|P62820|Ras-related protein Rab-1A (YPT1-related protein);15;8;66,3
"Q9H0U4;Q92928";Q9H0U4;Ras-related protein Rab-1B;RAB1B;>RAB1B_HUMAN|Q9H0U4|Ras-related protein Rab-1B;13;6;70,6
Q9UL25;Q9UL25;Ras-related protein Rab-21;RAB21;>RAB21_HUMAN|Q9UL25|Ras-related protein Rab-21 (Precursor);11;11;53,3
"Q9UL26;Q13636";Q9UL26;Ras-related protein Rab-22A;RAB22A;>RB22A_HUMAN|Q9UL26|Ras-related protein Rab-22A (Rab-22);7;7;41,8
Q9ULC3;Q9ULC3;Ras-related protein Rab-23;RAB23;>RAB23_HUMAN|Q9ULC3|Ras-related protein Rab-23 (Precursor);9;9;45,6
P57735;P57735;Ras-related protein Rab-25;RAB25;>RAB25_HUMAN|P57735|Ras-related protein Rab-25 (CATX-8) (Precursor);9;8;40,4
P51159;P51159;Ras-related protein Rab-27A;RAB27A;>RB27A_HUMAN|P51159|Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram);14;12;59,3
O00194;O00194;Ras-related protein Rab-27B;RAB27B;>RB27B_HUMAN|O00194|Ras-related protein Rab-27B (C25KG);14;12;63,8
"O14966;P57729";O14966;Ras-related protein Rab-7L1;RAB29;>RAB7L_HUMAN|O14966|Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29);7;6;36,9
P61019;P61019;Ras-related protein Rab-2A;RAB2A;>RAB2A_HUMAN|P61019|Ras-related protein Rab-2A;14;8;67,5
Q8WUD1;Q8WUD1;Ras-related protein Rab-2B;RAB2B;>RAB2B_HUMAN|Q8WUD1|Ras-related protein Rab-2B;10;4;54,6
"Q9H082;Q14088";"Q9H082;Q14088";"Ras-related protein Rab-33B;Ras-related protein Rab-33A";RAB33B;">RB33B_HUMAN|Q9H082|Ras-related protein Rab-33B;>RB33A_HUMAN|Q14088|Ras-related protein Rab-33A (Small GTP-binding protein S10)";2;2;10
Q9BZG1;Q9BZG1;Ras-related protein Rab-34;RAB34;>RAB34_HUMAN|Q9BZG1|Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah);4;4;17,4
"Q15286;Q15771";Q15286;Ras-related protein Rab-35;RAB35;>RAB35_HUMAN|Q15286|Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C);10;10;42,8
Q96DA2;Q96DA2;Ras-related protein Rab-39B;RAB39B;>RB39B_HUMAN|Q96DA2|Ras-related protein Rab-39B;4;4;18,3
P20336;P20336;Ras-related protein Rab-3A;RAB3A;>RAB3A_HUMAN|P20336|Ras-related protein Rab-3A;8;4;42,3
P20337;P20337;Ras-related protein Rab-3B;RAB3B;>RAB3B_HUMAN|P20337|Ras-related protein Rab-3B;10;8;45,7
"O95716;Q96E17";O95716;Ras-related protein Rab-3D;RAB3D;>RAB3D_HUMAN|O95716|Ras-related protein Rab-3D;15;10;53,9
Q86YS6;Q86YS6;Ras-related protein Rab-43;RAB43;>RAB43_HUMAN|Q86YS6|Ras-related protein Rab-43 (Ras-related protein Rab-41);6;5;27,4
P20338;P20338;Ras-related protein Rab-4A;RAB4A;>RAB4A_HUMAN|P20338|Ras-related protein Rab-4A;8;7;46,8
P61018;P61018;Ras-related protein Rab-4B;RAB4B;>RAB4B_HUMAN|P61018|Ras-related protein Rab-4B;3;2;17,4
P20339;P20339;Ras-related protein Rab-5A;RAB5A;>RAB5A_HUMAN|P20339|Ras-related protein Rab-5A;9;6;54
P61020;P61020;Ras-related protein Rab-5B;RAB5B;>RAB5B_HUMAN|P61020|Ras-related protein Rab-5B;9;6;48,8
P51148;P51148;Ras-related protein Rab-5C;RAB5C;>RAB5C_HUMAN|P51148|Ras-related protein Rab-5C (L1880) (RAB5L);9;6;54,2
"P20340;Q9NRW1;Q14964";P20340;Ras-related protein Rab-6A;RAB6A;>RAB6A_HUMAN|P20340|Ras-related protein Rab-6A (Rab-6);11;11;43,8
P51149;P51149;Ras-related protein Rab-7a;RAB7A;>RAB7A_HUMAN|P51149|Ras-related protein Rab-7a;14;14;76,8
P61006;P61006;Ras-related protein Rab-8A;RAB8A;>RAB8A_HUMAN|P61006|Ras-related protein Rab-8A (Oncogene c-mel) (Precursor);10;6;40,1
Q92930;Q92930;Ras-related protein Rab-8B;RAB8B;>RAB8B_HUMAN|Q92930|Ras-related protein Rab-8B (Precursor);8;4;35,7
"P51151;Q9NP90";P51151;Ras-related protein Rab-9A;RAB9A;>RAB9A_HUMAN|P51151|Ras-related protein Rab-9A;5;5;28,9
"Q9Y3P9;B7ZAP0";Q9Y3P9;Rab GTPase-activating protein 1;RABGAP1;>RBGP1_HUMAN|Q9Y3P9|Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA);5;5;5,7
Q92696;Q92696;Geranylgeranyl transferase type-2 subunit alpha;RABGGTA;>PGTA_HUMAN|Q92696|Geranylgeranyl transferase type-2 subunit alpha (2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase sub;7;7;11,6
"P63000;P60763";"P63000;P60763";"Ras-related C3 botulinum toxin substrate 1;Ras-related C3 botulinum toxin substrate 3";RAC1;">RAC1_HUMAN|P63000|Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1) (Precursor);>RAC3_HUMAN|P60763|Ras-related C3 botulinum toxin substrate 3 (p21-Rac3) (Precursor)";9;4;50
P54727;P54727;UV excision repair protein RAD23 homolog B;RAD23B;>RD23B_HUMAN|P54727|UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58);11;9;31,1
P11233;P11233;Ras-related protein Ral-A;RALA;>RALA_HUMAN|P11233|Ras-related protein Ral-A (Precursor);8;6;32,5
P11234;P11234;Ras-related protein Ral-B;RALB;>RALB_HUMAN|P11234|Ras-related protein Ral-B (Precursor);8;6;34
Q2PPJ7;Q2PPJ7;Ral GTPase-activating protein subunit alpha-2;RALGAPA2;>RGPA2_HUMAN|Q2PPJ7|Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220);5;5;3,3
P62826;P62826;GTP-binding nuclear protein Ran;RAN;>RAN_HUMAN|P62826|GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein);7;7;31
P43487;P43487;Ran-specific GTPase-activating protein;RANBP1;>RANG_HUMAN|P43487|Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1);3;3;21,4
P62834;P62834;Ras-related protein Rap-1A;RAP1A;>RAP1A_HUMAN|P62834|Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1) (Precursor);12;3;44
"P61224;A6NIZ1";"P61224;A6NIZ1";"Ras-related protein Rap-1b;Ras-related protein Rap-1b-like protein";RAP1B;">RAP1B_HUMAN|P61224|Ras-related protein Rap-1b (GTP-binding protein smg p21B) (Precursor);>RP1BL_HUMAN|A6NIZ1|Ras-related protein Rap-1b-like protein (Precursor)";11;3;44
P47736;P47736;Rap1 GTPase-activating protein 1;RAP1GAP;>RPGP1_HUMAN|P47736|Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);3;3;5
P52306;P52306;Rap1 GTPase-GDP dissociation stimulator 1;RAP1GDS1;>GDS1_HUMAN|P52306|Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein);7;7;13,5
P61225;P61225;Ras-related protein Rap-2b;RAP2B;>RAP2B_HUMAN|P61225|Ras-related protein Rap-2b (Precursor);6;3;33,9
Q9Y3L5;Q9Y3L5;Ras-related protein Rap-2c;RAP2C;>RAP2C_HUMAN|Q9Y3L5|Ras-related protein Rap-2c (Precursor);6;3;32,2
O95398;O95398;Rap guanine nucleotide exchange factor 3;RAPGEF3;>RPGF3_HUMAN|O95398|Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanin;15;15;17,2
P54136;P54136;Arginine--tRNA ligase, cytoplasmic;RARS;>SYRC_HUMAN|P54136|Arginine--tRNA  ligase,  cytoplasmic (6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS);12;12;21,2
P20936;P20936;Ras GTPase-activating protein 1;RASA1;>RASA1_HUMAN|P20936|Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP);2;2;2,4
Q8IZ41;Q8IZ41;Ras and EF-hand domain-containing protein;RASEF;>RASEF_HUMAN|Q8IZ41|Ras and EF-hand domain-containing protein (Ras-related protein Rab-45);17;17;25,9
O75884;O75884;Putative hydrolase RBBP9;RBBP9;>RBBP9_HUMAN|O75884|Putative hydrolase RBBP9 (3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9);4;4;27,4
P82980;P82980;Retinol-binding protein 5;RBP5;>RET5_HUMAN|P82980|Retinol-binding protein 5 (Cellular retinol-binding protein III) (CRBP-III) (HRBPiso);4;4;34,8
Q8TC12;Q8TC12;Retinol dehydrogenase 11;RDH11;>RDH11_HUMAN|Q8TC12|Retinol dehydrogenase 11 (1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/;7;7;30,8
Q9HBH5;Q9HBH5;Retinol dehydrogenase 14;RDH14;>RDH14_HUMAN|Q9HBH5|Retinol dehydrogenase 14 (1.1.1.-) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4);4;4;13,7
P35241;P35241;Radixin;RDX;>RADI_HUMAN|P35241|Radixin;34;17;44,8
P51606;P51606;N-acylglucosamine 2-epimerase;RENBP;>RENBP_HUMAN|P51606|N-acylglucosamine 2-epimerase (AGE) (5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP);3;3;7,5
Q8NFH8;Q8NFH8;RalBP1-associated Eps domain-containing protein 2;REPS2;>REPS2_HUMAN|Q8NFH8|RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2);3;2;6,4
Q9Y3B8;Q9Y3B8;Oligoribonuclease, mitochondrial;REXO2;>ORN_HUMAN|Q9Y3B8| Oligoribonuclease,  mitochondrial (3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease) (Precursor);3;3;18,1
Q8WZ73;Q8WZ73;E3 ubiquitin-protein ligase rififylin;RFFL;>RFFL_HUMAN|Q8WZ73|E3 ubiquitin-protein ligase rififylin  (2.3.2.27 ) (Caspase regulator CARP2) (Caspases-8 and #NAME RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING f;5;5;24,5
Q9UBD6;Q9UBD6;Ammonium transporter Rh type C;RHCG;>RHCG_HUMAN|Q9UBD6|Ammonium transporter Rh type C (Rh glycoprotein kidney) (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein) (Tumor-related protein DRC2);5;5;15,9
Q15382;Q15382;GTP-binding protein Rheb;RHEB;>RHEB_HUMAN|Q15382|GTP-binding protein Rheb (Ras homolog enriched in brain) (Precursor);8;8;36,4
P61586;P61586;Transforming protein RhoA;RHOA;>RHOA_HUMAN|P61586|Transforming protein RhoA (Rho cDNA clone 12) (h12) (Precursor);13;6;52,8
P62745;P62745;Rho-related GTP-binding protein RhoB;RHOB;>RHOB_HUMAN|P62745|Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6) (Precursor);7;5;38,8
P08134;P08134;Rho-related GTP-binding protein RhoC;RHOC;>RHOC_HUMAN|P08134|Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9) (Precursor);12;5;52,8
Q9HBH0;Q9HBH0;Rho-related GTP-binding protein RhoF;RHOF;>RHOF_HUMAN|Q9HBH0|Rho-related GTP-binding protein RhoF (Rho family GTPase Rif) (Rho in filopodia) (Precursor);8;8;50,2
"P84095;Q9H4E5";P84095;Rho-related GTP-binding protein RhoG;RHOG;>RHOG_HUMAN|P84095|Rho-related GTP-binding protein RhoG (Precursor);12;11;66,5
P17081;P17081;Rho-related GTP-binding protein RhoQ;RHOQ;>RHOQ_HUMAN|P17081|Rho-related GTP-binding protein RhoQ (Ras-like protein TC10) (Ras-like protein family member 7A) (Precursor);4;3;28,3
"Q8IUC4;A8MT19";Q8IUC4;Rhophilin-2;RHPN2;>RHPN2_HUMAN|Q8IUC4|Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE);11;11;18,7
P34096;P34096;Ribonuclease 4;RNASE4;>RNAS4_HUMAN|P34096|Ribonuclease 4 (RNase 4) (3.1.27.-) (Precursor);3;3;22,4
P13489;P13489;Ribonuclease inhibitor;RNH1;>RINI_HUMAN|P13489|Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI);21;21;62
Q9H4A4;Q9H4A4;Aminopeptidase B;RNPEP;>AMPB_HUMAN|Q9H4A4|Aminopeptidase B (AP-B) (3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase);26;26;43,2
Q13464;Q13464;Rho-associated protein kinase 1;ROCK1;>ROCK1_HUMAN|Q13464|Rho-associated protein kinase 1 (2.7.11.1) (Renal carcinoma antigen NY-REN-35)  (Rho-associated,  coiled-coil-containing protein kinase 1)  (Rho-associated,  coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK);13;12;10,3
Q9GZN7;Q9GZN7;Protein rogdi homolog;ROGDI;>ROGDI_HUMAN|Q9GZN7|Protein rogdi homolog;3;3;14,6
O75695;O75695;Protein XRP2;RP2;>XRP2_HUMAN|O75695|Protein XRP2;9;9;18,3
C9J7I0;C9J7I0;;RPA3OS;>UMAD1_HUMAN|C9J7I0|UBAP1-MVB12-associated (UMA)-domain containing protein 1  (RPA3 antisense RNA 1 ) (RPA3 opposite strand );3;3;29,4
"Q96AT9;Q2QD12";Q96AT9;Ribulose-phosphate 3-epimerase;RPE;>RPE_HUMAN|Q96AT9|Ribulose-phosphate 3-epimerase (5.1.3.1) (Ribulose-5-phosphate-3-epimerase);3;3;15,4
Q9UNE2;Q9UNE2;Rab effector Noc2;RPH3AL;>RPH3L_HUMAN|Q9UNE2|Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein);3;3;12,4
"P27635;Q96L21";"P27635;Q96L21";"60S ribosomal protein L10;60S ribosomal protein L10-like";RPL10;">RL10_HUMAN|P27635|60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16 ) (Protein QM) (Tumor suppressor QM);>RL10L_HUMAN|Q96L21|60S ribosomal protein L10-like (Large ribosomal subunit protein uL16-like)";4;4;19,6
P62913;P62913;60S ribosomal protein L11;RPL11;>RL11_HUMAN|P62913|60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5 );5;5;28,1
P30050;P30050;60S ribosomal protein L12;RPL12;>RL12_HUMAN|P30050|60S ribosomal protein L12 (Large ribosomal subunit protein uL11 );4;4;33,9
Q02543;Q02543;60S ribosomal protein L18a;RPL18A;>RL18A_HUMAN|Q02543|60S ribosomal protein L18a (Large ribosomal subunit protein eL20 );4;4;25
P39023;P39023;60S ribosomal protein L3;RPL3;>RL3_HUMAN|P39023|60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3 );3;3;6,7
"Q8NHW5;P05388";"Q8NHW5;P05388";"60S acidic ribosomal protein P0-like;60S acidic ribosomal protein P0";RPLP0P6;">RLA0L_HUMAN|Q8NHW5|60S acidic ribosomal protein P0-like (Large ribosomal subunit protein uL10-like);>RLA0_HUMAN|P05388|60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10 )";4;4;17,4
P05387;P05387;60S acidic ribosomal protein P2;RPLP2;>RLA2_HUMAN|P05387|60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2 ) (Renal carcinoma antigen NY-REN-44);5;5;76,5
P62280;P62280;40S ribosomal protein S11;RPS11;>RS11_HUMAN|P62280|40S ribosomal protein S11 (Small ribosomal subunit protein uS17 );3;3;15,8
P25398;P25398;40S ribosomal protein S12;RPS12;>RS12_HUMAN|P25398|40S ribosomal protein S12 (Small ribosomal subunit protein eS12 );4;4;28
P62277;P62277;40S ribosomal protein S13;RPS13;>RS13_HUMAN|P62277|40S ribosomal protein S13 (Small ribosomal subunit protein uS15 );4;4;31,1
P62249;P62249;40S ribosomal protein S16;RPS16;>RS16_HUMAN|P62249|40S ribosomal protein S16 (Small ribosomal subunit protein uS9 );4;4;28,1
P62269;P62269;40S ribosomal protein S18;RPS18;>RS18_HUMAN|P62269|40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13 );4;4;21,7
P39019;P39019;40S ribosomal protein S19;RPS19;>RS19_HUMAN|P39019|40S ribosomal protein S19 (Small ribosomal subunit protein eS19 );5;5;35,9
P23396;P23396;40S ribosomal protein S3;RPS3;>RS3_HUMAN|P23396|40S ribosomal protein S3 (4.2.99.18 ) (Small ribosomal subunit protein uS3 );8;8;32,9
P61247;P61247;40S ribosomal protein S3a;RPS3A;>RS3A_HUMAN|P61247|40S ribosomal protein S3a  (Small ribosomal subunit protein eS1 ) (v-fos transformation effector protein) (Fte-1);7;7;29,5
"P62701;P22090;Q8TD47";"P62701;P22090";"40S ribosomal protein S4, X isoform;40S ribosomal protein S4, Y isoform 1";RPS4X;">RS4X_HUMAN|P62701|40S ribosomal protein  S4,  X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4 );>RS4Y1_HUMAN|P22090|40S ribosomal protein  S4,  Y isoform 1 (Small ribosomal subunit protein eS4 )";8;8;28,9
P46782;P46782;"40S ribosomal protein S5;40S ribosomal protein S5, N-terminally processed";RPS5;>RS5_HUMAN|P46782|40S ribosomal protein S5 (Small ribosomal subunit protein uS7 ) (40S ribosomal protein  S5,  N-terminally processed);3;3;18,6
"P51812;Q15349;Q9UK32;Q96GX5;O60307;Q9Y2H9;Q6P0Q8;O15021";P51812;Ribosomal protein S6 kinase alpha-3;RPS6KA3;>KS6A3_HUMAN|P51812|Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein ki;14;10;23,5
P62241;P62241;40S ribosomal protein S8;RPS8;>RS8_HUMAN|P62241|40S ribosomal protein S8 (Small ribosomal subunit protein eS8 );7;7;39,9
P08865;P08865;40S ribosomal protein SA;RPSA;>RSSA_HUMAN|P08865|40S ribosomal protein SA  (37 kDa laminin receptor precursor ) (37LRP ) (37/67 kDa laminin receptor ) (LRP/LR ) (67 kDa laminin receptor ) (67LR ) (Colon carcinoma laminin-binding protein) (Laminin receptor 1 ) (LamR ) (Laminin-binding p;5;5;23,4
P10301;P10301;Ras-related protein R-Ras;RRAS;>RRAS_HUMAN|P10301|Ras-related protein R-Ras (p23) (Precursor);12;10;63,3
P62070;P62070;Ras-related protein R-Ras2;RRAS2;>RRAS2_HUMAN|P62070|Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene) (Precursor);10;8;48
Q96DX4;Q96DX4;RING finger and SPRY domain-containing protein 1;RSPRY1;>RSPRY_HUMAN|Q96DX4|RING finger and SPRY domain-containing protein 1 (Precursor);4;4;10,4
Q15404;Q15404;Ras suppressor protein 1;RSU1;>RSU1_HUMAN|Q15404|Ras suppressor protein 1 (RSP-1) (Rsu-1);2;2;9,4
O00442;O00442;RNA 3-terminal phosphate cyclase;RTCA;>RTCA_HUMAN|O00442|RNA 3-terminal phosphate cyclase (RNA cyclase) (RNA-3-phosphate cyclase) (6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1);3;3;9
Q9Y3I0;Q9Y3I0;tRNA-splicing ligase RtcB homolog;RTCB;>RTCB_HUMAN|Q9Y3I0|tRNA-splicing ligase RtcB homolog  (6.5.1.3  );3;3;6,5
Q96T51;Q96T51;RUN and FYVE domain-containing protein 1;RUFY1;>RUFY1_HUMAN|Q96T51|RUN and FYVE domain-containing protein 1 (FYVE-finger protein EIP1) (La-binding protein 1) (Rab4-interacting protein) (Zinc finger FYVE domain-containing protein 12);6;6;10,2
Q9Y265;Q9Y265;RuvB-like 1;RUVBL1;>RUVB1_HUMAN|Q9Y265|RuvB-like 1 (3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (;5;5;14
P60903;P60903;Protein S100-A10;S100A10;>S10AA_HUMAN|P60903|Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11);2;2;35,1
P31949;P31949;"Protein S100-A11;Protein S100-A11, N-terminally processed";S100A11;>S10AB_HUMAN|P31949|Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11) (Protein  S100-A11,  N-terminally processed);6;6;52,4
Q99584;Q99584;Protein S100-A13;S100A13;>S10AD_HUMAN|Q99584|Protein S100-A13 (S100 calcium-binding protein A13);3;3;28,6
Q9HCY8;Q9HCY8;Protein S100-A14;S100A14;>S10AE_HUMAN|Q9HCY8|Protein S100-A14 (S100 calcium-binding protein A14) (S114);5;5;51
P26447;P26447;Protein S100-A4;S100A4;>S10A4_HUMAN|P26447|Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4);2;2;19,8
P06703;P06703;Protein S100-A6;S100A6;>S10A6_HUMAN|P06703|Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6);4;4;26,7
P05109;P05109;"Protein S100-A8;Protein S100-A8, N-terminally processed";S100A8;>S10A8_HUMAN|P05109|Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone;6;6;47,3
P06702;P06702;Protein S100-A9;S100A9;>S10A9_HUMAN|P06702|Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9);5;5;50,9
P25815;P25815;Protein S100-P;S100P;>S100P_HUMAN|P25815|Protein S100-P (Migration-inducing gene 9 protein) (MIG9) (Protein S100-E) (S100 calcium-binding protein P);4;4;31,6
Q9NR31;Q9NR31;GTP-binding protein SAR1a;SAR1A;>SAR1A_HUMAN|Q9NR31|GTP-binding protein SAR1a (COPII-associated small GTPase);4;2;22,2
Q9BW04;Q9BW04;Specifically androgen-regulated gene protein;SARG;>SARG_HUMAN|Q9BW04|Specifically androgen-regulated gene protein;22;22;54,9
P49591;P49591;Serine--tRNA ligase, cytoplasmic;SARS;>SYSC_HUMAN|P49591|Serine--tRNA  ligase,  cytoplasmic (6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);13;13;29,4
Q9Y3A5;Q9Y3A5;Ribosome maturation protein SBDS;SBDS;>SBDS_HUMAN|Q9Y3A5|Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein);5;5;21,6
O15126;O15126;Secretory carrier-associated membrane protein 1;SCAMP1;>SCAM1_HUMAN|O15126|Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1);8;8;26,6
O15127;O15127;Secretory carrier-associated membrane protein 2;SCAMP2;>SCAM2_HUMAN|O15127|Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2);5;5;14,6
O14828;O14828;Secretory carrier-associated membrane protein 3;SCAMP3;>SCAM3_HUMAN|O14828|Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3);3;3;13
Q8WTV0;Q8WTV0;Scavenger receptor class B member 1;SCARB1;>SCRB1_HUMAN|Q8WTV0|Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I  receptor,  thrombospondin receptor-like 1) (SR-BI) (CD36);4;4;7,6
Q14108;Q14108;Lysosome membrane protein 2;SCARB2;>SCRB2_HUMAN|Q14108|Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD36);11;11;20,9
Q8WVM8;Q8WVM8;Sec1 family domain-containing protein 1;SCFD1;>SCFD1_HUMAN|Q8WVM8|Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2);4;4;10,1
Q9Y6U3;Q9Y6U3;Adseverin;SCIN;>ADSV_HUMAN|Q9Y6U3|Adseverin (Scinderin);14;14;22,4
Q12765;Q12765;Secernin-1;SCRN1;>SCRN1_HUMAN|Q12765|Secernin-1;13;13;36,5
Q96FV2;Q96FV2;Secernin-2;SCRN2;>SCRN2_HUMAN|Q96FV2|Secernin-2;5;5;13,4
Q96KG9;Q96KG9;N-terminal kinase-like protein;SCYL1;>SCYL1_HUMAN|Q96KG9|N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase);3;3;4,3
Q6P3W7;Q6P3W7;SCY1-like protein 2;SCYL2;>SCYL2_HUMAN|Q6P3W7|SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa);2;2;2,5
P34741;P34741;Syndecan-2;SDC2;>SDC2_HUMAN|P34741|Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD362) (Precursor);2;2;4,5
P31431;P31431;Syndecan-4;SDC4;>SDC4_HUMAN|P31431|Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein) (Precursor);5;5;22,7
O00560;O00560;Syntenin-1;SDCBP;>SDCB1_HUMAN|O00560|Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1);18;18;75,8
Q9H190;Q9H190;Syntenin-2;SDCBP2;>SDCB2_HUMAN|Q9H190|Syntenin-2 (Syndecan-binding protein 2);5;5;17,1
O76054;O76054;SEC14-like protein 2;SEC14L2;>S14L2_HUMAN|O76054|SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (hTAP) (Squalene transfer protein) (Supernatant protein factor) (SPF);10;10;27
O75396;O75396;Vesicle-trafficking protein SEC22b;SEC22B;>SC22B_HUMAN|O75396|Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1);3;3;16,7
Q15437;Q15437;Protein transport protein Sec23B;SEC23B;>SC23B_HUMAN|Q15437|Protein transport protein Sec23B (SEC23-related protein B);4;4;6,5
P53992;P53992;Protein transport protein Sec24C;SEC24C;>SC24C_HUMAN|P53992|Protein transport protein Sec24C (SEC24-related protein C);4;4;4,4
O94979;O94979;Protein transport protein Sec31A;SEC31A;>SC31A_HUMAN|O94979|Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein);7;7;6,6
Q13228;Q13228;Selenium-binding protein 1;SELENBP1;>SBP1_HUMAN|Q13228|Selenium-binding protein 1 (56 kDa selenium-binding protein) (SBP56) (SP56);23;23;57,4
Q99985;Q99985;Semaphorin-3C;SEMA3C;>SEM3C_HUMAN|Q99985|Semaphorin-3C (Semaphorin-E) (Sema E) (Precursor);3;3;4,8
Q13591;Q13591;Semaphorin-5A;SEMA5A;>SEM5A_HUMAN|Q13591|Semaphorin-5A (Semaphorin-F) (Sema F) (Precursor);8;8;8,3
"Q9NVA2;Q14141";Q9NVA2;Septin-11;SEPT11;>SEP11_HUMAN|Q9NVA2|Septin-11;3;3;10
Q15019;Q15019;Septin-2;SEPT2;>SEPT2_HUMAN|Q15019|Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5);7;7;25,5
"Q16181;Q6ZU15";Q16181;Septin-7;SEPT7;>SEPT7_HUMAN|Q16181|Septin-7 (CDC10 protein homolog);4;4;10,3
Q9NRX5;Q9NRX5;Serine incorporator 1;SERINC1;>SERC1_HUMAN|Q9NRX5|Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2);4;4;11,3
Q13530;Q13530;Serine incorporator 3;SERINC3;>SERC3_HUMAN|Q13530|Serine incorporator 3 (Tumor differentially expressed protein 1 );3;3;4,9
Q86VE9;Q86VE9;Serine incorporator 5;SERINC5;>SERC5_HUMAN|Q86VE9|Serine incorporator 5;7;7;15,4
"P01009;P20848";P01009;"Alpha-1-antitrypsin;Short peptide from AAT";SERPINA1;>A1AT_HUMAN|P01009|Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) (Short peptide from AAT) (SPAAT) (Precursor);12;12;32,8
P01011;P01011;"Alpha-1-antichymotrypsin;Alpha-1-antichymotrypsin His-Pro-less";SERPINA3;>AACT_HUMAN|P01011|Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) (Alpha-1-antichymotrypsin His-Pro-less) (Precursor);10;10;19,9
P05154;P05154;Plasma serine protease inhibitor;SERPINA5;>IPSP_HUMAN|P05154|Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5) (Precursor);9;9;22,2
P36952;P36952;Serpin B5;SERPINB5;>SPB5_HUMAN|P36952|Serpin B5 (Maspin) (Peptidase inhibitor 5) (PI-5);4;4;12,3
"P35237;P50452";P35237;Serpin B6;SERPINB6;>SPB6_HUMAN|P35237|Serpin B6 (Cytoplasmic antiproteinase) (CAP) (Peptidase inhibitor 6) (PI-6) (Placental thrombin inhibitor);15;15;51,1
"P05155;CON__P50448";P05155;Plasma protease C1 inhibitor;SERPING1;>IC1_HUMAN|P05155|Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1) (Precursor);5;5;12
Q8WTS6;Q8WTS6;Histone-lysine N-methyltransferase SETD7;SETD7;>SETD7_HUMAN|Q8WTS6|Histone-lysine N-methyltransferase SETD7 (2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);2;2;5,2
P31947;P31947;14-3-3 protein sigma;SFN;>1433S_HUMAN|P31947|14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin);17;14;59,7
P51688;P51688;N-sulphoglucosamine sulphohydrolase;SGSH;>SPHM_HUMAN|P51688|N-sulphoglucosamine sulphohydrolase (3.10.1.1  ) (Sulfoglucosamine sulfamidase) (Sulphamidase) (Precursor);4;4;11,6
O43147;O43147;Small G protein signaling modulator 2;SGSM2;>SGSM2_HUMAN|O43147|Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1);2;2;2,2
Q96HU1;Q96HU1;Small G protein signaling modulator 3;SGSM3;>SGSM3_HUMAN|Q96HU1|Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP);14;14;18,8
O43765;O43765;Small glutamine-rich tetratricopeptide repeat-containing protein alpha;SGTA;>SGTA_HUMAN|O43765|Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP);3;3;10,2
Q9H788;Q9H788;SH2 domain-containing protein 4A;SH2D4A;>SH24A_HUMAN|Q9H788|SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38);5;5;14,1
O75368;O75368;SH3 domain-binding glutamic acid-rich-like protein;SH3BGRL;>SH3L1_HUMAN|O75368|SH3 domain-binding glutamic acid-rich-like protein;7;7;79,8
Q9H299;Q9H299;SH3 domain-binding glutamic acid-rich-like protein 3;SH3BGRL3;>SH3L3_HUMAN|Q9H299|SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1) (SH3BP-1);3;3;32,3
Q9P0V3;Q9P0V3;SH3 domain-binding protein 4;SH3BP4;>SH3B4_HUMAN|Q9P0V3|SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein);12;12;14,6
Q99961;Q99961;Endophilin-A2;SH3GL1;>SH3G1_HUMAN|Q99961|Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1);5;3;14,1
Q9Y371;Q9Y371;Endophilin-B1;SH3GLB1;>SHLB1_HUMAN|Q9Y371|Endophilin-B1 (Bax-interacting factor 1) (Bif-1) (SH3 domain-containing GRB2-like protein B1);7;6;20
Q9NR46;Q9NR46;Endophilin-B2;SH3GLB2;>SHLB2_HUMAN|Q9NR46|Endophilin-B2 (SH3 domain-containing GRB2-like protein B2);10;9;25,6
Q9UPX8;Q9UPX8;SH3 and multiple ankyrin repeat domains protein 2;SHANK2;>SHAN2_HUMAN|Q9UPX8|SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1);5;5;3,7
"P34896;P34897";P34896;Serine hydroxymethyltransferase, cytosolic;SHMT1;>GLYC_HUMAN|P34896|Serine  hydroxymethyltransferase,  cytosolic (SHMT) (2.1.2.1  ) (Glycine hydroxymethyltransferase) (Serine methylase);13;13;33,5
P14410;P14410;"Sucrase-isomaltase, intestinal;Sucrase;Isomaltase";SI;>SUIS_HUMAN|P14410| Sucrase-isomaltase,  intestinal (Sucrase) (3.2.1.48) (Isomaltase) (3.2.1.10);20;19;13,5
Q9HAT2;Q9HAT2;Sialate O-acetylesterase;SIAE;>SIAE_HUMAN|Q9HAT2|Sialate O-acetylesterase (3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase) (Precursor);5;5;11,9
P78324;P78324;Tyrosine-protein phosphatase non-receptor type substrate 1;SIRPA;>SHPS1_HUMAN|P78324|Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fus;11;3;28,4
Q8IXJ6;Q8IXJ6;NAD-dependent protein deacetylase sirtuin-2;SIRT2;>SIR2_HUMAN|Q8IXJ6|NAD-dependent protein deacetylase sirtuin-2 (3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2);4;4;12,1
Q15477;Q15477;Helicase SKI2W;SKIV2L;>SKIV2_HUMAN|Q15477|Helicase SKI2W (Ski2) (3.6.4.-) (Helicase-like protein) (HLP);5;5;6,2
P63208;P63208;S-phase kinase-associated protein 1;SKP1;>SKP1_HUMAN|P63208|S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation;8;8;45,4
Q9P270;Q9P270;SLAIN motif-containing protein 2;SLAIN2;>SLAI2_HUMAN|Q9P270|SLAIN motif-containing protein 2;6;6;14,5
P49281;P49281;Natural resistance-associated macrophage protein 2;SLC11A2;>NRAM2_HUMAN|P49281|Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2);2;2;4,6
"Q13621;P55011";Q13621;Solute carrier family 12 member 1;SLC12A1;>S12A1_HUMAN|Q13621|Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter);38;38;36,8
P55017;P55017;Solute carrier family 12 member 3;SLC12A3;>S12A3_HUMAN|P55017|Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter);30;30;29,8
Q13183;Q13183;Solute carrier family 13 member 2;SLC13A2;>S13A2_HUMAN|Q13183|Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter);6;6;10,5
Q8WWT9;Q8WWT9;Solute carrier family 13 member 3;SLC13A3;>S13A3_HUMAN|Q8WWT9|Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2);5;5;10
P46059;P46059;Solute carrier family 15 member 1;SLC15A1;>S15A1_HUMAN|P46059|Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide  transporter,  small intestine isoform) (Peptide transporter 1);8;8;11,4
Q16348;Q16348;Solute carrier family 15 member 2;SLC15A2;>S15A2_HUMAN|Q16348|Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide  transporter,  kidney isoform) (Peptide transporter 2);17;17;23
O00476;O00476;Sodium-dependent phosphate transport protein 4;SLC17A3;>NPT4_HUMAN|O00476|Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3);4;4;9,5
Q9NRA2;Q9NRA2;Sialin;SLC17A5;>S17A5_HUMAN|Q9NRA2|Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);6;6;13,1
Q9BZV2;Q9BZV2;Thiamine transporter 2;SLC19A3;>S19A3_HUMAN|Q9BZV2|Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3);2;2;12,3
P43005;P43005;Excitatory amino acid transporter 3;SLC1A1;>EAA3_HUMAN|P43005|Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);5;5;12,8
Q15758;Q15758;Neutral amino acid transporter B(0);SLC1A5;>AAAT_HUMAN|Q15758|Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5);8;8;17,6
Q9NSA0;Q9NSA0;Solute carrier family 22 member 11;SLC22A11;>S22AB_HUMAN|Q9NSA0|Solute carrier family 22 member 11 (Organic anion transporter 4);4;4;8,5
Q96S37;Q96S37;Solute carrier family 22 member 12;SLC22A12;>S22AC_HUMAN|Q96S37|Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1);6;6;12,8
Q9Y226;Q9Y226;Solute carrier family 22 member 13;SLC22A13;>S22AD_HUMAN|Q9Y226|Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3);5;5;8,7
O15244;O15244;Solute carrier family 22 member 2;SLC22A2;>S22A2_HUMAN|O15244|Solute carrier family 22 member 2 (Organic cation transporter 2) (hOCT2);4;4;5,9
A1A5C7;A1A5C7;Solute carrier family 22 member 23;SLC22A23;>S22AN_HUMAN|A1A5C7|Solute carrier family 22 member 23;4;4;5,7
Q4U2R8;Q4U2R8;Solute carrier family 22 member 6;SLC22A6;>S22A6_HUMAN|Q4U2R8|Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1);8;8;13,5
"Q8TCC7;REV__P98194";Q8TCC7;Solute carrier family 22 member 8;SLC22A8;>S22A8_HUMAN|Q8TCC7|Solute carrier family 22 member 8 (Organic anion transporter 3) (hOAT3);9;9;16,2
Q9UHI7;Q9UHI7;Solute carrier family 23 member 1;SLC23A1;>S23A1_HUMAN|Q9UHI7|Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3);11;11;22,1
P50443;P50443;Sulfate transporter;SLC26A2;>S26A2_HUMAN|P50443|Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2);6;6;8,7
O43511;O43511;Pendrin;SLC26A4;>S26A4_HUMAN|O43511|Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4);6;6;10,1
O00337;O00337;Sodium/nucleoside cotransporter 1;SLC28A1;>S28A1_HUMAN|O00337|Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1);3;3;6
Q99808;Q99808;Equilibrative nucleoside transporter 1;SLC29A1;>S29A1_HUMAN|Q99808|Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside  transporter,  es-type) (Solute carrier family;3;3;9,6
P11166;P11166;Solute carrier family 2, facilitated glucose transporter member 1;SLC2A1;>GTR1_HUMAN|P11166|Solute carrier family  2,  facilitated glucose transporter member 1 (Glucose transporter type  1,  erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter);2;2;3,7
P11168;P11168;Solute carrier family 2, facilitated glucose transporter member 2;SLC2A2;>GTR2_HUMAN|P11168|Solute carrier family  2,  facilitated glucose transporter member 2 (Glucose transporter type  2,  liver) (GLUT-2);2;2;3,6
P22732;P22732;Solute carrier family 2, facilitated glucose transporter member 5;SLC2A5;>GTR5_HUMAN|P22732|Solute carrier family  2,  facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type  5,  small intestine) (GLUT-5);11;11;12,2
Q9NRM0;Q9NRM0;Solute carrier family 2, facilitated glucose transporter member 9;SLC2A9;>GTR9_HUMAN|Q9NRM0|Solute carrier family  2,  facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9);2;2;3,3
O14863;O14863;Zinc transporter 4;SLC30A4;>ZNT4_HUMAN|O14863|Zinc transporter 4 (ZnT-4) (Solute carrier family 30 member 4);4;4;9,1
O15431;O15431;High affinity copper uptake protein 1;SLC31A1;>COPT1_HUMAN|O15431|High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1);3;3;16,3
O95436;O95436;Sodium-dependent phosphate transport protein 2B;SLC34A2;>NPT2B_HUMAN|O95436|Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier fami;3;3;4,3
Q8IXU6;Q8IXU6;Solute carrier family 35 member F2;SLC35F2;>S35F2_HUMAN|Q8IXU6|Solute carrier family 35 member F2;3;3;11,8
Q8N357;Q8N357;Solute carrier family 35 member F6;SLC35F6;>S35F6_HUMAN|Q8N357|Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog) (Precursor);2;2;7
Q7Z2H8;Q7Z2H8;Proton-coupled amino acid transporter 1;SLC36A1;>S36A1_HUMAN|Q7Z2H8|Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1);3;3;13,4
Q495M3;Q495M3;Proton-coupled amino acid transporter 2;SLC36A2;>S36A2_HUMAN|Q495M3|Proton-coupled amino acid transporter 2 (Proton/amino acid transporter 2) (Solute carrier family 36 member 2) (Tramdorin-1);6;6;13,5
Q07837;Q07837;Neutral and basic amino acid transport protein rBAT;SLC3A1;>SLC31_HUMAN|Q07837|Neutral and basic amino acid transport protein rBAT (NBAT) (D2h) (Solute carrier family 3 member 1)  (b(0,+)-type  amino acid transport protein);9;9;15,8
P08195;P08195;4F2 cell-surface antigen heavy chain;SLC3A2;>4F2_HUMAN|P08195|4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD98);16;16;31,1
Q8WWI5;Q8WWI5;Choline transporter-like protein 1;SLC44A1;>CTL1_HUMAN|Q8WWI5|Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD92);3;3;6,4
Q8IWA5;Q8IWA5;Choline transporter-like protein 2;SLC44A2;>CTL2_HUMAN|Q8IWA5|Choline transporter-like protein 2 (Solute carrier family 44 member 2);22;22;27,9
Q53GD3;Q53GD3;Choline transporter-like protein 4;SLC44A4;>CTL4_HUMAN|Q53GD3|Choline transporter-like protein 4 (Solute carrier family 44 member 4);10;10;12,7
Q96FL8;Q96FL8;Multidrug and toxin extrusion protein 1;SLC47A1;>S47A1_HUMAN|Q96FL8|Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1);6;6;15,8
P02730;P02730;Band 3 anion transport protein;SLC4A1;>B3AT_HUMAN|P02730|Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD233);4;4;4,7
"Q9Y6R1;Q9BY07";Q9Y6R1;Electrogenic sodium bicarbonate cotransporter 1;SLC4A4;>S4A4_HUMAN|Q9Y6R1|Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1);12;12;12,4
Q9NQ40;Q9NQ40;Solute carrier family 52, riboflavin transporter, member 3;SLC52A3;>S52A3_HUMAN|Q9NQ40|Solute carrier family  52,  riboflavin  transporter,  member 3 (Riboflavin transporter 2) (hRFT2);2;2;7,9
"P13866;Q9NY91";P13866;Sodium/glucose cotransporter 1;SLC5A1;>SC5A1_HUMAN|P13866|Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1);7;7;10,7
A0PJK1;A0PJK1;Sodium/glucose cotransporter 5;SLC5A10;>SC5AA_HUMAN|A0PJK1|Sodium/glucose cotransporter 5 (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10);7;7;14,6
Q1EHB4;Q1EHB4;Sodium-coupled monocarboxylate transporter 2;SLC5A12;>SC5AC_HUMAN|Q1EHB4|Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12);6;6;9,4
P31639;P31639;Sodium/glucose cotransporter 2;SLC5A2;>SC5A2_HUMAN|P31639|Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2);12;12;17,4
Q8N695;Q8N695;Sodium-coupled monocarboxylate transporter 1;SLC5A8;>SC5A8_HUMAN|Q8N695|Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8);5;5;9,5
Q695T7;Q695T7;Sodium-dependent neutral amino acid transporter B(0)AT1;SLC6A19;>S6A19_HUMAN|Q695T7|Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1);4;4;8,7
P52569;P52569;Low affinity cationic amino acid transporter 2;SLC7A2;>CTR2_HUMAN|P52569|Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);3;3;5,8
Q9UHI5;Q9UHI5;Large neutral amino acids transporter small subunit 2;SLC7A8;>LAT2_HUMAN|Q9UHI5|Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8);3;3;7,9
O14745;O14745;Na(+)/H(+) exchange regulatory cofactor NHE-RF1;SLC9A3R1;>NHRF1_HUMAN|O14745|Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 is;22;22;62
Q15599;Q15599;Na(+)/H(+) exchange regulatory cofactor NHE-RF2;SLC9A3R2;>NHRF2_HUMAN|Q15599|Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory facto;16;16;52,8
Q6ZQN7;Q6ZQN7;Solute carrier organic anion transporter family member 4C1;SLCO4C1;>SO4C1_HUMAN|Q6ZQN7|Solute carrier organic anion transporter family member 4C1 (OATP-H) (Organic anion transporter M1) (OATP-M1) (Solute carrier family 21 member 20);8;8;17,1
Q9H2G2;Q9H2G2;STE20-like serine/threonine-protein kinase;SLK;>SLK_HUMAN|Q9H2G2|STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2);31;30;29,2
"P84022;O15198";"P84022;O15198";"Mothers against decapentaplegic homolog 3;Mothers against decapentaplegic homolog 9";SMAD3;">SMAD3_HUMAN|P84022|Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3);>SMAD9_HUMAN|O15198|Mothers against decapentaplegic homolog 9 (MAD homol";3;1;8
Q99717;Q99717;Mothers against decapentaplegic homolog 5;SMAD5;>SMAD5_HUMAN|Q99717|Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (JV5-1) (SMAD family member 5) (SMAD 5) (Smad5) (hSmad5);3;1;7,7
B2RUZ4;B2RUZ4;Small integral membrane protein 1;SMIM1;>SMIM1_HUMAN|B2RUZ4|Small integral membrane protein 1   (Vel blood group antigen );3;3;43,6
K7EJ46;K7EJ46;Small integral membrane protein 22;SMIM22;>SIM22_HUMAN|K7EJ46|Small integral membrane protein 22;2;2;19,3
O75264;O75264;Small integral membrane protein 24;SMIM24;>SIM24_HUMAN|O75264|Small integral membrane protein 24 (Precursor);4;4;34,6
Q71RC9;Q71RC9;Small integral membrane protein 5;SMIM5;>SMIM5_HUMAN|Q71RC9|Small integral membrane protein 5;2;2;23,4
Q99835;Q99835;Smoothened homolog;SMO;>SMO_HUMAN|Q99835|Smoothened homolog (SMO) (Protein Gx) (Precursor);12;12;16,4
Q92485;Q92485;Acid sphingomyelinase-like phosphodiesterase 3b;SMPDL3B;>ASM3B_HUMAN|Q92485|Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (3.1.4.- ) (Precursor);10;10;29,9
P52788;P52788;Spermine synthase;SMS;>SPSY_HUMAN|P52788|Spermine synthase (SPMSY) (2.5.1.22) (Spermidine aminopropyltransferase);15;15;56,8
O00161;O00161;Synaptosomal-associated protein 23;SNAP23;>SNP23_HUMAN|O00161|Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23);14;14;75,8
O95721;O95721;Synaptosomal-associated protein 29;SNAP29;>SNP29_HUMAN|O95721|Synaptosomal-associated protein 29  (SNAP-29 ) (Soluble 29 kDa NSF attachment protein ) (Vesicle-membrane fusion protein SNAP-29);4;4;20,9
"O76070;Q16143";O76070;Gamma-synuclein;SNCG;>SYUG_HUMAN|O76070|Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR);6;6;53,5
Q7KZF4;Q7KZF4;Staphylococcal nuclease domain-containing protein 1;SND1;>SND1_HUMAN|Q7KZF4|Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator);18;18;21,5
Q96H20;Q96H20;Vacuolar-sorting protein SNF8;SNF8;>SNF8_HUMAN|Q96H20|Vacuolar-sorting protein SNF8 (ELL-associated protein of 30 kDa) (ESCRT-II complex subunit VPS22) (hVps22);5;5;23,6
Q13596;Q13596;Sorting nexin-1;SNX1;>SNX1_HUMAN|Q13596|Sorting nexin-1;15;13;32,8
Q96RF0;Q96RF0;Sorting nexin-18;SNX18;>SNX18_HUMAN|Q96RF0|Sorting nexin-18 (SH3 and PX domain-containing protein 3B) (Sorting nexin-associated Golgi protein 1);12;12;21,5
O60749;O60749;Sorting nexin-2;SNX2;>SNX2_HUMAN|O60749|Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9);14;12;32,4
Q96L92;Q96L92;Sorting nexin-27;SNX27;>SNX27_HUMAN|Q96L92|Sorting nexin-27;5;5;9,8
O60493;O60493;Sorting nexin-3;SNX3;>SNX3_HUMAN|O60493|Sorting nexin-3 (Protein SDP3);6;4;35,8
Q9Y5X3;Q9Y5X3;Sorting nexin-5;SNX5;>SNX5_HUMAN|Q9Y5X3|Sorting nexin-5;7;6;20
"Q9UNH7;Q86XE0";Q9UNH7;"Sorting nexin-6;Sorting nexin-6, N-terminally processed";SNX6;>SNX6_HUMAN|Q9UNH7|Sorting nexin-6 (TRAF4-associated factor 2) (Sorting  nexin-6,  N-terminally processed);9;8;24,9
Q9Y5X1;Q9Y5X1;Sorting nexin-9;SNX9;>SNX9_HUMAN|Q9Y5X1|Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A);13;13;25,5
P00441;P00441;Superoxide dismutase [Cu-Zn];SOD1;>SODC_HUMAN|P00441|Superoxide dismutase [Cu-Zn] (1.15.1.1) (Superoxide dismutase 1) (hSod1);7;7;67,5
P08294;P08294;Extracellular superoxide dismutase [Cu-Zn];SOD3;>SODE_HUMAN|P08294|Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (1.15.1.1) (Precursor);3;3;18,3
Q00796;Q00796;Sorbitol dehydrogenase;SORD;>DHSO_HUMAN|Q00796|Sorbitol dehydrogenase (1.1.1.14) (L-iditol 2-dehydrogenase);26;26;85,7
"O60271;Q9UPT6";O60271;C-Jun-amino-terminal kinase-interacting protein 4;SPAG9;>JIP4_HUMAN|O60271|C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated prote;14;14;13,5
Q9UBP0;Q9UBP0;Spastin;SPAST;>SPAST_HUMAN|Q9UBP0|Spastin   (3.6.4.3  ) (Spastic paraplegia 4 protein);12;12;25
Q5M775;Q5M775;Cytospin-B;SPECC1;>CYTSB_HUMAN|Q5M775|Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1);2;2;1,7
Q8N0X7;Q8N0X7;Spartin;SPG20;>SPG20_HUMAN|Q8N0X7|Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1);5;5;8,7
O43278;O43278;Kunitz-type protease inhibitor 1;SPINT1;>SPIT1_HUMAN|O43278|Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1) (Precursor);10;10;15,5
O43291;O43291;Kunitz-type protease inhibitor 2;SPINT2;>SPIT2_HUMAN|O43291|Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2) (HAI-2) (Placental bikunin) (Precursor);8;8;42,5
Q8TCT8;Q8TCT8;Signal peptide peptidase-like 2A;SPPL2A;>SPP2A_HUMAN|Q8TCT8|Signal peptide peptidase-like 2A   (SPP-like 2A ) (SPPL2a ) (3.4.23.-) (Intramembrane protease 3 ) (IMP-3 ) (Presenilin-like protein 2) (Precursor);4;4;8,5
"P35270;REV__Q16649";P35270;Sepiapterin reductase;SPR;>SPRE_HUMAN|P35270|Sepiapterin reductase (SPR) (1.1.1.153);10;10;45,2
Q9UBC9;Q9UBC9;Small proline-rich protein 3;SPRR3;>SPRR3_HUMAN|Q9UBC9|Small proline-rich protein 3 (22 kDa pancornulin) (Cornifin beta) (Esophagin);4;4;42,6
Q13813;Q13813;Spectrin alpha chain, non-erythrocytic 1;SPTAN1;>SPTN1_HUMAN|Q13813|Spectrin alpha  chain,  non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain)  (Spectrin,  non-erythroid alpha subunit);8;8;4,4
Q01082;Q01082;Spectrin beta chain, non-erythrocytic 1;SPTBN1;>SPTB2_HUMAN|Q01082|Spectrin beta  chain,  non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain)  (Spectrin,  non-erythroid beta chain 1);5;5;2,4
Q13501;Q13501;Sequestosome-1;SQSTM1;>SQSTM_HUMAN|Q13501|Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62);4;4;15,9
P12931;P12931;Proto-oncogene tyrosine-protein kinase Src;SRC;>SRC_HUMAN|P12931|Proto-oncogene tyrosine-protein kinase Src (2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src);20;12;42,9
P30626;P30626;Sorcin;SRI;>SORCN_HUMAN|P30626|Sorcin (22 kDa protein) (CP-22) (CP22) (V19);11;11;55,1
Q8TE77;Q8TE77;Protein phosphatase Slingshot homolog 3;SSH3;>SSH3_HUMAN|Q8TE77|Protein phosphatase Slingshot homolog 3 (3.1.3.16) (3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L);8;8;14,1
"P50502;Q8NFI4;Q8IZP2";"P50502;Q8NFI4;Q8IZP2";"Hsc70-interacting protein;Putative protein FAM10A5;Putative protein FAM10A4";ST13;>F10A1_HUMAN|P50502|Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein;10;10;29,8
Q92783;Q92783;Signal transducing adapter molecule 1;STAM;>STAM1_HUMAN|Q92783|Signal transducing adapter molecule 1 (STAM-1);7;5;15,4
O75886;O75886;Signal transducing adapter molecule 2;STAM2;>STAM2_HUMAN|O75886|Signal transducing adapter molecule 2 (STAM-2) (Hrs-binding protein);7;5;13
O95630;O95630;STAM-binding protein;STAMBP;>STABP_HUMAN|O95630|STAM-binding protein (3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase);14;14;34,9
Q9Y365;Q9Y365;PCTP-like protein;STARD10;>PCTL_HUMAN|Q9Y365|PCTP-like protein (PCTP-L) (Antigen NY-CO-28) (START domain-containing protein 10) (StARD10) (Serologically defined colon cancer antigen 28) (StAR-related lipid transfer protein 10);4;4;18,6
P42224;P42224;Signal transducer and activator of transcription 1-alpha/beta;STAT1;>STAT1_HUMAN|P42224|Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84);13;13;20,4
P52630;P52630;Signal transducer and activator of transcription 2;STAT2;>STAT2_HUMAN|P52630|Signal transducer and activator of transcription 2 (p113);2;2;4,3
P40763;P40763;Signal transducer and activator of transcription 3;STAT3;>STAT3_HUMAN|P40763|Signal transducer and activator of transcription 3  (Acute-phase response factor);20;20;35,6
P42226;P42226;Signal transducer and activator of transcription 6;STAT6;>STAT6_HUMAN|P42226|Signal transducer and activator of transcription 6 (IL-4 Stat);7;7;10,2
"Q9UHE8;Q6NZ63";"Q9UHE8;Q6NZ63";"Metalloreductase STEAP1;STEAP family member 1B";STEAP1;">STEA1_HUMAN|Q9UHE8|Metalloreductase STEAP1 (1.16.1.-) (Six-transmembrane epithelial antigen of prostate 1);>STEAL_HUMAN|Q6NZ63|STEAP family member 1B";4;4;11,8
Q8NFT2;Q8NFT2;Metalloreductase STEAP2;STEAP2;>STEA2_HUMAN|Q8NFT2|Metalloreductase STEAP2 (1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1);11;11;25,9
Q687X5;Q687X5;Metalloreductase STEAP4;STEAP4;>STEA4_HUMAN|Q687X5|Metalloreductase STEAP4 (1.16.1.-) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis  factor,  alpha-induced protein 9);19;19;47,9
P31948;P31948;Stress-induced-phosphoprotein 1;STIP1;>STIP1_HUMAN|P31948|Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521);22;22;45,3
O94804;O94804;Serine/threonine-protein kinase 10;STK10;>STK10_HUMAN|O94804|Serine/threonine-protein kinase 10 (2.7.11.1) (Lymphocyte-oriented kinase);5;4;6
Q15831;Q15831;Serine/threonine-protein kinase STK11;STK11;>STK11_HUMAN|Q15831|Serine/threonine-protein kinase STK11 (2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) (Precursor);7;7;23,6
Q9Y6E0;Q9Y6E0;"Serine/threonine-protein kinase 24;Serine/threonine-protein kinase 24 36 kDa subunit;Serine/threonine-protein kinase 24 12 kDa subunit";STK24;>STK24_HUMAN|Q9Y6E0|Serine/threonine-protein kinase 24 (2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) (Serine/threonine-protein kinase 24 36 kDa subunit) (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N) (Seri;16;10;39,1
O00506;O00506;Serine/threonine-protein kinase 25;STK25;>STK25_HUMAN|O00506|Serine/threonine-protein kinase 25 (2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1);9;5;25,6
Q9UEW8;Q9UEW8;STE20/SPS1-related proline-alanine-rich protein kinase;STK39;>STK39_HUMAN|Q9UEW8|STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39);15;12;30,6
P27105;P27105;Erythrocyte band 7 integral membrane protein;STOM;>STOM_HUMAN|P27105|Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin);11;11;44,8
Q9Y6Q2;Q9Y6Q2;Stonin-1;STON1;>STON1_HUMAN|Q9Y6Q2|Stonin-1 (Stoned B-like factor);3;3;4,6
Q9C0K7;Q9C0K7;STE20-related kinase adapter protein beta;STRADB;>STRAB_HUMAN|Q9C0K7|STE20-related kinase adapter protein beta (STRAD beta) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein) (CALS-21) (ILP-interacting protein) (Pseudokinase ALS2CR2);8;8;25,8
Q9Y3F4;Q9Y3F4;Serine-threonine kinase receptor-associated protein;STRAP;>STRAP_HUMAN|Q9Y3F4|Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD);8;8;31,4
Q9UNE7;Q9UNE7;E3 ubiquitin-protein ligase CHIP;STUB1;>CHIP_HUMAN|Q9UNE7|E3 ubiquitin-protein ligase CHIP  (2.3.2.27  ) (Antigen NY-CO-7 ) (CLL-associated antigen KW-8 ) (Carboxy terminus of Hsp70-interacting protein ) (RING-type E3 ubiquitin transferase CHIP ) (STIP1 homology and U box-containing protein 1 );4;4;14,5
Q86Y82;Q86Y82;Syntaxin-12;STX12;>STX12_HUMAN|Q86Y82|Syntaxin-12;7;7;32,2
Q13277;Q13277;Syntaxin-3;STX3;>STX3_HUMAN|Q13277|Syntaxin-3;9;9;26,6
O15400;O15400;Syntaxin-7;STX7;>STX7_HUMAN|O15400|Syntaxin-7;3;3;15,7
P61764;P61764;Syntaxin-binding protein 1;STXBP1;>STXB1_HUMAN|P61764|Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67);12;11;22,6
Q15833;Q15833;Syntaxin-binding protein 2;STXBP2;>STXB2_HUMAN|Q15833|Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Unc18-2) (Protein unc-18 homolog B) (Unc-18B);33;32;55
O00186;O00186;Syntaxin-binding protein 3;STXBP3;>STXB3_HUMAN|O00186|Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C);6;6;11,3
Q6ZWJ1;Q6ZWJ1;Syntaxin-binding protein 4;STXBP4;>STXB4_HUMAN|Q6ZWJ1|Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip);5;5;11
"Q5T5C0;Q9Y2K9";Q5T5C0;Syntaxin-binding protein 5;STXBP5;>STXB5_HUMAN|Q5T5C0|Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1);9;9;10,9
Q8NFX7;Q8NFX7;Syntaxin-binding protein 6;STXBP6;>STXB6_HUMAN|Q8NFX7|Syntaxin-binding protein 6 (Amisyn);2;2;14,3
Q6J9G0;Q6J9G0;Tyrosine-protein kinase STYK1;STYK1;>STYK1_HUMAN|Q6J9G0|Tyrosine-protein kinase STYK1 (2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1);3;3;7,3
Q9Y2Z0;Q9Y2Z0;Suppressor of G2 allele of SKP1 homolog;SUGT1;>SGT1_HUMAN|Q9Y2Z0|Protein SGT1 homolog  (Protein 40-6-3 ) (Sgt1 ) (Suppressor of G2 allele of SKP1 homolog );6;6;21,4
O00204;O00204;Sulfotransferase family cytosolic 2B member 1;SULT2B1;>ST2B1_HUMAN|O00204|Sulfotransferase family cytosolic 2B member 1 (ST2B1) (Sulfotransferase 2B1) (2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2);12;12;37,5
Q9UGT4;Q9UGT4;Sushi domain-containing protein 2;SUSD2;>SUSD2_HUMAN|Q9UGT4|Sushi domain-containing protein 2 (Precursor);12;12;26,2
Q8NHG7;Q8NHG7;Small VCP/p97-interacting protein;SVIP;>SVIP_HUMAN|Q8NHG7|Small VCP/p97-interacting protein;3;3;42,9
Q9UH65;Q9UH65;Switch-associated protein 70;SWAP70;>SWP70_HUMAN|Q9UH65|Switch-associated protein 70 (SWAP-70);6;6;10,6
Q96A49;Q96A49;Synapse-associated protein 1;SYAP1;>SYAP1_HUMAN|Q96A49|Synapse-associated protein 1;3;3;9,7
Q16563;Q16563;Synaptophysin-like protein 1;SYPL1;>SYPL1_HUMAN|Q16563|Synaptophysin-like protein 1 (Pantophysin);3;3;19,7
"P21579;Q8N9I0;O00445";P21579;Synaptotagmin-1;SYT1;>SYT1_HUMAN|P21579|Synaptotagmin-1 (Synaptotagmin I) (SytI) (p65);16;16;36
O43581;O43581;Synaptotagmin-7;SYT7;>SYT7_HUMAN|O43581|Synaptotagmin-7  (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);14;14;33
Q8IYJ3;Q8IYJ3;Synaptotagmin-like protein 1;SYTL1;>SYTL1_HUMAN|Q8IYJ3|Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1);23;22;49,8
Q9HCH5;Q9HCH5;Synaptotagmin-like protein 2;SYTL2;>SYTL2_HUMAN|Q9HCH5|Synaptotagmin-like protein 2 (Breast cancer-associated antigen SGA-72M) (Exophilin-4);9;9;14,9
Q4VX76;Q4VX76;Synaptotagmin-like protein 3;SYTL3;>SYTL3_HUMAN|Q4VX76|Synaptotagmin-like protein 3 (Exophilin-6);8;8;14,6
Q96C24;Q96C24;Synaptotagmin-like protein 4;SYTL4;>SYTL4_HUMAN|Q96C24|Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin);29;29;46,9
O95359;O95359;Transforming acidic coiled-coil-containing protein 2;TACC2;>TACC2_HUMAN|O95359|Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1);51;49;24,8
P09758;P09758;Tumor-associated calcium signal transducer 2;TACSTD2;>TACD2_HUMAN|P09758|Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1) (Precursor);2;2;9,9
"P37802;Q9UI15";P37802;Transgelin-2;TAGLN2;>TAGL2_HUMAN|P37802|Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog);10;10;58,8
P37837;P37837;Transaldolase;TALDO1;>TALDO_HUMAN|P37837|Transaldolase (2.2.1.2);9;9;27,9
Q7L7X3;Q7L7X3;Serine/threonine-protein kinase TAO1;TAOK1;>TAOK1_HUMAN|Q7L7X3|Serine/threonine-protein kinase TAO1 (2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino aci;18;14;21,8
Q9H2K8;Q9H2K8;Serine/threonine-protein kinase TAO3;TAOK3;>TAOK3_HUMAN|Q9H2K8|Serine/threonine-protein kinase TAO3 (2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinas;18;16;21,9
"P26639;A2RTX5";P26639;Threonine--tRNA ligase, cytoplasmic;TARS;>SYTC_HUMAN|P26639|Threonine--tRNA  ligase,  cytoplasmic (6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS);16;16;27,7
Q9BXI6;Q9BXI6;TBC1 domain family member 10A;TBC1D10A;>TB10A_HUMAN|Q9BXI6|TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha);8;8;18,1
Q9NVG8;Q9NVG8;TBC1 domain family member 13;TBC1D13;>TBC13_HUMAN|Q9NVG8|TBC1 domain family member 13;3;3;7,5
Q8TC07;Q8TC07;TBC1 domain family member 15;TBC1D15;>TBC15_HUMAN|Q8TC07|TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP);6;6;9,7
Q9ULP9;Q9ULP9;TBC1 domain family member 24;TBC1D24;>TBC24_HUMAN|Q9ULP9|TBC1 domain family member 24;5;5;10,9
"O60343;Q86TI0";O60343;TBC1 domain family member 4;TBC1D4;>TBCD4_HUMAN|O60343|TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160);14;14;13,7
"Q66K14;Q6ZT07";Q66K14;TBC1 domain family member 9B;TBC1D9B;>TBC9B_HUMAN|Q66K14|TBC1 domain family member 9B;4;4;3,1
O75347;O75347;Tubulin-specific chaperone A;TBCA;>TBCA_HUMAN|O75347|Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA);8;8;54,6
Q99426;Q99426;Tubulin-folding cofactor B;TBCB;>TBCB_HUMAN|Q99426|Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B);3;3;15,6
Q9BTW9;Q9BTW9;Tubulin-specific chaperone D;TBCD;>TBCD_HUMAN|Q9BTW9|Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D);6;6;6,1
Q8N9U0;Q8N9U0;Tandem C2 domains nuclear protein;TC2N;>TAC2N_HUMAN|Q8N9U0|Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus) (Tac2-N);21;21;48
Q15369;Q15369;Transcription elongation factor B polypeptide 1;TCEB1;>ELOC_HUMAN|Q15369|Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1);5;5;58
Q15370;Q15370;Transcription elongation factor B polypeptide 2;TCEB2;>ELOB_HUMAN|Q15370|Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2);6;6;41,5
P17987;P17987;T-complex protein 1 subunit alpha;TCP1;>TCPA_HUMAN|P17987|T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha);16;16;32,4
Q7Z6L1;Q7Z6L1;Tectonin beta-propeller repeat-containing protein 1;TECPR1;>TCPR1_HUMAN|Q7Z6L1|Tectonin beta-propeller repeat-containing protein 1;14;14;17,7
Q9UGI8;Q9UGI8;Testin;TES;>TES_HUMAN|Q9UGI8|Testin (TESS);4;4;10,7
P02787;P02787;Serotransferrin;TF;>TRFE_HUMAN|P02787|Serotransferrin (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin) (Precursor);9;9;17,5
Q92734;Q92734;Protein TFG;TFG;>TFG_HUMAN|Q92734|Protein TFG (TRK-fused gene protein);6;6;24,2
Q03167;Q03167;Transforming growth factor beta receptor type 3;TGFBR3;>TGBR3_HUMAN|Q03167|Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III) (Precursor);7;7;10,8
"P21980;O43548";P21980;Protein-glutamine gamma-glutamyltransferase 2;TGM2;>TGM2_HUMAN|P21980|Protein-glutamine gamma-glutamyltransferase 2 (2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2);18;17;31
P49221;P49221;Protein-glutamine gamma-glutamyltransferase 4;TGM4;>TGM4_HUMAN|P49221|Protein-glutamine gamma-glutamyltransferase 4 (2.3.2.13) (Fibrinoligase) (Prostate transglutaminase) (Prostate-specific transglutaminase) (Transglutaminase P) (TG(P)) (TGP) (TGase P) (Transglutaminase-4) (TGase-4);44;43;63,7
P52888;P52888;Thimet oligopeptidase;THOP1;>THOP1_HUMAN|P52888|Thimet oligopeptidase (3.4.24.15) (Endopeptidase 24.15) (MP78);5;5;9,7
P04216;P04216;Thy-1 membrane glycoprotein;THY1;>THY1_HUMAN|P04216|Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD90) (Precursor);4;4;24,8
P01033;P01033;Metalloproteinase inhibitor 1;TIMP1;>TIMP1_HUMAN|P01033|Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1) (Precursor);5;5;34,3
O75663;O75663;TIP41-like protein;TIPRL;>TIPRL_HUMAN|O75663|TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP);4;4;15,1
Q9UDY2;Q9UDY2;Tight junction protein ZO-2;TJP2;>ZO2_HUMAN|Q9UDY2|Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2);6;6;5
P29401;P29401;Transketolase;TKT;>TKT_HUMAN|P29401|Transketolase (TK) (2.2.1.1 );17;17;33,2
Q6P9B6;Q6P9B6;TLD domain-containing protein 1;TLDC1;>TLDC1_HUMAN|Q6P9B6|TLD domain-containing protein 1 (TBC/LysM-associated domain-containing protein 1);6;6;23,2
"Q9Y490;Q9Y4G6";Q9Y490;Talin-1;TLN1;>TLN1_HUMAN|Q9Y490|Talin-1;53;53;27,1
Q9NS93;Q9NS93;Transmembrane 7 superfamily member 3;TM7SF3;>TM7S3_HUMAN|Q9NS93|Transmembrane 7 superfamily member 3 (Seven span transmembrane protein) (Precursor);3;3;6
Q969X1;Q969X1;Protein lifeguard 3;TMBIM1;>LFG3_HUMAN|Q969X1|Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1);5;5;10,9
Q7Z404;Q7Z404;Transmembrane channel-like protein 4;TMC4;>TMC4_HUMAN|Q7Z404|Transmembrane channel-like protein 4;11;11;16,4
Q6UXY8;Q6UXY8;Transmembrane channel-like protein 5;TMC5;>TMC5_HUMAN|Q6UXY8|Transmembrane channel-like protein 5;19;19;23,2
Q5TGY1;Q5TGY1;Transmembrane and coiled-coil domain-containing protein 4;TMCO4;>TMCO4_HUMAN|Q5TGY1|Transmembrane and coiled-coil domain-containing protein 4;2;2;5,8
Q15363;Q15363;Transmembrane emp24 domain-containing protein 2;TMED2;>TMED2_HUMAN|Q15363|Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1) (Precursor);1;1;6
Q9Y3B3;Q9Y3B3;Transmembrane emp24 domain-containing protein 7;TMED7;>TMED7_HUMAN|Q9Y3B3|Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27) (Precursor);3;3;15,6
Q8IY95;Q8IY95;Transmembrane protein 192;TMEM192;>TM192_HUMAN|Q8IY95|Transmembrane protein 192;7;7;23,2
Q9HBJ8;Q9HBJ8;Collectrin;TMEM27;>TMM27_HUMAN|Q9HBJ8|Collectrin (Transmembrane protein 27) (Precursor);4;4;19,8
Q9NV96;Q9NV96;Cell cycle control protein 50A;TMEM30A;>CC50A_HUMAN|Q9NV96|Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A);11;9;28
Q3MIR4;Q3MIR4;Cell cycle control protein 50B;TMEM30B;>CC50B_HUMAN|Q3MIR4|Cell cycle control protein 50B (P4-ATPase flippase complex beta subunit TMEM30B) (Transmembrane protein 30B);5;3;13,7
Q4KMG9;Q4KMG9;Transmembrane protein 52B;TMEM52B;>TM52B_HUMAN|Q4KMG9|Transmembrane protein 52B (Precursor);2;2;9,8
O94886;O94886;CSC1-like protein 1;TMEM63A;>CSCL1_HUMAN|O94886|CSC1-like protein 1 (Transmembrane protein 63A);11;11;13,8
Q9HCN3;Q9HCN3;Transmembrane protein 8A;TMEM8A;>TMM8A_HUMAN|Q9HCN3|Transmembrane protein 8A (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Precursor);6;6;10
"Q9NYL9;Q9NZR1";Q9NYL9;Tropomodulin-3;TMOD3;>TMOD3_HUMAN|Q9NYL9|Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod);4;4;13,9
O15393;O15393;"Transmembrane protease serine 2;Transmembrane protease serine 2 non-catalytic chain;Transmembrane protease serine 2 catalytic chain";TMPRSS2;>TMPS2_HUMAN|O15393|Transmembrane protease serine 2 (3.4.21.-) (Serine protease 10) (Transmembrane protease serine 2 non-catalytic chain) (Transmembrane protease serine 2 catalytic chain) (Precursor);12;12;28,3
P62328;P62328;"Thymosin beta-4;Hematopoietic system regulatory peptide";TMSB4X;>TYB4_HUMAN|P62328|Thymosin beta-4 (T beta-4) (Fx) (Hematopoietic system regulatory peptide) (Seraspenide);4;4;75
Q92973;Q92973;Transportin-1;TNPO1;>TNPO1_HUMAN|Q92973|Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP);6;5;7,7
Q9H0E2;Q9H0E2;Toll-interacting protein;TOLLIP;>TOLIP_HUMAN|Q9H0E2|Toll-interacting protein;12;12;45,6
O60784;O60784;Target of Myb protein 1;TOM1;>TOM1_HUMAN|O60784|Target of Myb protein 1;13;13;36
O75674;O75674;TOM1-like protein 1;TOM1L1;>TM1L1_HUMAN|O75674|TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1);6;6;18,5
Q6ZVM7;Q6ZVM7;TOM1-like protein 2;TOM1L2;>TM1L2_HUMAN|Q6ZVM7|TOM1-like protein 2 (Target of Myb-like protein 2);17;17;36,7
Q53FA7;Q53FA7;Quinone oxidoreductase PIG3;TP53I3;>QORX_HUMAN|Q53FA7|Quinone oxidoreductase PIG3 (1.-.-.-) (Tumor protein p53-inducible protein 3) (p53-induced gene 3 protein);3;3;10,5
P55327;P55327;Tumor protein D52;TPD52;>TPD52_HUMAN|P55327|Tumor protein D52 (Protein N8);7;7;56,2
Q16890;Q16890;Tumor protein D53;TPD52L1;>TPD53_HUMAN|Q16890|Tumor protein D53 (hD53) (Tumor protein D52-like 1);3;3;18,1
O43399;O43399;Tumor protein D54;TPD52L2;>TPD54_HUMAN|O43399|Tumor protein D54 (hD54) (Tumor protein D52-like 2);3;3;19,4
P60174;P60174;Triosephosphate isomerase;TPI1;>TPIS_HUMAN|P60174|Triosephosphate isomerase (TIM) (5.3.1.1) (Triose-phosphate isomerase);20;20;79
"P67936;P09493;Q2TAC2";P67936;Tropomyosin alpha-4 chain;TPM4;>TPM4_HUMAN|P67936|Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4);12;4;32,7
P51580;P51580;Thiopurine S-methyltransferase;TPMT;>TPMT_HUMAN|P51580|Thiopurine S-methyltransferase (2.1.1.67) (Thiopurine methyltransferase);8;8;31
O14773;O14773;Tripeptidyl-peptidase 1;TPP1;>TPP1_HUMAN|O14773|Tripeptidyl-peptidase 1 (TPP-1) (3.4.14.9) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) (Precursor);4;4;9,4
Q9BW30;Q9BW30;Tubulin polymerization-promoting protein family member 3;TPPP3;>TPPP3_HUMAN|Q9BW30|Tubulin polymerization-promoting protein family member 3 (TPPP/p20);3;3;29,5
"P13693;Q56UQ5;Q9HAU6";P13693;Translationally-controlled tumor protein;TPT1;>TCTP_HUMAN|P13693|Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23);7;7;44,8
O43617;O43617;Trafficking protein particle complex subunit 3;TRAPPC3;>TPPC3_HUMAN|O43617|Trafficking protein particle complex subunit 3 (BET3 homolog);3;3;16,1
O43280;O43280;Trehalase;TREH;>TREA_HUMAN|O43280|Trehalase (3.2.1.28)  (Alpha,alpha-trehalase)   (Alpha,alpha-trehalose  glucohydrolase) (Precursor);9;9;19,4
Q14258;Q14258;E3 ubiquitin/ISG15 ligase TRIM25;TRIM25;>TRI25_HUMAN|Q14258|E3 ubiquitin/ISG15 ligase TRIM25 (6.3.2.n3 ) (Estrogen-responsive finger protein) (RING finger protein 147) (RING-type E3 ubiquitin transferase) (2.3.2.27 ) (RING-type E3 ubiquitin transferase TRIM25 ) (Tripartite motif-containing prote;7;7;14,9
Q96LD4;Q96LD4;Tripartite motif-containing protein 47;TRIM47;>TRI47_HUMAN|Q96LD4|Tripartite motif-containing protein 47 (Gene overexpressed in astrocytoma protein) (RING finger protein 100);13;13;24,8
Q9UI30;Q9UI30;Multifunctional methyltransferase subunit TRM112-like protein;TRMT112;>TR112_HUMAN|Q9UI30|Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog);2;2;20,8
P10155;P10155;60 kDa SS-A/Ro ribonucleoprotein;TROVE2;>RO60_HUMAN|P10155|60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2);4;4;8,7
Q7Z2W7;Q7Z2W7;Transient receptor potential cation channel subfamily M member 8;TRPM8;>TRPM8_HUMAN|Q7Z2W7|Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8);7;7;8,2
Q9NQA5;Q9NQA5;Transient receptor potential cation channel subfamily V member 5;TRPV5;>TRPV5_HUMAN|Q9NQA5|Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3);16;13;23,3
P49815;P49815;Tuberin;TSC2;>TSC2_HUMAN|P49815|Tuberin (Tuberous sclerosis 2 protein);3;3;2
Q99816;Q99816;Tumor susceptibility gene 101 protein;TSG101;>TS101_HUMAN|Q99816|Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101);25;25;46,4
Q15631;Q15631;Translin;TSN;>TSN_HUMAN|Q15631|Translin (3.1.-.-) (Component 3 of promoter of RISC) (C3PO);4;4;20,6
O60635;O60635;Tetraspanin-1;TSPAN1;>TSN1_HUMAN|O60635|Tetraspanin-1 (Tspan-1) (Tetraspan NET-1) (Tetraspanin TM4-C);4;4;22,8
Q8NG11;Q8NG11;Tetraspanin-14;TSPAN14;>TSN14_HUMAN|Q8NG11|Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14);3;3;15,9
O14817;O14817;Tetraspanin-4;TSPAN4;>TSN4_HUMAN|O14817|Tetraspanin-4 (Tspan-4) (Novel antigen 2) (NAG-2) (Transmembrane 4 superfamily member 7);3;3;6,7
O43657;O43657;Tetraspanin-6;TSPAN6;>TSN6_HUMAN|O43657|Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6);9;9;27,3
P19075;P19075;Tetraspanin-8;TSPAN8;>TSN8_HUMAN|P19075|Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029);5;5;21,1
O75954;O75954;Tetraspanin-9;TSPAN9;>TSN9_HUMAN|O75954|Tetraspanin-9 (Tspan-9) (Tetraspan NET-5);3;3;20,1
Q13630;Q13630;GDP-L-fucose synthase;TSTA3;>FCL_HUMAN|Q13630|GDP-L-fucose synthase (1.1.1.271)  (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase)  (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1);11;11;38,6
Q8NFU3;Q8NFU3;Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1;TSTD1;>TSTD1_HUMAN|Q8NFU3|Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1;8;8;54,8
Q6PGP7;Q6PGP7;Tetratricopeptide repeat protein 37;TTC37;>TTC37_HUMAN|Q6PGP7|Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (SKI3 homolog) (Ski3) (Tricho-hepatic-enteric syndrome protein) (Thespin);12;12;9,5
Q5R3I4;Q5R3I4;Tetratricopeptide repeat protein 38;TTC38;>TTC38_HUMAN|Q5R3I4|Tetratricopeptide repeat protein 38 (TPR repeat protein 38);9;9;23,2
Q5SRH9;Q5SRH9;Tetratricopeptide repeat protein 39A;TTC39A;>TT39A_HUMAN|Q5SRH9|Tetratricopeptide repeat protein 39A (TPR repeat protein 39A) (Differentially expressed in MCF7 with estradiol protein 6) (DEME-6);7;7;14,8
Q86TV6;Q86TV6;Tetratricopeptide repeat protein 7B;TTC7B;>TTC7B_HUMAN|Q86TV6|Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1);3;3;4
Q14166;Q14166;Tubulin--tyrosine ligase-like protein 12;TTLL12;>TTL12_HUMAN|Q14166|Tubulin--tyrosine ligase-like protein 12;14;14;33,2
Q9C0H2;Q9C0H2;Protein tweety homolog 3;TTYH3;>TTYH3_HUMAN|Q9C0H2|Protein tweety homolog 3 (hTTY3);9;9;18
"Q71U36;Q13748;Q6PEY2;Q9NY65";"Q71U36;Q13748;Q6PEY2";"Tubulin alpha-1A chain;Tubulin alpha-3C/D chain;Tubulin alpha-3E chain";TUBA1A;">TBA1A_HUMAN|Q71U36|Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) (Detyrosinated tubulin alpha-1A chain);>TBA3C_HUMAN|Q13748|Tubulin alpha-3C/D chain (Alpha-tubulin 2) (Alpha-tubulin 3C/D) (Tubulin alpha-2 chain) (Det";20;0;48,1
"P68363;A6NHL2";P68363;Tubulin alpha-1B chain;TUBA1B;>TBA1B_HUMAN|P68363|Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) (Detyrosinated tubulin alpha-1B chain);20;0;48,1
P68366;P68366;Tubulin alpha-4A chain;TUBA4A;>TBA4A_HUMAN|P68366|Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain);20;4;48,4
P07437;P07437;Tubulin beta chain;TUBB;>TBB5_HUMAN|P07437|Tubulin beta chain (Tubulin beta-5 chain);20;3;58,1
"Q13885;Q9BVA1;Q9BUF5";"Q13885;Q9BVA1";"Tubulin beta-2A chain;Tubulin beta-2B chain";TUBB2A;">TBB2A_HUMAN|Q13885|Tubulin beta-2A chain (Tubulin beta class IIa);>TBB2B_HUMAN|Q9BVA1|Tubulin beta-2B chain";19;3;50,3
"P68371;P04350;A6NNZ2;CON__ENSEMBL:ENSBTAP00000025008;Q9H4B7";"P68371;P04350";"Tubulin beta-4B chain;Tubulin beta-4A chain";TUBB4B;">TBB4B_HUMAN|P68371|Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain);>TBB4A_HUMAN|P04350|Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)";24;4;66,1
Q12792;Q12792;Twinfilin-1;TWF1;>TWF1_HUMAN|Q12792|Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9);12;9;34,3
Q6IBS0;Q6IBS0;Twinfilin-2;TWF2;>TWF2_HUMAN|Q6IBS0|Twinfilin-2 (A6-related protein) (hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein);11;8;38,4
P10599;P10599;Thioredoxin;TXN;>THIO_HUMAN|P10599|Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP);7;7;51,4
Q9BRA2;Q9BRA2;Thioredoxin domain-containing protein 17;TXNDC17;>TXD17_HUMAN|Q9BRA2|Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5);5;5;44,7
O43396;O43396;Thioredoxin-like protein 1;TXNL1;>TXNL1_HUMAN|O43396|Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein);10;10;39,4
Q16881;Q16881;Thioredoxin reductase 1, cytoplasmic;TXNRD1;>TRXR1_HUMAN|Q16881|Thioredoxin reductase  1,  cytoplasmic (TR) (1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-l;5;5;8,6
Q06418;Q06418;Tyrosine-protein kinase receptor TYRO3;TYRO3;>TYRO3_HUMAN|Q06418|Tyrosine-protein kinase receptor TYRO3 (2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) (Precursor);4;4;7,1
Q16222;Q16222;"UDP-N-acetylhexosamine pyrophosphorylase;UDP-N-acetylgalactosamine pyrophosphorylase;UDP-N-acetylglucosamine pyrophosphorylase";UAP1;>UAP1_HUMAN|Q16222|UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) (UDP-N-acetylgalactosamine pyrophosphorylase) (2.7.7.83) (AGX-1) (UDP-N-acetylglucosamine pyrophosphorylase) (2.7.7.23) (AGX-2);9;7;21,6
Q3KQV9;Q3KQV9;UDP-N-acetylhexosamine pyrophosphorylase-like protein 1;UAP1L1;>UAP1L_HUMAN|Q3KQV9|UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (2.7.7.-);6;4;12,8
P22314;P22314;Ubiquitin-like modifier-activating enzyme 1;UBA1;>UBA1_HUMAN|P22314|Ubiquitin-like modifier-activating enzyme 1 (6.2.1.45 ) (Protein A1S9) (Ubiquitin-activating enzyme E1);33;33;38,5
Q9GZZ9;Q9GZZ9;Ubiquitin-like modifier-activating enzyme 5;UBA5;>UBA5_HUMAN|Q9GZZ9|Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1);5;5;16,6
"P62987;P62979;P0CG47;P0CG48";"P62987;P62979;P0CG47;P0CG48";"Ubiquitin-60S ribosomal protein L40;Ubiquitin;60S ribosomal protein L40;Ubiquitin-40S ribosomal protein S27a;Ubiquitin;40S ribosomal protein S27a;Polyubiquitin-B;Ubiquitin;Polyubiquitin-C;Ubiquitin";UBA52;">RL40_HUMAN|P62987|Ubiquitin-60S ribosomal protein L40 (CEP52) (Ubiquitin A-52 residue ribosomal protein fusion product 1) (Ubiquitin) (60S ribosomal protein L40) (Large ribosomal subunit protein eL40 ) (Precursor);>RS27A_HUMAN|P62979|Ubiquitin-40S ribosom";11;11;51,6
A0AVT1;A0AVT1;Ubiquitin-like modifier-activating enzyme 6;UBA6;>UBA6_HUMAN|A0AVT1|Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (6.2.1.45 ) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2);20;20;21,6
P61086;P61086;Ubiquitin-conjugating enzyme E2 K;UBE2K;>UBE2K_HUMAN|P61086|Ubiquitin-conjugating enzyme E2 K (2.3.2.23 ) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ub;5;5;27
P68036;P68036;Ubiquitin-conjugating enzyme E2 L3;UBE2L3;>UB2L3_HUMAN|P68036|Ubiquitin-conjugating enzyme E2 L3 (2.3.2.23 ) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3);4;4;33,1
P61081;P61081;NEDD8-conjugating enzyme Ubc12;UBE2M;>UBC12_HUMAN|P61081|NEDD8-conjugating enzyme Ubc12 (6.3.2.-) (NEDD8 carrier protein) (NEDD8 protein ligase) (Ubiquitin-conjugating enzyme E2 M);5;5;25,7
"P61088;Q5JXB2";"P61088;Q5JXB2";"Ubiquitin-conjugating enzyme E2 N;Putative ubiquitin-conjugating enzyme E2 N-like";UBE2N;">UBE2N_HUMAN|P61088|Ubiquitin-conjugating enzyme E2 N (2.3.2.23 ) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N);>UE2NL_HUMAN|Q5JXB2|Putative ubiq";7;7;40,1
Q13404;Q13404;Ubiquitin-conjugating enzyme E2 variant 1;UBE2V1;>UB2V1_HUMAN|Q13404|Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A);9;4;53,7
Q15819;Q15819;Ubiquitin-conjugating enzyme E2 variant 2;UBE2V2;>UB2V2_HUMAN|Q15819|Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein);8;3;50,3
Q9H832;Q9H832;Ubiquitin-conjugating enzyme E2 Z;UBE2Z;>UBE2Z_HUMAN|Q9H832|Ubiquitin-conjugating enzyme E2 Z (2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z);2;2;5,1
O95164;O95164;Ubiquitin-like protein 3;UBL3;>UBL3_HUMAN|O95164|Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1) (Precursor);4;4;36,8
"Q9UHD9;Q9UMX0";"Q9UHD9;Q9UMX0";"Ubiquilin-2;Ubiquilin-1";UBQLN2;">UBQL2_HUMAN|Q9UHD9|Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2);>UBQL1_HUMAN|Q9UMX0|Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1)";3;3;7,7
Q9HAC8;Q9HAC8;Ubiquitin domain-containing protein 1;UBTD1;>UBTD1_HUMAN|Q9HAC8|Ubiquitin domain-containing protein 1;9;5;31,7
Q8WUN7;Q8WUN7;Ubiquitin domain-containing protein 2;UBTD2;>UBTD2_HUMAN|Q8WUN7|Ubiquitin domain-containing protein 2 (Dendritic cell-derived ubiquitin-like protein) (DC-UbP) (Ubiquitin-like protein SB72);6;2;23,5
Q9BZV1;Q9BZV1;UBX domain-containing protein 6;UBXN6;>UBXN6_HUMAN|Q9BZV1|UBX domain-containing protein 6 (UBX domain-containing protein 1);7;7;24,5
P09936;P09936;Ubiquitin carboxyl-terminal hydrolase isozyme L1;UCHL1;>UCHL1_HUMAN|P09936|Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (3.4.19.12) (6.-.-.-) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1) (Precursor);7;7;43
P15374;P15374;Ubiquitin carboxyl-terminal hydrolase isozyme L3;UCHL3;>UCHL3_HUMAN|P15374|Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (3.4.19.12) (Ubiquitin thioesterase L3);7;7;40,9
Q9Y5K5;Q9Y5K5;Ubiquitin carboxyl-terminal hydrolase isozyme L5;UCHL5;>UCHL5_HUMAN|Q9Y5K5|Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5);3;3;11,6
Q8IX04;Q8IX04;Ubiquitin-conjugating enzyme E2 variant 3;UEVLD;>UEVLD_HUMAN|Q8IX04|Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein);20;20;44,6
O60701;O60701;UDP-glucose 6-dehydrogenase;UGDH;>UGDH_HUMAN|O60701|UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (1.1.1.22);22;22;49,6
Q16851;Q16851;UTP--glucose-1-phosphate uridylyltransferase;UGP2;>UGPA_HUMAN|Q16851|UTP--glucose-1-phosphate uridylyltransferase (2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase);17;17;35
Q6PHR2;Q6PHR2;Serine/threonine-protein kinase ULK3;ULK3;>ULK3_HUMAN|Q6PHR2|Serine/threonine-protein kinase ULK3 (2.7.11.1) (Unc-51-like kinase 3);12;12;28,8
P07911;P07911;"Uromodulin;Uromodulin, secreted form";UMOD;>UROM_HUMAN|P07911|Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP)  (Uromodulin,  secreted form) (Precursor);24;24;36,2
P11172;P11172;"Uridine 5-monophosphate synthase;Orotate phosphoribosyltransferase;Orotidine 5-phosphate decarboxylase";UMPS;>UMPS_HUMAN|P11172|Uridine 5-monophosphate synthase (UMP synthase) (Orotate phosphoribosyltransferase) (OPRT) (OPRTase) (2.4.2.10) (Orotidine 5-phosphate decarboxylase) (ODC) (4.1.1.23) (OMPdecase);4;4;9,8
"O14795;Q8NB66";O14795;Protein unc-13 homolog B;UNC13B;>UN13B_HUMAN|O14795|Protein unc-13 homolog B (Munc13-2) (munc13);34;28;26,4
Q9H3U1;Q9H3U1;Protein unc-45 homolog A;UNC45A;>UN45A_HUMAN|Q9H3U1|Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1);6;6;7,7
Q92900;Q92900;Regulator of nonsense transcripts 1;UPF1;>RENT1_HUMAN|Q92900|Regulator of nonsense transcripts 1 (3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1);5;5;5
O00322;O00322;Uroplakin-1a;UPK1A;>UPK1A_HUMAN|O00322|Uroplakin-1a (UP1a) (Tetraspanin-21) (Tspan-21) (Uroplakin Ia) (UPIa) (UPKa);8;8;34,9
O75841;O75841;Uroplakin-1b;UPK1B;>UPK1B_HUMAN|O75841|Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb);4;4;26,9
O00526;O00526;Uroplakin-2;UPK2;>UPK2_HUMAN|O00526|Uroplakin-2 (UP2) (Uroplakin II) (UPII) (Precursor);7;7;38,6
O75631;O75631;Uroplakin-3a;UPK3A;>UPK3A_HUMAN|O75631|Uroplakin-3a (UP3a) (Uroplakin III) (UPIII) (Precursor);4;4;14,6
P06132;P06132;Uroporphyrinogen decarboxylase;UROD;>DCUP_HUMAN|P06132|Uroporphyrinogen decarboxylase (UPD) (URO-D) (4.1.1.37);5;5;15,8
O60763;O60763;General vesicular transport factor p115;USO1;>USO1_HUMAN|O60763|General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein);7;7;8,1
P54578;P54578;Ubiquitin carboxyl-terminal hydrolase 14;USP14;>UBP14_HUMAN|P54578|Ubiquitin carboxyl-terminal hydrolase 14 (3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14);18;18;41,3
Q96K76;Q96K76;Ubiquitin carboxyl-terminal hydrolase 47;USP47;>UBP47_HUMAN|Q96K76|Ubiquitin carboxyl-terminal hydrolase 47 (3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47);7;7;6,4
P45974;P45974;Ubiquitin carboxyl-terminal hydrolase 5;USP5;>UBP5_HUMAN|P45974|Ubiquitin carboxyl-terminal hydrolase 5 (3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5);23;23;30,4
"Q93008;O00507";Q93008;Probable ubiquitin carboxyl-terminal hydrolase FAF-X;USP9X;>USP9X_HUMAN|Q93008|Probable ubiquitin carboxyl-terminal hydrolase FAF-X (3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets  protein-related,  X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease  9,  X ;11;11;4,7
Q08AM6;Q08AM6;Protein VAC14 homolog;VAC14;>VAC14_HUMAN|Q08AM6|Protein VAC14 homolog (Tax1-binding protein 2);7;7;10,6
"P63027;P23763";P63027;Vesicle-associated membrane protein 2;VAMP2;>VAMP2_HUMAN|P63027|Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2);6;3;60,3
Q15836;Q15836;Vesicle-associated membrane protein 3;VAMP3;>VAMP3_HUMAN|Q15836|Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3);6;3;53
O95183;O95183;Vesicle-associated membrane protein 5;VAMP5;>VAMP5_HUMAN|O95183|Vesicle-associated membrane protein 5 (VAMP-5) (Myobrevin);4;4;34,5
Q9BV40;Q9BV40;Vesicle-associated membrane protein 8;VAMP8;>VAMP8_HUMAN|Q9BV40|Vesicle-associated membrane protein 8  (VAMP-8 ) (Endobrevin ) (EDB );5;5;51
P26640;P26640;Valine--tRNA ligase;VARS;>SYVC_HUMAN|P26640|Valine--tRNA ligase (6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS);3;3;3,2
Q6EMK4;Q6EMK4;Vasorin;VASN;>VASN_HUMAN|Q6EMK4|Vasorin (Protein slit-like 2) (Precursor);10;10;16,6
P50552;P50552;Vasodilator-stimulated phosphoprotein;VASP;>VASP_HUMAN|P50552|Vasodilator-stimulated phosphoprotein (VASP);9;9;32,6
Q99536;Q99536;Synaptic vesicle membrane protein VAT-1 homolog;VAT1;>VAT1_HUMAN|Q99536|Synaptic vesicle membrane protein VAT-1 homolog (1.-.-.-);18;18;54,2
P52735;P52735;Guanine nucleotide exchange factor VAV2;VAV2;>VAV2_HUMAN|P52735|Guanine nucleotide exchange factor VAV2 (VAV-2);2;2;2,3
Q9UKW4;Q9UKW4;Guanine nucleotide exchange factor VAV3;VAV3;>VAV3_HUMAN|Q9UKW4|Guanine nucleotide exchange factor VAV3 (VAV-3);4;4;4,4
P18206;P18206;Vinculin;VCL;>VINC_HUMAN|P18206|Vinculin (Metavinculin) (MV);31;31;32,2
P55072;P55072;Transitional endoplasmic reticulum ATPase;VCP;>TERA_HUMAN|P55072|Transitional endoplasmic reticulum ATPase (TER ATPase) (3.6.4.6 ) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP);40;40;48,5
P21796;P21796;Voltage-dependent anion-selective channel protein 1;VDAC1;>VDAC1_HUMAN|P21796|Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM);4;4;21,9
P09327;P09327;Villin-1;VIL1;>VILI_HUMAN|P09327|Villin-1;7;7;10,5
O15195;O15195;Villin-like protein;VILL;>VILL_HUMAN|O15195|Villin-like protein;4;4;5,1
Q7Z5L0;Q7Z5L0;Vitelline membrane outer layer protein 1 homolog;VMO1;>VMO1_HUMAN|Q7Z5L0|Vitelline membrane outer layer protein 1 homolog (Precursor);2;2;14,4
"O95497;Q9NY84";O95497;Pantetheinase;VNN1;>VNN1_HUMAN|O95497|Pantetheinase (3.5.1.92  ) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1) (Precursor);5;5;14,6
Q709C8;Q709C8;Vacuolar protein sorting-associated protein 13C;VPS13C;>VP13C_HUMAN|Q709C8|Vacuolar protein sorting-associated protein 13C;10;10;2,7
Q9BRG1;Q9BRG1;Vacuolar protein-sorting-associated protein 25;VPS25;>VPS25_HUMAN|Q9BRG1|Vacuolar protein-sorting-associated protein 25 (hVps25) (Dermal papilla-derived protein 9) (ELL-associated protein of 20 kDa) (ESCRT-II complex subunit VPS25);10;10;59,7
O75436;O75436;Vacuolar protein sorting-associated protein 26A;VPS26A;>VP26A_HUMAN|O75436|Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26);8;7;26,9
Q9UK41;Q9UK41;Vacuolar protein sorting-associated protein 28 homolog;VPS28;>VPS28_HUMAN|Q9UK41|Vacuolar protein sorting-associated protein 28 homolog (H-Vps28) (ESCRT-I complex subunit VPS28);16;16;62,9
Q9UBQ0;Q9UBQ0;Vacuolar protein sorting-associated protein 29;VPS29;>VPS29_HUMAN|Q9UBQ0|Vacuolar protein sorting-associated protein 29 (hVPS29) (PEP11 homolog) (Vesicle protein sorting 29);4;4;24,2
Q96QK1;Q96QK1;Vacuolar protein sorting-associated protein 35;VPS35;>VPS35_HUMAN|Q96QK1|Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35);20;20;29,6
Q86VN1;Q86VN1;Vacuolar protein-sorting-associated protein 36;VPS36;>VPS36_HUMAN|Q86VN1|Vacuolar protein-sorting-associated protein 36 (ELL-associated protein of 45 kDa) (ESCRT-II complex subunit VPS36);19;19;56
Q8NEZ2;Q8NEZ2;Vacuolar protein sorting-associated protein 37A;VPS37A;>VP37A_HUMAN|Q8NEZ2|Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1);5;5;19,1
Q9H9H4;Q9H9H4;Vacuolar protein sorting-associated protein 37B;VPS37B;>VP37B_HUMAN|Q9H9H4|Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B);9;9;42,1
A5D8V6;A5D8V6;Vacuolar protein sorting-associated protein 37C;VPS37C;>VP37C_HUMAN|A5D8V6|Vacuolar protein sorting-associated protein 37C (hVps37C) (ESCRT-I complex subunit VPS37C);8;8;26,8
Q86XT2;Q86XT2;Vacuolar protein sorting-associated protein 37D;VPS37D;>VP37D_HUMAN|Q86XT2|Vacuolar protein sorting-associated protein 37D (ESCRT-I complex subunit VPS37D) (Williams-Beuren syndrome chromosomal region 24 protein);13;13;53
"Q9UN37;Q6PIW4";Q9UN37;Vacuolar protein sorting-associated protein 4A;VPS4A;>VPS4A_HUMAN|Q9UN37|Vacuolar protein sorting-associated protein 4A (3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4);30;21;59,7
O75351;O75351;Vacuolar protein sorting-associated protein 4B;VPS4B;>VPS4B_HUMAN|O75351|Vacuolar protein sorting-associated protein 4B (3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1);28;19;53,6
Q9UID3;Q9UID3;Vacuolar protein sorting-associated protein 51 homolog;VPS51;>VPS51_HUMAN|Q9UID3|Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog);3;3;5
Q9Y2B5;Q9Y2B5;VPS9 domain-containing protein 1;VPS9D1;>VP9D1_HUMAN|Q9Y2B5|VPS9 domain-containing protein 1 (Protein ATP-BL);10;10;22,8
Q9NP79;Q9NP79;Vacuolar protein sorting-associated protein VTA1 homolog;VTA1;>VTA1_HUMAN|Q9NP79|Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1);13;13;41
Q7Z7D3;Q7Z7D3;V-set domain-containing T-cell activation inhibitor 1;VTCN1;>VTCN1_HUMAN|Q7Z7D3|V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x) (Precursor);4;4;14,2
"P04004;CON__Q3ZBS7";P04004;"Vitronectin;Vitronectin V65 subunit;Vitronectin V10 subunit;Somatomedin-B";VTN;>VTNC_HUMAN|P04004|Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) (Vitronectin V65 subunit) (Vitronectin V10 subunit) (Somatomedin-B) (Precursor);6;6;15,7
P23381;P23381;"Tryptophan--tRNA ligase, cytoplasmic;T1-TrpRS;T2-TrpRS";WARS;>SYWC_HUMAN|P23381|Tryptophan--tRNA  ligase,  cytoplasmic (6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) (T1-TrpRS) (T2-TrpRS);9;9;26,1
O00401;O00401;Neural Wiskott-Aldrich syndrome protein;WASL;>WASL_HUMAN|O00401|Neural Wiskott-Aldrich syndrome protein (N-WASP);7;7;20
Q969T9;Q969T9;WW domain-binding protein 2;WBP2;>WBP2_HUMAN|Q969T9|WW domain-binding protein 2 (WBP-2);6;6;24,1
Q8IWB7;Q8IWB7;WD repeat and FYVE domain-containing protein 1;WDFY1;>WDFY1_HUMAN|Q8IWB7|WD repeat and FYVE domain-containing protein 1 (FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17);6;6;19
O75083;O75083;WD repeat-containing protein 1;WDR1;>WDR1_HUMAN|O75083|WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1);27;27;60,7
Q9BZH6;Q9BZH6;WD repeat-containing protein 11;WDR11;>WDR11_HUMAN|Q9BZH6|WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15);4;4;3,8
Q9Y2I8;Q9Y2I8;WD repeat-containing protein 37;WDR37;>WDR37_HUMAN|Q9Y2I8|WD repeat-containing protein 37;2;2;4,7
Q9Y4E6;Q9Y4E6;WD repeat-containing protein 7;WDR7;>WDR7_HUMAN|Q9Y4E6|WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG);18;18;15,8
Q9BQA1;Q9BQA1;Methylosome protein 50;WDR77;>MEP50_HUMAN|Q9BQA1|Methylosome protein 50 (MEP-50) (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50);5;5;17,8
Q8TF74;Q8TF74;WAS/WASL-interacting protein family member 2;WIPF2;>WIPF2_HUMAN|Q8TF74|WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein);3;3;6,4
Q9H0M0;Q9H0M0;NEDD4-like E3 ubiquitin-protein ligase WWP1;WWP1;>WWP1_HUMAN|Q9H0M0|NEDD4-like E3 ubiquitin-protein ligase WWP1 (2.3.2.26) (Atrophin-1-interacting protein 5) (AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1) (Tiul1) (WW domain-containing protein 1);11;6;12,3
Q9NQW7;Q9NQW7;Xaa-Pro aminopeptidase 1;XPNPEP1;>XPP1_HUMAN|Q9NQW7|Xaa-Pro aminopeptidase 1 (3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase  1,  soluble);15;14;27,3
O43895;O43895;Xaa-Pro aminopeptidase 2;XPNPEP2;>XPP2_HUMAN|O43895|Xaa-Pro aminopeptidase 2 (3.4.11.9 ) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2) (Precursor);20;20;33,7
O14980;O14980;Exportin-1;XPO1;>XPO1_HUMAN|O14980|Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog);6;6;5,6
Q9UIA9;Q9UIA9;Exportin-7;XPO7;>XPO7_HUMAN|Q9UIA9|Exportin-7 (Exp7) (Ran-binding protein 16);7;7;8,1
P54577;P54577;"Tyrosine--tRNA ligase, cytoplasmic;Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed";YARS;>SYYC_HUMAN|P54577|Tyrosine--tRNA  ligase,  cytoplasmic (6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) (Tyrosine--tRNA  ligase,   cytoplasmic,  N-terminally processed);19;19;41,3
"P07947;P06241;P06239";P07947;Tyrosine-protein kinase Yes;YES1;>YES_HUMAN|P07947|Tyrosine-protein kinase Yes (2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes);20;13;41,8
O15498;O15498;Synaptobrevin homolog YKT6;YKT6;>YKT6_HUMAN|O15498|Synaptobrevin homolog YKT6 (2.3.1.-) (Precursor);9;9;54
P31946;P31946;"14-3-3 protein beta/alpha;14-3-3 protein beta/alpha, N-terminally processed";YWHAB;>1433B_HUMAN|P31946|14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) (14-3-3 protein  beta/alpha,  N-terminally processed);14;7;57,3
P62258;P62258;14-3-3 protein epsilon;YWHAE;>1433E_HUMAN|P62258|14-3-3 protein epsilon (14-3-3E);24;21;77,6
P61981;P61981;"14-3-3 protein gamma;14-3-3 protein gamma, N-terminally processed";YWHAG;>1433G_HUMAN|P61981|14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) (14-3-3 protein  gamma,  N-terminally processed);15;10;59,1
Q04917;Q04917;14-3-3 protein eta;YWHAH;>1433F_HUMAN|Q04917|14-3-3 protein eta (Protein AS1);13;10;54,1
P27348;P27348;14-3-3 protein theta;YWHAQ;>1433T_HUMAN|P27348|14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1);16;11;53,5
P63104;P63104;14-3-3 protein zeta/delta;YWHAZ;>1433Z_HUMAN|P63104|14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1);19;14;66,1
Q7Z2W4;Q7Z2W4;Zinc finger CCCH-type antiviral protein 1;ZC3HAV1;>ZCCHV_HUMAN|Q7Z2W4|Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP);16;16;25,2
Q8WTX9;Q8WTX9;Probable palmitoyltransferase ZDHHC1;ZDHHC1;>ZDHC1_HUMAN|Q8WTX9|Probable palmitoyltransferase ZDHHC1 (2.3.1.225) (DHHC domain-containing cysteine-rich protein 1) (Zinc finger DHHC domain-containing protein 1) (DHHC-1) (Zinc finger protein 377);5;5;14,6
Q5W0Z9;Q5W0Z9;Probable palmitoyltransferase ZDHHC20;ZDHHC20;>ZDH20_HUMAN|Q5W0Z9|Probable palmitoyltransferase ZDHHC20 (2.3.1.225) (Zinc finger DHHC domain-containing protein 20) (DHHC-20);7;6;21,9
Q96K21;Q96K21;Abscission/NoCut checkpoint regulator;ZFYVE19;>ANCHR_HUMAN|Q96K21|Abscission/NoCut checkpoint regulator (ANCHR) (MLL partner containing FYVE domain) (Zinc finger FYVE domain-containing protein 19);5;5;13
Q96DA0;Q96DA0;Zymogen granule protein 16 homolog B;ZG16B;>ZG16B_HUMAN|Q96DA0|Zymogen granule protein 16 homolog B (Precursor);3;3;21,6
